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INTRODUCTION 
 
Áñ½¢É¢ø ´ýÚ ÁÄ÷ ¿£Õ Áí¸¡Ìõ 
¦À¡ýÉ¢É¢ø «í¸¢ Ò¸ú Åª¢ Â¡¸¡Âõ 
ÁýÛ Á§É¡Òò¾¢ Â¡í¸¡Ãõ µ¦Ã¡ýÈ¡ö 
¯ýÉ¢ý ÓÊó¾ ¦¾¡Õ â¾ ºÂ§Á. 
 
-
 
Siddha system of medicine is one of the ancient system of medicine originates from 
the southern part of India by siddhars. The creation, protection, and destruction are the 
major part of this system, to appears the universe and the human. The energy for these 
actions is considered to be derived from basis of three humors of the body namely Vaatham, 
Pitham and  Iyam. This three are the fundamental principles in the composition of human 
body. Hence the derangement of  Vaatham, Pitham  and Iyam causes diseases and the 
diseases can be observed through the Naadi.  Siddha system of medicine is not only heals 
physical ailments but also heals  mental and spiritual components of human beings.  
 
Á¢¸¢Ûí Ì¨ÈÂ¢Ûõ §¿¡ö ¦ºöÔõ á§Ä¡÷ 
Åª¢Ó¾Ä¡ ¦Åñ½¢Â ãýÚ. 
- 
In the siddha system of medicine, the whole universe in turn is believed to be 
constituted of five primordial elements or Panchabootham (Earth, water, Fire, Air, and 
Space). The origin and formation of these basic elements, as well as role of these elements 
in the formation of every substance both in the universe and in humans. The nature of this 
combination to form the basis of three humors of the body.  
                                                                
-  
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In siddha system of medicine the diseases are classified as 4448. Among them the 
skin dermatological disorders  are classified into 18 types of  kuttam by siddhar  yugi 
munivar . He mentioned about kaalanjaga vaatham in the classification of vaatha diseases. 
The kuttam is a common term usually referring to the complex skin disorders. In Yugi 
chinthamani , an authentic siddha text , also described eighteen types of skin disorders   
(kuta noygal). The classical description of,  Virpodaga kuttam, and Satharu  kuttam    may 
be correlated with  kaalanjagapadai (psoriasis). 
In the text, Siddha maruthuvam sirappu, Kaalanjagapadai  is a chronic non-
infectious, recurrent, inflammatory disorder of the skin characterised by reddish, slightly 
elevated patches covered with the silvery white scales. The clinical features of 
kaalanjagapadai may be correlated to Psoriasis described in Modern dermatology. Psoriasis 
is a chronic inflammatory dermatosis that affects about 2 to 3% of the population. The 
lesions are characterised by brownish - red papules and plaques which are sharply 
demarcated and are covered with fine, silvery white scales. 
 
ÁÉ¿Äõ ÁýÛÂ¢÷ì ¸¡ì¸õ É¿Äõ 
±øÄ¡ô Ò¸Øõ ¾Õõ 
-¾¢ÕÅûÙÅ÷ 
 
The mind is the most potent tool to attain the health of the body because it allows us 
to determine how to manage our health. In this modern world 
many kinds of stress. This is affirmed by the  their literature as root cause of 
most of the diseases especially psychosomatic problems. Prevalence studies from India are 
mostly hospital-based. The prevalence of psoriasis to be 0.44% to 2.8% among the skin 
patients in India. Highest incidence was noted in the age group of 20-39 years and the mean 
age of onset in males and females were comparable.  
 
The exact cause of psoriasis remains unknown. There may be a combination of 
elements, including genetic predisposition, environmental factors, stress also a trigger for a 
psoriasis flare. Psoriasis independently associated with stress related disorders. The siddha 
system approaches diseases by holistic way to prevent and treat the condition. Hence the 
proper assessment of disease through various diagnostic tools mentioned in siddha 
literatures and with modern scientific methods.  
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Every day more number of cases reporting OPD of Ayothidoss pandithar Hospital, National 
institute of siddha. Even though, Kaalanjaga padai is non-contagious dermatological 
problems, It causes more stress to the mind of concerned persons. Some times this may 
leads to several mental depressions. Remissions and relapse of this disease is quite common 
and there is no specific treatment available in other systems of medicine. 
 
 However encouraging results are obtained in our Siddha system. With this back 
ground the disease Kaalanjaga padai was chosen for the dissertation work.  
 
Many herbal & herbo-mineral formulations practiced in siddha system of medicine 
to treat  Psoriasis and it gives immense results too. The investigator has selected the 
following drugs as trial drugs for kaalanjagapadai, 
 
Internal drug   : PARANGIPATTAI CHOORANAM 
External drug: SANGAM VER THYLAM 
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AIM & OBJECTIVES 
AIM 
 The purpose of this trial is to evaluate the efficacy of the Siddha herbal formulation 
Parangipattai Chooranam (Internal) and Sangamver Thylam (External) in the treatment of 
Kaalanjagapadai  
PRIMARY OBJECTIVE 
Parangipattai Chooranam (Internal) and 
Sangam ver Thylam (External) in the treatment of Kaalanjagapadai  
SECONDARY OBJECTIVE 
To examine the Kaalanjagapadai Siddha diagnostic methods such as Envagai 
Thervu, Neerkkuri in patients. 
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REVIEW OF LITERATURE 
 
SIDDHA ASPECTS OF KAALANJAGAPADAI 
 
In Siddha System of medicine, Skin diseases are commonly termed as Kuttam, 
Thorpini and as Sarma noi. Kaalanjagapadai (Psoriasis) is under this classification. 
 
Aetiology of Kuttam 
 
 In the text of Thirumoolar Vaithiyam : 
 
 
ÍÂ¡¾¢ì ¸¢Ãó¾¢ ÍÆø §Á¸ò¾¡ Ä¡Úõ 
ÀÂ¡¾¢ ÁñÏªô ÀÄ ÅñÊÉ¡ ¦ÄðÎõ 
¿¢Â¡¾  
 
 Six types of skin diseases are caused by venereal disease. 
 Eight types of skin diseases are caused by insect bites. 
 Four types are caused by worm infestations 
 
 Guru Naadi Nool describes Aetiology as follows: 
 
ÀÕ¸×ñÎ 
§¸ð¸¢ Ä¾ý À¢Ã¢×¾¨É ¸¢ÃÁÁ¡¸ô 
ÒØì¸Ê §À¡ø ¸¡ÏÁÐ ¸¢ÕÁ¢Â¡§Ä 
¦ºÕÁ¢ ÅÕõ À×ò¾¢Ãí¸û ¸¢ÕÁ¢Â¡§Ä 
§¾¸Á¾¢ø ¦º¡È¢ìÌð¼õ ¸¢ÕÁ¢Â¡§Ä 
ÐÕÁ¢ ÅÕï Í§Ã¡½¢¾í ¸¢ÕÁ¢Â¡§Ä 
ÝðºÓ¼ý ¸¢Ã¢¨  
 
 In the text Yugi Vaidhya Chinthamani, 
 
     
         Á¢Ìó¾ º£¾ªò¾¡Ö ÁÆüº¢ Â¡Öõ 
   ÅªõÀ§Å Áó¾ò¾¡ø Å¡ó¾¢ Â¡Öõ 
   Á¸ò¾¡É ¦Àñ§½¡Î ÁÕÅ Á¡Öõ 
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   ¸¢ªõÀ§Å ¸¢§Äíº¸û Á¢Ì¾ Ä¡Öõ 
  ¦¸ÊÂ¡É ×Ãì¸í¸ª ¨¼¾ Ä¡Öõ 
  ¾ªõÀ§Å ÁÂ¢Õ¸ü¸û ¾Å¢Î Áñ¸û 
     
 
Excessive heat and cold, laziness, excessive sexual indulgence, robbery etc. These 
habits are prominent among the factors which lower the immune mechanism of the body 
(Udal vanmai) and make the body liable to disease. Added to excessive intake of food items 
which are hard to digest, imbalanced food, and Vomiting due to Indigestion, food mixed 
with stone and hair.  
 
 The text Agasthiyar paripooranam -400 describes the Psycho social causes 
(Kanma varalaru) 
 
 
   À¡¾¸÷ìÌ ´Õ ¿¡Ùõ ¾£÷Å¾¢ø¨Ä 
 ¯ªÅ¢¨ÉÂ¡ø æ¼¡À¢ì ¦¸¡ûª Åó¾ 
 ¯ñ¨ÁÂÐ «È¢Â¡Áøã÷ì¸ï ¦ºöÅ¡÷  
 ¸ªÅ¢¨ÉÔó ¾£÷Å¾¢ø¨Ä ¸ÊÉ¦Áò¾ 
 ¸Õ¨½Ôûª âÃ½ò¾¢ø ¸ñ¸¡ðº¢ 
 «¼Å¢¨É ¿£¸¡ÏÓý¦É «¸Äî ¦º¡øÄ¢ 
  
 
  ¦ÁöÂØóÐó ¾¨Ä ÍÆÖõ ¦ÅÙìÌõ §ÁÉ¢ 
 ÀÃÁ¡É §¾¸¦ÁøÄ¡ó ¾ÊòÐ Å£íÌõ 
 À¡¾¦ÁøÄ¡õ ¦ÅÊòÐÁ¢ìÌÒñÏ ¸¡Ïõ 
 ºÃºÓ¼ý ¦º¡È¢ ¸ÃôÀ¡ý À½õ §À¡ø §¾¡Ïõ 
 ºó¨¾Â¡§Á Å¢ó¨¾¦¸Îò ¾ÊòÐ Å£íÌõ 
 À¡ÕÄ¸¢ Ä¢ó§¿¡öìÌ ÁÕ¾£Â¡§¾ 
  
 
In this text it has been mentioned that diseases which are caused due to sins 
committed in the previous birth will be cured only if Kanmam is expiated. Siddhar 
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Agasthiyar mentioned that kanmam (Genetic predisposition) is the main cause for kuttam in 
the text Kanmam kandam as follows: 
 
 §º¾¢§¸û ÁÄÃ¡¾ ÅÕõÀ ¦¸¡ö¾ø  
¾¡Ã¢ó¾ º£÷ ¦ºóÐ Å¨¾¸û ¦ºö¾ø 
 ¾¡ö ¾ó¨¾ ÁÉÐ ¦¿¡óÐ §Ã¡¸ó¾¡§É. 
¾¡¦ÉýÈ ¦¾öÅ×Õò ¾¨ÉÂÆ¢ò¾ø 
 º¡÷Å¡É ¦ÀÃ¢§Â¡÷¸û ¾¨Áô ÀÆ¢ò¾ø 
¸¡¦ÉýÈ ¿ó¾ÅÉõ âï¦ºÊ¸û ¦Åð¼ø 
 ¸ÕÁÁ¼¡ ºÃ£Ãò¾¢ü ¸¡Í §À¡§Ä 
ä¦ÉýÈ ×¼õ¦ÀøÄ¡õ ¦Á¡ðÎ ¦Á¡ð¼¡ 
 Ô¼ý ¦ÅÙòÐ Ì¨È§Â¡Ô¾¢Ãï º¢óÐõ 
Å¡¦ÉýÈ ¸ÕÁí¸û ¾£÷ôÀ¾üÌ 
  
 
 Plucking the flower buds  
 Cruetly to animals 
 Destroying statues of god 
 Abuse elderly people 
 Destroying forests and gardens 
 
Triggering Factors of Kaalanjagapadai 
 Tonsillitis  (Lasunathabitham) 
 Respiratory disorders 
 Allergic disorders 
 Stress and strain 
 Anxiety,Depression 
 Seasonal variations 
 Certain drugs (eg : Thamirachendhuram) 
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CLASSIFICATIONS: 
According to Thiru T.V.Sambasivam Pillai there are 18 types of kuttam: 
 
1.Neerkuttam-     Leprosy with serous 
exudation 
10. Viral kuraikuttam-Lepramutilans 
 2.Venkuttam   - White Leprosy 11. Sadaikuttam-Leprosy with confluent ulcers 
 3.Sorikuttam   - Psoriasis 12. Yaanaikuttam -Thick skinned Leprosy 
4.Karunkuttam  - Black Leprosy 13. Thimirkuttam -Anaesthetic Leprosy 
 5.Perumkuttam   - True Leprosy 14. Viranakuttam -Ulcerated Leprosy 
 6. Senkuttam -Macular Leprosy 15. Kaaikuttam- Nodular Leprosy 
7. Porikuttam- Leprosy with Granules 16. Azhikuttam- A form with sloughing ulcers 
 8.Viri kuttam -Leprosy with Fissures  17. Kirumikuttam -Leprosy with microbes 
 9.Yeri kuttam- Leprosy with burning 
sensation 
 18. Aarakuttam-Incurable Leprosy 
 
Classification by Dhanvanthri 
1.Kabala kuttam 10. Bamakuttam 
2. Sarmeegakuttam 11.Kagananthi kuttam 
3. Kideepakuttam 12.Sithuma kuttam 
4. Mutdhumbakuttam 13.Vibhathega kuttam 
5. Visharchigakuttam 14.Sadhariga kuttam 
6. Mandalakirakuttam 15.Vispodaga kuttam 
7. Agauvaikuttam 16.Sarmathala kuttam 
8. Thathrukuttam 17.Ven kuttam 
9. Pundareegakuttam 18.Alasa kuttam 
 
  "Å¡¾À¢ò¾î º¢§ÄüÀÉò¾¢ý Å¡¾§Ã¡¸ó ¾¡¦ÉÉ¢Ûõ 
¾£Ð Ìð¼§ÁØó ¾£Õõ Ìð¼õ À¾¢¦É¡ýÚ 
§Á¡Ðí Ìð¼õ À¾¢¦ÉðÎ¼ý§È¡Â ¨ÅÂ¢ÛüÀÅÓõ 
§À¾ìÌ½ÓÅ¢Â¡¾¢Â¢ýÓýÀ¢ÈìÌõÌ½Ó Ó¨Ãô§À§É". 
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 Classification of yugivaithyachinthamani 
 "Óò¾¡Ìí Ìð¼ó¾¡ý À¾¢¦ÉðÎìÌõ 
  ÓÉ¢Â¡É ä¸¢¿¡ý ¦º¡øÄì §¸ª¡ö 
  Òò¾¡Ìõ Òñ¼Ã£¸ Ìð¼ò §¾¡Î  
    
      º  
   ÀÃ¢Å¡É ¸÷½Ìð¼õ º¢ÌÁ Ìð¼õ 
   
   ¦¸ÊÂ¡É Áñ¼ÄÌð ¼ÓÁ¡ ¦Áý§É 
  Ìð¼Á¡õ ÀÃôÀÃ¢º Ìð¼ ¦Á¡Î  
   ÌÊÄÁ¡õ Å¢º÷îº£¸ Ìð¼ Á¡Ìõ 
  Åð¼Á¡õ ¨ÅÂ¡¾¢ Ìð¼ §Á¡Î 
   ÁÕÅÄ¡í ¸¢ËÀÌð¼ï º÷Á §¾Åõ 
  ¾¢ð¼Á¡ §¾ò¾¢Õì Ìð¼ §Á¡Î  
   º¢òÐÁ¡ Ìð¼ïº¡ ¸¡ÚÌð¼õ 
  Ðð¼Á¡ï Í§Å¾Ìð¼ó ¾ý§É¡ ¦¼¡ì¸î 
    
1. Pundareegam-Padarthamarai 10. Mandalam  -Valayaperunoi 
2. Virpodagam Koppulaperunoi 11. Abarisam  -Valiperunoi 
3. Bamam- Siranguperunoi 12. Visharchigam -Soriperunoi 
4. Gajasarmam- Yaanaitholperunoi 13. Vibhadhigam-Senkuttam 
5. Karnam- Kaadhuperunoi 14. Sarmathalam  -Tholvedippuperunoi 
6. Sikuram-Tholperunoi 15. Kidepam  - Pandritholperunoi 
7. Krishnam   - Karuperunoi 16. Thethuru   -Thadippuperunoi 
8. Avudhumbaram  Athikkaiperunoi 17. Sithuma -Naaperunoi 
  9. Sadharu  Puraiperunoi 18. Suvedham   -Venkuttam 
 
 The clinical features of Virpodagakuttam and Sadharukuttam resembles 
Kaalanjagapadai. 
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Å¢ü§À¡¼¸ Ìð¼õ 
ÒÐ¨ÁÂ¡öî ºÃ£Ã¦ÁíÌó ¾¢É×ñ ¼¡Ìõ 
¦À¡Õ¦ÅÊÂ¡öò ¾¢ì ¦¸Éò¾£ì ¦¸¡ØóÐ §À¡Ä 
¦ÁÐ¨ÁÂ¡ö Å¢ð¦¼Ã¢Ôõ ¿øÄÀ¡õÀ¢ý 
 
ÍÐ¨ÁÂ¡öÁ¢¸î ¦º¡Ã¢Ôïº¢ÅôÒÁ¡Ìõ 
àì¸¦Á¡Î ºïºÄÓõ Á¢¸ ×ñ ¼¡Ìõ 
¸Ð¨ÁÂ¡ö §¾¡¦ÄøÄ¡ó ¾ÊôÒñ¼¡Ìõ 
¸Éò¾Å¢ü§À¡¼¸Á¡É Ìð¼ó¾¡§É. 
                                     ä¸¢ ÓÉ¢ ¨Åò¾¢Â º¢ó¾¡Á½¢-800 
 
Characterized by elevated skin lesions with erythema and itching, 
Burning sensation will be present on and off. Usually these entities are 
associated with anxiety and despair. 
 
º¾¡Õ Ìð¼õ 
 
º¢ò¾¡É¾ñÊôÀ¡ö Ãò¾Å÷½õ 
¦ºØõÀî¨º ¦Åû¨ªÂ¡öî º¢ÅôÒÁ¡Ìõ 
±ò¾¡É ¦ÅÃ¢ô§À¡Î ¾¢É×Á¡Ìõ 
±ª¢¾¡É §ºðÎÁÅ¡¾ò ÐüÀò¾¢ 
Àò¾¡É ¸ÃÎ¸ðÊô ÒñÏÁ¡Ìõ 
À¡õÒ §¾¡ø §À¡üÈ¢¨ÃóÑ ÀÕòÐì¸¡Ïõ 
Å¢ò¾¡É ãì§¸¡Î ¸¡Ð ¸ýÉõ 
  
                        ä¸¢ ÓÉ¢ ¨Åò¾¢Â º¢ó¾¡Á½¢-800 
 
Characterized by skin lesions covered with silvery White scales, 
erythema, itching, burning sensation and thickness of ears, cheeks and nose. 
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Kaalanjagapadai 
Synonyms 
Venparusedhil, Sedhiluthirnoi 
 
According to the text Maruthuvam Sirappu, Kaalanjagapadai is defined as, a chronic 
non-infectious, recurrent, inflammatory disorder of the skin characterised by round 
circumscribed, erythematous, slightly elevated patches covered with silvery white scales.  
 
CLINICAL FEATURES: 
In the text,  
have been described as follows: 
The lesions are patches and macules which are red in colour with raised margin and 
the lesions are covered by silvery, White and rough thick scales. 
The patches are coin shaped over them.In some,the shape may be either round or 
oval. 
There are variations in the size and shape of patches according to the site. 
The skin lesions occur over the front and back of the elbows 
Sometimes as per the severity, it is seen all over the body. Excessive scaling and 
generalized erythema develops all over the body. 
In children this lesion may be like water drops and these may occur in scalp and 
face. 
Mild oozing will be present if flexure region (axilla,groin&infra mammary regions) 
are the involved in females. 
One fourth of patients have nail involvement like pitting and dimpling in nature  
30% of patients develop affection of joints as psoriatic arthropathy. 
                                                                        (https//en.m.wikipedia.org) 
Psoriatic arthropathy 
Kalanjapadai is often associated with painful joints known as Kalanjagavatham. It 
may affect any joint .The most often affected joints are terminal interphalangeal joints.In 
these cases, the affected fingers show nail changes.This combination is termed Psoriatic 
arthropathica. 
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Yugi muni describes the clinical features of Kaalanjagasanthuvathasoolaias follows: 
 
Prevalence of Kaalanjagapadai 
 2 - 3% of population affected by psoriasis 
 5-25 years is the commonest age group  
 Remission and relapses occur 
 Females are commonly affected than male 
 
Seasonal variations of Kaalanjagapadai 
Vaatham  
The vaatham activities increased during the period of MuthuvenilkaalamAani (june-
july), Aadi (july-august)  
 
Iyyam  
The iyyamactivities increased during the period of PinpanikaalamMaasi, (february-
march) Panguni (march-april)   
 
The signs and symptoms of Kaalanjagapadai will aggravated in above mentioned 
months. 
 
Psoriatic Arthropathy: 
 Kaalanjagapadai is often associated with painful joints known as 
Kaalanjagavaatham
inter-phalangeal joints. In these cases, the affected fingers show nail changes. This 
combination is termed   
 
Yugi muni describes the clinical features of Kaalanjagavatham as follows: 
 
  
   ÅÕòÐ ºóÐÓÚì¸¢§Â Ì¨¼óÐ ¦¿¡óÐ 
  ¿¡¾Á¡ ¿¨¼¾¡Ûó ¾¡ý¦¸¡¼¡Áø 
   ¿Ä¢óÐ§Á Ó¼Á¡¸¢ì ¸ÃÎ ¸ðÊî 
  §º¾Á¡ï º¼ó¾¡Û Á¢¸¦Å ÙòÐó 
   ¾¢É §Å¡Î º¢ÃíÌÁ¡öî §ºðÀ Á¡¸¢ì 
       ¸¡¾Á¡Â Õº¢¦Â¡Î ÁÂì¸ Á¡Ìõ 
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 The joints of fingers, feet, ankles, knees and sacroiliac are selectively affected and 
these joints are painful. The deforming erosive arthritis targets fingers and toes. Marked 
cartilage destruction and bony articulation results in loss of joint space and marked 
instability. The whole body becomes pale (anaemic). Lesions of well-defined erythematous 
papules which are sharply demarcated appear on the skin. There is also loss of taste and 
giddiness. 
 
MUKKUTTRA VERUPADUGAL: 
           Human body is influenced by three Thathus such as Vaatham, Pitham and Kabam. 
They are responsible for normal physiological conditions of the body. In Kaalanjagapadai, 
the following Mukkutram are commonly affected, 
 
Vatham 
1. Abanan  - Habitual Constipation 
2. Viyanan  - Erythematous changes in the affected areas of skin 
3. Samanan  - Due to other vaayus, it is affected 
4. Kirukaran  - Loss of appetite 
5. Devathathan - Insomnia like condition 
 
Pitham 
1. Aakkanal             - Indigestion of food 
2. Vannaeri  - Paleness of the conjunctiva and tongue 
3. Aatralangi  - Difficulty to do the routine works and sluggishness 
4. Olloli thee  - Dryness and roughness of skin  
 
Kabam 
            In case of kaalanjakapadai kabam were not affected 
 
Udalthathukkal  
 Our body consists of seven Udaltha thukkal. It gives strength and structure to our 
body. 
 
In Kaalanjagapadai patients, Saaram, Senneer and Oon are commonly affected. 
 Saaram :  Dryness, roughness, tiredness 
 Senneer :  Erythematous patches present 
 Oon  :  Fissured lesion present in few cases. 
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Udalvanmai 
 It is classified into 3 types, they are 
 Iyarkai Vanmai 
 Natural immunity of the body by birth 
 Seyarkai Vanmai 
 Improving the health by intake of nutritious food materials and medicines. 
 Kaala Vanmai 
 
 Development of immunity according to age and the environment. When the  
Udal vanmai is affected there may be possibilities of occurrence of Kaalanjagapadai. 
 
Iymporigal  
             In Kaalanjagapadai, Mei is affected. Roughness of the skin, white silvery scales is 
seen. 
 
Kanmenthriyam 
 In case of Kaalanjagapadai no abnormalities were seen in Kanmenthriyam. 
 
Piniyariyummuraimai (Diagnostic Methods) 
 Piniyariyummuraimai is the method of diagnosing disease. It is based on the 
following principles: 
 Poriyalaridhal 
 Pulanalaridhal 
 Vinaathal 
 
 Poriyalaridhal and Pulanalaridhal   
wi and  is a method of enquiring about the 
taking care of the patient, when the patient is not able to speak (or) if the patient is a child. 
 
ENVAGAI THERVUGAL (Eight tools of examination) : 
 
 
 
 Naadi (Pulse): In Kalanjagapadai, the following types of Naadi could be felt.  
They were, 
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a) Vaathapitham 
b) Vaathakabam 
c) Pithakabam 
 
Sparism: In case of Kaalanjagapadai, slightly raised well defined dry erythematous 
macules or plaques, covered with white silvery scales can be noticed in affected areas. 
Naa (tongue): In case of Kaalanjagapadai abnormality of tongue like geographical tongue 
may be noted. 
Niram(complexion): In case of Kaalanjagapadai, white patches with silvery scales could 
be noticed at affected areas. 
Mozhi (voice): In case of Kaalanjagapadai no abnormalities were observed. 
Vizhi (eye): In case of Kalanjagapadai, no abnormality was seen in Vizhi. 
Malam (stool): In case of Kalanjagapadai, constipation was reported in some cases. 
Moothiram (urine): Collection of urine for the determination of Neerkkuri and Neikkuri, is 
an important diagnostic method 
 Neerkkuri 
 Prior to the day of urine examination the patient is instructed to take a balanced diet. 
The patient should have good sleep. After waking up in the morning, the first urine voided 
is collected in a clear wide mouthed glass container and is subjected to analysis of 
Neerkkuri . In aKalanjagapadai patients, pale, yellow, 
colourless, pale yellow, straw colored, urine was noticed.  
 
 Neikkuri 
 The collected specimen (Urine) is kept open in a glass dish or china clay container. 
It is to be examined under direct sunlight, without any shaking of the vessel. 
            Then add one drop of gingelly oil without disturbing the urinary specimen and the 
neikkuri was noted in direct sunlight and conclude the diagnosis as follows,  
Character of Vaathaneer 
  
 Vaathaneer  
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Character of Pithaneer 
 
  
Character of Kabaneer 
Óò¦¾¡òÐ ¿¢ü¸¢ý ¦Á¡Æ¢Å¦¾ý  
Kabaneer  
 
Character of Thonthaneer 
 Snake in the ring, ring in the snake, snake in the pearl and ring in the pearl are the 
characters of Thonthaneer (mixed type). In Kaalanjagapadai, the Neikkuri was Vaathaneer, 
Pithaneer and Kabaneer. 
 
LINE OF TREATMENT 
 
 
    -¾¢ÕÅûÙÅ÷ 
 
 Thiruvalluvar says in 
study the cause, seek subsiding ways and do what is proper and effective. 
 
 
ÈôÀÉ¡üÜü§È  
    -¾¢ÕÅûÙÅ÷ 
 
            In Siddha system of medicine, the main aim of the treatment is to cure Udalpini and 
Manapini. Treatment is not only for perfect healing but also for prevention and 
rejuvenation. 
 
Line of treatment is as follows: 
 Neekam (Treatment) 
 Niraivu (Restoration) 
 Kaappu (Prevention) 
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Neekam (Treatment) 
 Å¢§ÃºÉõ 
 ¯ûÁÕóÐ 
 ¦Åª¢ÁÕóÐ 
 Àò¾¢Âõ 
 
Virechanam: 
 
ÅÁÉò¾¡ø À¢ò¾õ ¾¡Øõ 
 
 
 
 According to the body constitution and age of the patients, Meganathakuligai with 
hot water quantity was administered at early morning as purgative (Kazhichal Medicine) 
before starting the treatment to bring the vitiated vaatham to normal.  
 
Internal Medicine: Parangipattai chooranam, two times a day with warm water. 
External Medicine: Sangamver thylam 
 
Anubanam:  
 
É¢¾¡É ÍìÌ ïº¢ - À¢ÛÓÐ¸¡ø 
§¸¡ÁÂõÀ¡øÓ¨ÄôÀ¡ø §¸¡¦¿ö§¾ý ¦ÅüÈ¢¨Ä¿£÷ 
                  
   - 
 
Pathiyam (Dietary Regimen): 
           In mild conditions of the disease, salt and tamarind can be taken in little quantities. 
When the condition is severe, tamarind should be avoided and salt must be consumed after 
frying. 
 
 
 Àò¾¢Âí¸û §À¡É¡øÀÄý §À¡Ìõ Àò¾¢Âò¾¢ø 
 Àò¾¢Â§Á ¦ÅüÈ¢ ¾Õõ ÀñÊò÷ìÌ ¬¾Ä¢É¡ø  
  
    - 
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ÅÃÌ ¸¡Õ¼ý Å¡¨ÆÂ¢ý ¸¡¦Â¡Î 
¯¨Ã¦¸¡û À¡¸ü ¦¸ª¢üÚÁ£ý ¯ñÊÊø 
  Å¢Ã¢Å ¾¡öì  
      - 
 
   
     - 
 
Diet Restriction (Pathiyam) 
 
 Fish, crab, prawn are some sea foods should be avoided. 
 Curd, Jaggery, oil, White gram should be avoided. 
 Non vegetarian diet should be avoided.  
 Alcohol beverages should be avoided. 
 Brinjal should be avoided. 
 In severe cases tamarind should be avoided. 
 Dietary taken salt in minimum quantities.  
 
NIRAIVU: 
     Substances used for neutralizing the three humors are: 
  "´ýÈ¢Â Å¡¾ À¢ò¾ ¸ÀÁ¢¨ÅÔÂÃ¡ Åñ½õ 
  ¿ýÚÚ ¸È¢¸¦ªøÄ¡õ ¿¡Ù§Á º¨ÁôÀÃ¡öóò §¾¡÷ 
  ¾¢ýÈ¢Î Á¢ªÌ Áïºû º£Ã¸ ÓÂ÷ó¾ ¸¡Âõ 
 ¦ÅýÈ¢ ¦¸¡û Íì §¸¡§¼Äõ ¦Åó¾¢Âõ ¯ûª¢ §º÷ò§¾" 
                              -À¾¡÷ò¾ Ì½ º¢ó¾¡Á½¢ 
 
The patients are well motivated. The nature and course of the disease is explained to 
them, Life-style modification advised. 
 
Substances advised for Vaatha disease are: 
  
¾íÌ ¦ÀÕí¸¡Âò ¾Ø¾¡¨Æ - ±í¦¸íÌõ 
¸ðÎ º¢Ú ÓòÐ ¦¿ö §¸¡¾¢ø ¯Ùó¾¢¨Å¸û 
 
-À¾¡÷ò¾ Ì½ º¢ó¾¡Á½¢ 
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Honey collected during summer, pepper, gingely oil, asafoetida, castor oil and black 
gram are very useful in Vaatha disease. 
 
KAAPPU (Prevention) 
 As per siddha system the aetiology of the diseases are various. The ultimate 
speciality of siddha system is to prevent the diseases. 
 
 In the siddha classical text Patharthaguna chinthamani has given so many ideal 
measures to prevent the diseases. These are given below 
 
 ü 
 ¦Àñ½¢ýÀ¡ ¦Ä¡ý¨Èô ¦ÀÕì¸¡Áø ¯ñÏí¸¡ø 
 ¿£÷ÍÕì¸¢ §Á¡÷¦ÀÕì¸¢ ¦¿öÔÕì¸¢ ÔñÀÅ÷¾õ 
  
 
 
  «¼÷¿¡ýÌ Á¾¢ì¦¸¡Õ¸¡ü §À¾¢Ô¨È Ñ¸÷§Å¡õ 
 §¾ÚÁ¾¢ ¦Â¡ýÈ¨Ãì§¸¡÷ ¾Ã¿º¢Âõ ¦ÀÚ§Å¡õ 
   ¾¢í¸ª¨Ãì ¸¢ÃñÎ¾Ãï ºÅÃÅ¢ÕôÒÚ§Å¡õ 
Å£ÚºÐ÷ ¿¡ð¦¸¡Õ¸¡ø ¦¿öÓØì¨¸ò ¾Å¢§Ã¡õ 
   Å¢Æ¢¸Ùì¸ï ºÉãýÚ ¿¡ð¦¸¡Õ¸¡ Ä¢Î§Å¡õ 
¿¡Ú¸ó¾õ ÒðÀÁ¢¨Å ¿Î¿¢º¢Â¢ý Ó¸§Ã¡õ  
    
  
The  Siddhar Theraiyar explains above lines are the rules to maintain healthy life 
and prevent diseases. 
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MODERN ASPECT 
Anatomy of Skin 
Skin is the outermost part of the human body which covers and protects the internal 
organs injurious effects of the environment and the harmful organisms. It is made up of 
three layers of the tissue.  
 Superficial epithelial layer -The epidermis. 
 Connective tissue layer - The dermis or Corium. 
 Another Connective tissue layer loose in texture - The 
hypodermis or subcutaneous layer. 
 
It has two appendages, hair and nail, two glands sweat gland (eccrine, apocrine 
glands) and sebaceous gland. The human skin shows 2 wide variations in structure. 
1. Thick skin found in Scalp 
                                 Ear lobes 
                                 Palms 
                                 Soles. 
 
2. Thin skin over the rest of the body. 
 The average thickness of the skin is about 1 to 2 mm. 
 In the sole of the foot, palm of the hand and inter scapular 
region, it is considerably thick measuring about 5 mm. 
 Skin is very thinnest in eyelids and penis measuring about 
0.5mm only 
 
Layers of the skin 
1. Epidermis 
 The epidermis is formed of nonvascular stratified epithelium. 
 The average thickness of the skin is between 0.07 mm to0.12 mm. 
 Certain parts like the soles of the feet and the palms of the hands it is 
very thick ranging from 0.8mm to1.4mm. 
 Squamous epithelium is 10 to 11 cells thick in the palms and soles. 
 Squamous epithelium is 3 to 4 cells over the eyelids. 
 The nutrition is provided to epidermis by the capillaries of dermis. 
 It has two main system keratinizing or malpighian system (keratinocytes) 
and  pigmentary system (melanocytes)  which produces the pigment. 
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In addition of four types of cells. These are 
1. Keratinocytes 
2. Melanocytes 
3. Langherhans cell 
4. Intermittent cells 
           
In the epidermis, another unique cell known as Markel cell or Hascheiben or Touch   
cells here found at the base of epidermal ridges, which are in contact with nerve fibers, they 
are mostly present in palms, soles, nail beds, oral and genital epithelium, and act as slow 
touch receptors. 
 
LAYERS OF EPIDERMIS: 
          Epidermis layer can be made out microscopically in a section of perpendicular to the 
skin surfaces, the following 5 main layers of the epidermis. 
            These are 
1. Stratum germinatum 
2. Stratum malpighii 
3. Stratum granulosum 
4. Stratum lucidum 
5. Stratum corneum. 
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1. SRATUM  GERMINATUM: 
 This is the deepest potion of the epidermis and it is composed of 
columnar cells placed perpendicular to the skin surface, it is also 
known as basal cell layer. 
 The whole of the epidermis germinates from this stratum hence the 
 
 Any trauma to this layer would result in scarring; trauma above the 
level of this layer heals without scarring. 
 Melanoblasts or melanocytes are found in this layer. 
 Stratum germinatum contain granules of pigment called melanin. 
 
2. STRATUM  SPINOSUM: 
 It is also known as stratum malpighii or the prickle cell layer. 
 It is superficial to the basal cell layer. 
 It is composed of several layers of polyhedral cells connected to each 
other by intercellular bridges. 
 Desmosomes present in this layer only. 
 Half size desmosomes occur on the under surface on the under surface 
of the basal cells, which play an important part in the anchoring the 
epidermis and dermis. 
 All keratinocytes adhere together by desmosomes. 
 
3. STRATUM  GRANULOSUM: 
 It is superficial to the stratum malpighii 
 It is composed of flat, fusiform cells which are one to three layers thick, 
the. Cells contain irregular granules of keratohyalin and lysosomal 
enzymes and cysteine rich proteins. 
 Lamellar granules also known as odland bodies. 
 These odland  bodies take part in the waterproof barrier function of the 
epidermal permeability. 
 
4. STRATUM  LUCIDUM: 
 Superficial to the stratum granulosum. 
 It is pale, wavy looking layer known as stratum lucidum 
 It is made up of many layers of flattened epithelial cells. 
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 This layer contains retractile droplets of eleidin. 
 
5. STRATUM CORNEUM: 
 This is the most superficial layer, the outer surface of which is exposed 
to the atmosphere. 
 It is also known as horny layer. It is outer most layers and consists of 
dead cells, which are called as corneocytes. 
 It consists of many layers of non-nucleated, flattened, cornfied cells 
 It is this layer which becomes thicker with the application of intermittent 
mechanical pressure. 
 This layer is thickest in the palms of the hands and the soles of the feet, 
but thinnest on the outer surface of the lips, on the glans penis and the 
eyes. 
 
DENDRITIC CELLS OF EPIDERMIS: 
 These are melanocytes, Langerhans cells, and indeterminate cells 
 The melanocytes are the pigment producing cells and are derived in 
foetal life from neural crest. 
 The cells of Langerhans are found about the middle of epidermis. 
 The junction of epidermis and dermis is formed by basement 
membrane 
        (Basal lamina) 
 
 DERMIS: (CUTIS VERA OR CORIUM) 
           Dermis is profusely supplied with blood vessels, Thickness of dermis is 1 to 3 mm, it 
is made up of dense collagen fibres and fibroblasts. The collagen fibres contain the enzyme 
collagenase which is responsible for wound healing. 
 
             Dermis is made up of 2 layer, these are 
 
1. Superficial papillary layer 
2. Deeper reticular layer 
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SUPERFICIAL  PAPILLARY  LAYER: 
 The layer projects in to the epidermis, it contain blood vessels, 
lymphatics and nerve fibers 
 Dermal papillae are finger like projections arising from the superficial 
papillary dermis. 
 
1. DEEPER RETICULAR LAYER: 
 It is made up of reticular and elastic fibers. 
 It is found around the hair, sweat glands and sebaceous glands. 
 It also contain mast cells, Nerve ending, lymphatics and fibroblasts. 
 
APPENDAGES OF THE SKIN: 
The appendages of the skin are five these are, 
1. Sweat gland 
2. Sebaceous gland 
3. Hair 
4. Arrector pili muscle 
5. Nails. 
 
1. SWEAT GLAND: 
       These are 2 types 
i. Eccrine gland. 
ii. Apocrine gland. 
 
ECCRINE GLAND: 
 They are the ordinary, small sized 0.3 mm to 0.4 mm. 
 Sweat glands are distributed all over the skin except on the beds of 
nail, margins of lips and the glans penis 
 Over 3 million sweat gland present at birth. 
 
APOCRINE GLAND:  
 Glandular portion is very large and may measure 3 mm to 5 mm in 
diameter. 
 They occur in the axilla, areola and nipples of breasts, umbilicus, 
around the anus and the genitalia. 
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 They are specialized sweat glands, and their secretion is odoriferous 
with a secondary sexual significance. 
 
2. SEBACEOUS GLAND: 
 They are scattered all over the integument in association with the hair 
follicles. 
 They are absent from the hairless portions of the body like the palms of the 
hands, the soles of the feet. 
 The ducts of the sebaceous glands are lined by stratified squamous epithelium 
which is continuous with the external sheath of the hair, and with the 
malpighian layer of epidermis. 
 
3. HAIR: 
 Hair is fund on almost every part of the body surface except on the palms, 
soles, the dorsal surface of the terminal phalanges, the inner surface of the 
labia, the inner surface of the prepuce and the glans penis. 
 Hairs differ in length, thickness and colour in different parts of the body and 
in different races. 
 There are three types of hair, long, short, thick bristles. 
 Hair grows about 1-2 cm per month. 
 Hair follicle and its hair can be anatomically divided in to 3 segments 
                 Infundibulam 
                 Isthumus 
                 Inferior. 
 
4. ARRECTOR PILI: 
 Arrector pili muscles are the small bundles of plain muscles fibers, which is 
extend from the connective tissue sheath of the hair follicles to the epiderm 
dermal junction. 
 When these contract under the effect of cold or emotions. 
 They move the hair into a more vertical portion is called appearance of 
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5. NAILS: 
 These are semitransparent, plate like horny structure, covering the dorsal 
surfaces of the distal phalanges of the fingers and toes. 
 Nail parts are 
                     Root 
                     Nail plate 
                     Nail bed 
                     Lunula 
                     Lateral and posterior nail fold 
 
BLOOD VESSELS OF SKIN: 
 The blood supply of the skin originates from the large number of arteries 
forming anastomosis in the deepest part of the dermis. From the single 
vessels run upwards and form a second network in the upper dermis. 
 Finally terminal arterioles ascend in to the papillae ending in capillary loops, 
which drain into connective venules. 
 The blood is returned to the large veins in the subcutaneous tissues. 
 
LYMPHATICS OF THE SKIN:      
 The skin contains a rich network of lymphatics which drains in to a larger 
vessel in the hypodermis. 
 
NERVE SUPPLY OF SKIN: 
 The nerve supply of the skin consists of a motor sympathetic portion 
derived from the sympathetic ganglia. 
 Sensory spinal portion arising from the dorsal root ganglia. 
 
PHYSIOLOGY OF SKIN: 
                The skin performs a multiple of functions, though the primary function of skin is 
the protection of organs, it has many other important functions. 
 
                   These are 
1. Protective function. 
2. Sensory function. 
3. Storage function. 
4. Synthetic function. 
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5. Regulation of body temperature. 
6. Regulation of water and electrolyte balance. 
7. Excretory function. 
8. Absorptive function. 
9. Secretory function. 
10. Gaseous exchange. 
 
1. PROTECTIVE FUNCTION: 
Skin forms the covering of all organs of the body and protects these organs from the 
following factors:     
 
i. Bacteria and toxic substances 
ii. Mechanical flow 
iii. Ultraviolet rays. 
 
2. SENSORY FUNCTION: 
Skin is considered as the largest sense organs in the body. It has many nerve 
endings, which form the specialized cutaneous receptors. These receptors are stimulated by 
the sensations of touch, pain, pressure or temperature sensation and convey these sensations 
to the brain via afferent nerves. 
 
3. STORAGE FUNCTION: 
            Skin stores fat, waters, chlorides and sugar. It can also store blood by the dilatation 
of  the cutaneous blood vessels.      
 
4. SYNTHETIC FUNCTION:  
       Vitamin D3 is synthesized in skin by the action of ultraviolet rays on cholesterol. 
 
5. REGULATION OF BODY TEMPERATURE: 
            Skin plays an important role in the regulation of body temperature. Excess heat is 
lost from body through skin by radiation, conduction and evaporation. 
 
6. REGULATION OF WATER AND ELECTROLYTE BALANCE: 
        Skin regulates water balance and electrolyte balance by excreting water and salts 
through sweat. 
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7. EXCRETORY FUNCTION: 
        Skin can excrete small quantities of waste materials like urea, salts and fatty 
substances. 
 
8. ABSORPTIVE FUNCTION: 
            Skin can absorb the fat soluble substances and some ointments. 
 
9. SECRETORY FUNCTION: 
     Skin regulates sweat through sweat glands and sebum through sebaceous glands. 
Sebum keeps the skin smooth and moist. 
 
10. GASEOUS EXCHANGE: 
     A small amount of gaseous exchange through the skin. 
 
EMBRYOLOGY OF THE SKIN: 
         The whole of the skin epidermis and dermis is a unified integrated organ system, but it 
develops from two different primitive embryonic layers epidermis from the ectoderm and 
dermis from the mesoderm. 
                                              
MODERN ASPECT OF KAALANJAGA PADAI (PSORIASIS) 
 
INTRODUCTION: 
             The word psoriasis is derived from the Greek word  meaning  
. It has been known since ancient times and was originally considered a type of 
leprosy, It is one of the most common human skin diseases. 
         
Psoriasis was considered to be a chronic inflammatory dermatosis, it is now 
considered a multifactorial disorder that has several factors like genetic predisposition, 
Environmental, immunologically mediated inflammation and several modifying factors 
including obesity, Trauma, infection are involved in psoriasis. 
 
DEFINITION: 
           It is a common chronic and non-infectious skin disorder, characterized by dry 
erythematous plaques, well defined slightly raised covered by a white silvery scales typical 
in extensor distribution, it affects all over the body.     
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EPIDEMIOLOGY: 
1. PREVALANCE: 
 It has distributed in world wide. 
 Fairly common in the tropical countries. 
 It is pandemic in temperate climate.  
 Attacks are more common in winter than summer. 
 Natural tendency to clear up with the warm weather. 
 A fair number of attacks develop in the monsoon. 
 It affects 0.6%-4.8% of people worldwide. 
 150,000-260,000 new cases of psoriasis are diagnosed each year. 
 About 400 people die from complications caused by psoriasis every 
year. 
 About 11% patients have psoriatic arthritis. 
 Plaque type is most common in 80% of psoriasis patients.  
 
2. AGE OF ONSET: 
1.  First peak of onset between 20-30 yrs. 
2.  Second peak of onset between 50-60 yrs. 
3. Early onset family history present. 
4. Late onset family history is not present. 
 
3. SEX: 
 Men and women are equally affected. 
 
4. SEASON: 
 Most patients worse in winters. 
 
AETIOLOGY:  
1. The exact cause is unknown- AUTOIMMUNE DISEASE   
2. Stress. 
3. Disturbed fat metabolism. 
4. Hormonal imbalance. 
5. Septic focus. 
6. Allergy. 
7. Anxiety states. 
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8. Lowered response of the cyclic AMP system to prostaglandin E1 in 
epidermis. 
9. Mental trauma. 
10. Fever. 
11. Digestive upsets. 
12. Physical injury: 
 Scratches. 
 Surgical incisions and injuries. 
 
13.  Infection: 
 - Hemolytic streptococcal infection- precipitates guttate lesions. 
 HIV infection-Explosive psoriasis. 
 
14. Heredo familial and Genetic factors: 
 Increased in familial cases. 
 Greater concordance in monozygotic twins (70%) 
 Dizygotic twins (30%) 
 Increased association of HLA- CW6 20 times increased risk with early 
onset of psoriasis. 
 
PRECIPITATING FACTORS: 
  
 Psychological stress. 
 Hot water bathing 
 Skin dryness. 
 Obesity. 
 Local Pressure. 
 HIV 
 Trauma. 
 Purines in the diet. 
 Identical twins. 
 Immune system reacting to skin cells. 
 Microbes. 
i. Staphylococcal aureus 
ii. Candida albicans. 
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 Drugs: 
i. Anti-malarial drugs. 
ii. Lithium. 
iii. Beta adrenergic blockers drugs. 
iv. NSAID drugs. 
v. Corticosteroid withdrawal may aggravate psoriasis.(Pustular 
psoriasis) 
 
PATHOGENESIS OF PSORIASIS:  
Psoriasis appears to be largely a disorder of keratinization 
 
The basic defect is rapid replacement of epidermis in psoriatic lesion. 
3 to 4days instead of 28 days in normal skin. 
 
There are marked vascular changes in upper dermis in the form of 
Recently the   presence of abnormal neural cells has been demonstrated in 
Psoriatic plaques. 
                               
PATHOGENESIS OF PSORIASIS 
 Psoriasis was long considered either a disorder of keratinocytes growth or a 
chronic inflammation. 
 Advancement in immunologic techniques and in genetic analyses has resulted 
in a reappraisal of the pathophysiology involved. 
 Psoriasis consider as an organ specific autoimmune disease that is triggered by 
an activated cellular immune system and it similar to other immune mediated 
disease. 
 The definition of autoimmune disease as 
activation of T cells and B cells, or both, in the absence of an ongoing 
 
 Pathogenesis of psoriasis still poses a challenge to the scientific community to 
once and for all, establish how and why it occurs and consequently to develop 
the magic drug to treat it.   
 Psoriasis is an immunological disease, characterized by interplay of 
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I. Immunological factors. 
II. Cellular components. 
III. Signalling molecules. 
IV. Biochemical changes. 
V. Histological changes. 
 
                                These are plays major role in pathogenesis. 
 
I. IMMUNOLOGICAL FACTORS IN PSORIASIS:  
                  Both innate or acquired immune changes are thought be responsible for the     
Development of psoriatic plaques 
 
Different types of helper T subsets, dendritic cells, plasmacytoid dendritic cells as 
well as Langerhans cells have been found to play a role in psoriasis. 
 
T cells plays important role in psoriasis 
 
Autoimmunity as a major factor in pathogenesis. 
 
The presence of T cells in the inflammatory infiltrate in psoriatic plaque obviously 
Indicated in immune mediated or an autoimmune basis for the 
Pathogenesis of psoriasis. 
 
II. CELLULAR COMPONENTS IN PATHOGENESIS OF PSORIASIS:   
           Cellular components are 
a) T cells 
b) Keratinocytes 
c) Langherhans   
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CELLULAR COMPONENTS OF PSORIASIS 
 
A. T CELLS: 
 T cells play a key role, with the epidermal T cells being CD8+ & Dermal 
cells being CD4+. 
  These cells include memory T cells, natural killer cells T cells& Th17& 
Th22. 
 Th17& Th22 cells which are subsets of CD4+ cells are now considered 
important in pathogenesis of the psoriatic plaque. 
 They are stimulated by IL-23 & respectively produce IL-17& IL-22 
which mediate dermal inflammation and epidermal hyperplasia. 
 
B. KERATINOCYTES: 
 Keratinocytes cells express transcription factor STAT- 3, which may 
be pathogenic. 
 
C. LANGERHANS CELLS: 
 Langherhans cells secrete cytokines, which are mitogenic and 
chemotatic. 
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III. SIGNALLING MOLECULES IN PATHOGENESIS OF PSORIASIS: 
 Include cytokines growth factors like interleukins, Chemokines, 
 
 Characterized by up regulation of Th1 cytokines and reduction of anti-
inflammatory cytokines IL-10. 
 Other important molecules include TNF- IL-15, IL-17, IL-22 and IL-23 
 
IV. BIOCHEMICAL CHANGES IN PATHOGENESIS OF PSORIASIS: 
 Cyclic nucleotide increased levels in cGMP or decreased levels of camp.  
 Arachidonic acid level is increased and it metabolites. 
 Polyamines also increased in levels. 
 PROTEINASE: increased in levels of plasminogen activator and their 
inhibitors. 
 Calmodulin also increased in levels. 
 
V. HISTOLOGICAL  CHANGES IN PATHOGENESIS OF PSORIASIS: 
 Epidermal changes is increased epidermal proliferation in two ways  
 One is increased growth fraction from normal of 30 to 100% in psoriasis. 
 2nd is shortened epidermal turn over time from normal of 60 to10 days in 
psoriasis. 
 Important changes seen in dermal layer. 
 Include dilated and tortuous capillary loops and proliferation of 
fibroblasts. 
 
35 
 
MOST COMMON SITES: 
        AREAS COMMONLY AFFECTED: 
 Scalp 
 Back of elbows 
 Front of knees and legs 
 Lower part of the back of the trunk 
 
        MAY ALSO BE AFFECTED: 
 Nail 
 Sole 
 Palm 
 
        RARELY AFFECTED: 
 Mucus membrane 
 
CLINICAL FEATURS OF PSORIASIS:   
 Typical distribution is extensor 
 Lesions are bilaterally symmetrical 
  Typical coin shaped lesion 
 Big plaques of the size of palm of the hand 
 The lesions are slightly raised above the surface of skin 
 Absence of itching 
 But itching present in tropical countries 
 Slight or moderate purities present 
 Secondary psychogenic stress present 
 Secondary lichenification present 
 Scalp is involved almost all cases 
 No matting of hair 
 Nail also involved 3types of lesion 
I. Pitting 
II. Seperation of nail from the nail bed and walls 
III. Thickening of the nail and collection of hyperkeratotic debris 
under the nail. 
 The palms of the hands and soles of the feet also involved in patches of 
hyperkeratosis and fissures on erythematous bases. 
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IMPORTANT SIGNS OF PSORIASIS: 
1. Candle grease  sign. 
2. Auspitz sign. 
3.  phenomenon. 
 
1. CANDLE GREASE  SIGN : 
         Psoriatic lesion is scratched with the point of a dissecting forceps a candle 
grease  like scale can be repeatedly produced even from the non scaling lesions this 
is called candle grease  sign. 
 
2. AUSPITZ  SIGN: 
        The complete removal of scale produces pin point bleeding.  
 
3.  
            Psoriatic lesions may develop along the scratch lines in the active phase this is 
called  phenomenon. 
 
SITES OF PREDILECATION OF PSORIASIS:     
 Lesions are usually bilaterally Symmetrical. 
 Favours pressure points are extensor surface of 
 Elbows 
 Knee  
 Scalp 
 Fore head 
 Nape of neck 
 Trunk 
 Buttocks 
 Lumbosacral region                                                                             
 Periumblical area    
 Palms and soles. 
 
 Usually with lesions at other sites, but sometimes in isolation. 
 Infrequent involvement of photo exposed sites, involvement of face uncommon 
and indicates refractory psoriasis. 
 Intertriginous involvement in flexural psoriasis. 
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CLINICAL TYPES OF PSORIASIS: 
CLASSIFICATION: 
 
                    Psoriasis is classified based on its onset, evolution and morphology into    
1. Chronic plaque psoriasis (psoriasis vulgaris) 
2. Acute guttate psoriasis 
3. Pustular  psoriasis 
 
1. CHRONIC PLAQUE PSORIASIS: 
                    There are several variants of chronic plaque psoriasis 
 
A) MORPHOLOGICAL VARIANTS: 
a) Small plaque psoriasis 
b) Rupioid psoriasis 
c) Para psoriasis 
 
B) VARIATION OF MORPHOLOGY DUE TO SITE: 
a) Flexural psoriasis 
b) Annular psoriasis 
c) Scalp psoriasis(Corona psoriatica) 
d) Penile psoriasis 
e) Psoriasis of palms and soles (psoriasis inverses) 
 
 ASSOCIATIONS OF PSORIASIS: 
In a patient with chronic psoriasis, always check for nails and joint involvement. 
a) Psoriatic nails 
b) Musculoskeletal system(Psoriasis arthopathica) 
c) Metabolic syndrome. 
 
1. CHRONIC PLAQUE PSORIASIS(CPP):  
         Chronic plaque psoriasis is the commonest form of psoriasis     
 
MORPHOLOGY: 
                 The prototype lesion of CPP is a mildly itchy papule which is 
 Well demarcated 
 Erythematous - Deep pink to red 
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 White silvery scales, but is profuse adherent in elephantine 
 Indurated and raised. 
 Size and number of lesions variable 
  phenomenon +ve 
 Auspitz sign +ve 
 
A) MORPHOLOGICAL VARIANTS: 
 
a) SMALL PLAQUE PSORIASIS(SPP): 
 Smaller 1- 2cm lesions 
 Resemble like guttate psoriasis 
 SPP occurs in older patients 
 It is scalier and has a more chronic course. 
 
b) RUPINOID PSORIASIS: 
 Lesions with heaped up scales so appear conical 
 Scales are firmly adherent to the underlying skin look like limpet 
 Lesions  
 Characterized by HLA B27 +ve, Antecedent infection, Arthritis, 
Conjunctivitis, Keratoderma blennorrhagicum. 
 
c) PARA PSORIASIS: 
 Para psoriasis is a group of rather infrequent, idiopathic and 
asymptomatic erythrodermic or scaly papule dermatoses.  
 It is a non specific reaction pattern of the skin which may represent an 
intermediary stage of psoriasis. 
 
B) VARIATION OF MORPHOLOGY DUE TO SITE:  
a) FLEXURAL PSORIASIS: 
 Commonly occurs in elderly females, because lesions are present in 
moist friction prone areas. 
 Lesions are well defined and erythematous (Salmon pink) 
 Occurs in flexure like the axilla, inframammary folds, vulva and gluteal 
cleft. 
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b) ANNULAR PSORIASIS: 
 The central clearing of the circular lesions produces ringed lesion. 
 
c) SCALP PSORIASIS: 
 Lesions may occur along the scalp border is called corona psoriatica. 
 Sharply defined, indurated, scaly plaques present. 
 Scaling looks like Asbestos, especially on the occipit. 
 
d) PENILE PSORIASIS: 
 In uncircumcised males, scaling is absent on glans but lesions continue 
to be erythematous and well defined. 
 In circumcised patients, the lesions on the glans are similar to psoriatic 
lesions. 
 
e) PSORIASIS OF PALMS AND SOLES:                 
 Lesions are bilaterally symmetrical (Psoriasis inversus) 
 Lesions are well defined, Symmetrical, erythematous, thick plaques 
with white silvery scales may be profuse or minimal. 
 
2. ACUTE GUTTATE PSORIASIS: 
 Occurs in children and adolescents 
 May be precipitate by streptococcal tonsillitis 
 Lesions appear in several crops of small, erythematous papules with 
minimal scaling 
 Side of predilection is trunk. 
 
3. PUSTULAR PSORIASIS: 
 It occurs mostly in withdrawal of topical or systemic steroids 
 LOCALIZED: In  chronic plaque psoriasis, when plaques are 
surrounded with pustules 
 Pustules and crusts are seen on distal part of fingers and in nail bed 
 GENERALISED: Is a serious condition 
 Constitutional symptoms like high fever, chills and tachypnea seen 
 Is characterized by generalized fiery red Erythema followed by 
appearance of waves of tiny. 
 Appearances of new pustules as the old ones are crusting. 
40 
 
ASSOCIATION OF PSORIASIS: 
 
NAIL PSORIASIS:      
                       
 Nail changes due to 
                    Nail matrix psoriasis 
                    Nail bed psoriasis 
 Nail matrix psoriasis: Manifests as pitting 
 Nail bed psoriasis: Nail plate thickening, subungual hyperkeratosis, 
discoloration and dystrophy of nail plate, oncholysis and oil spots are 
specific for psoriasis. 
 
A. MUSCULOSKELETAL SYSTEM (PSORIASIS ARTHOPATHICA): 
 Dactylitis and enthesitis is typically seen there are also seen 5 clinical 
patterns seen these are 
                  Asymmentrical oligoarthritis 
                  Symmetrical rheumatoid arthritis 
                  Distal inter phalangeal arthritis 
                  Arthritis mutilans 
                  Axial arthritis 
 
B. METABOLIC SYNDROME: 
            In patients with psoriasis, there is an increased prevalence of 
 Hypertension 
 Diabetes mellitus (Insulin resistance) 
 Obesity 
 Dyslipidemia 
 Coronary artery disease 
 
COMPLICATIONS 
 Complications of psoriasis may include the following: Secondary infections, 
Psoriatic arthritis, possible increased risk of lymphoma, cardiovascular disease, ischemic 
heart disease, and Mitral valve prolapse. Among these, Psoriatic arthritis is a major 
complication. (  Volume 64, Issue suppl 2) 
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Psoriatic arthritis facts 
 About one in 10 people with psoriasis also develop inflammation of joints (psoriatic 
arthritis). 
 The first appearance of the skin disease (psoriasis) can be separated from the onset 
of joint disease (arthritis) by years. 
 Psoriatic arthritis belongs to a group of arthritis conditions that cause inflammation 
of the spine (spondylo arthropathies). 
 Patients with psoriatic arthritis can develop inflammation of tendons, cartilage, eyes, 
lung lining, and, rarely, the aorta. 
(Ref: http://www.medicinenet.com/psoriatic_arthritis/article.htm) 
 
Risk for psoriatic arthritis: 
 Affecting men and women equally, about 10% to 30% of people with psoriasis 
develop psoriatic arthritis. Psoriatic arthritis may develop at any age, but usually affects 
people between the ages of 30 and 50. While the cause is not known, genetic factors, along 
with the immune system likely play a role in determining who will develop the disorder. 
 
 As many as 40% of people with psoriatic arthritis have a family history of skin or 
joint disease. Having a parent with psoriasis triples the chance of getting psoriasis yourself 
and thus increases the chance of developing psoriatic arthritis. 
 
Different types of psoriatic arthritis: 
 There are five types of psoriatic arthritis. It is important to know which type of 
psoriatic arthritis you have and to understand the characteristics so that it may be treated 
properly. 
 
Symmetric psoriatic arthritis:  
 Symmetric arthritis affects the same joints usually in multiple matching pairs on 
opposite sides of the body. Symmetric psoriatic arthritis can be disabling, causing varying 
degrees of progressive, destructive disease and loss of function in 50% of people with this 
type of arthritis. Symmetric psoriatic arthritis resembles rheumatoid arthritis. 
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Asymmetric psoriatic arthritis:  
 Asymmetric arthritis typically involves one to three joints in the body large or small 
such as the knee, hip, or one or several fingers. Asymmetric psoriatic arthritis does not 
affect matching pairs of joints on opposite sides of the body. 
 
Distal interphalangeal predominant (DIP):  
 It involves primarily the small joints in the fingers and toes closest to the nail. DIP 
psoriatic arthritis is sometimes confused with osteoarthritis, a chronic disease that causes the 
deterioration of joint cartilage and bone as well as bone spurs at the joints. 
 
Spondylitis:  
 Spondylitis affects the spinal column and may cause inflammation and stiffness in 
the neck, lower back, spinal vertebrae, or sacroiliac region (pelvic area), making motion 
difficult. Spondylitis also can attack connective tissue, such as ligaments, or cause arthritic 
disease in the joints of the arms, hips, legs, or feet. 
 
Arthritis mutilans:  
 Arthritis mutilans is a severe, deforming, and destructive form of psoriatic arthritis 
that primarily affects the small joints in the fingers and toes closest to the nail. This leads to 
lost function of the involved joints. It also is frequently associated with lower back and neck 
pain. Fortunately, this type of psoriatic arthritis is rare.  
 
(Ref: http://arthritis.webmd.com/psoriatic-arthritis/default.htm). 
 
SEVEARITY OF PSORIASIS: 
 A PASI score is a tool used to measure the severity and extant of psoriasis 
(Psoriasis area and severity index), it takes few minutes and experience to 
calculate it accurately. 
 A representative area of psoriasis is selected for each body region. The 
intensity of redness, thickness, scaling of the psoriasis is assessed as none (0) 
, mild(1), moderate(2), severe(3), very severe(4). 
  The percentage area affected by psoriasis is evaluated in the four regions of 
the body. In each region the area expressed as nil(0), 1-9%(1), 13-29(2), 30-
49%(3), 50-69%(4), 70-89%(5), 90-100%(6). 
 Head and neck, upper limbs, trunk, lower limbs calculations for area, each of 
the body area scores is multiplied by the area affected.  
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DIFFERENTIAL DIAGNOSIS 
Nummular eczema 
  Rounded, circular desquamative erythematous lesions covered with vesicles, crusts, 
and scales, very itchy. Patients have whether atopic or allergic diathesis. Epicutaneous 
allergy tests are frequently positive. 
 
Pityriasis rubra pilaris  
 In typical cases follicular papules and infiltrating scales are observed as well as 
typical hyperkeratosis. 
Lichen simplex chronic 
This disease shows dry and itchy oval plaques and resembles psoriasis as a shape 
but not have silvery scales Auspitz and candle signs. And shows violaceous tint. 
 
Pityriasis alba  
It shows a white plaque, like psoriasis but have not an erythema. It has been seen 
only face.  Psoriasis usually affects more than one area of the body. Red skin covered with 
greasy-looking white or yellowish scales. 
 
HISTOPATHOLOGICAL CHANGES  
EPIDERMAL CHANGES: 
 Parakeratosis 
 Loss of granular layer and regular acanthosis 
 Supra papillary thickening 
 Collection of polymorphs in the epidermis to form spongiform pustule of 
 
 
DERMAL CHANGES: 
 Dilatation and tortuosity of capillary loops in the dermal papillae 
 Lymphocytic infiltrate in the upper dermis is seen. 
 
HISTOLOGICAL CHANGES: 
 Thinning of supra papillary portion of stratum malpinghii 
 Elongation of ridges 
 Oedema and clubbing of papillae seen in histological study. 
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HISTOCHEMICAL CHANGES: 
 Histochemical studies have revealed an increase in both oxidative and 
anaerobic metabolism with increased pentose, glycon, purines, sulphydral 
groups, soluble proteins increased in level. 
 Decreased in activity of dipeptidases. 
 It has been discovered that apparently normal skin of both the psoriatics and 
their relations show these changes in miniature is called latent psoriasis. 
 
RADIOLOGICAL CHANGES: 
 . Simultaneous presence of ankylosis, periosteal new bone formation, 
erosions and osteolytis are strongly suggestive of psoriatic arthritis. 
 
RULE OUT OTHER TEST FOR PSORIASIS: 
 Metabolic syndrome, diabetes, hypertension and dyslipidemia 
 Hypocalcaemia especially in pustular psoriasis 
 Anaemia and hypoproteinemia in erythrodermic psoriasis. 
 
DIAGNOSIS OF PSORIASIS 
 There are no laboratory tests which will positively identify psoriasis. The blood 
count, Urine analysis, ESR and other hematologic chemical and serologic studies are within 
normal limits in most cases of psoriasis. 
 
The diagnosis of psoriasis is based upon: 
1. The family history of psoriasis 
2. The typical distribution of the lesions on the scalp, elbows, knees, the front of the 
legs, back and nails 
3. Well-defined non-indurated dry erythematous areas with silvery layer-upon-layer 
scaling 
4. The candle  grease sign (when a psoriatic lesion is scratched with the point of a 
dissecting forceps, a candle-grease-like scale can be repeatedly produced even from 
the non-scaling lesions. This is CG sign) 
5. Auspitz sign (Complete removal of a scale produces pin-point bleeding) 
6.  phenomenon (Psoriatic lesions may develop along the scratch lines in the 
active phase) 
7. Little or no itching 
8. History of previous attacks and seasonal variations of the disease. 
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TREATMENT OF PSORIASIS PATIENTS: 
                 Depending on the type of psoriasis, various therapeutic options are available 
 Topical agents like liquid paraffin, petroleum gel, vegetable oils etc. 
 Systemic agents like Methotrexate, Acitretin, and Cyclosporine. 
 Corticosteroids mostly in cream base. 
 Photochemo therphy and phototherapy in PUVA methods. 
 Biological response modifiers used in treatment of psoriasis. 
 
DIET FOR PSORIASIS PATIENTS: 
TO TAKE: 
1. All green leafy vegetables. 
2. Low consumption of animal fats and the quantity of food. 
3. High protein diet 
4. Fish and sea foods 
5. Carrot 
6. Tomatoes 
7. Grains. 
 
TO AVOID: 
1. Oil foods. 
2. High fat diet 
3. Alcohol 
4. Junk foods 
5. Red meat 
6. Dairy products 
7. Night shade vegetables 
8. Citrus fruits 
9. Gluten protein in diet 
10. Condiments. 
 
PROGNOSIS: 
 A permanent cure is not yet known 
 Individual attacks can, almost always controlled satisfactorly 
 Disease non infectious 
46 
 
 The disease does not leave scar 
 Flexural, erythrodermic and pustular psoriasis take longer to heal than 
the typical variety 
 The palmar and nail lesions are rather resistant to treatment. 
 Patient suffer from the disease on and off throughout their lives. 
 Complications in psoriasis are infrequent. 
 
MANAGEMENT: 
 The general health of the patient should be maintained. 
 
either body (or) mind. 
 A moderate, warm climate, frequent sunbaths before the onset of the 
winter, and visits to sulphur springs, all of which are useful in bringing 
down the relapse rate. 
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DRUG REVIEW 
Preparation of trial drugs:   Internal medicine    -Parangipattai chooranam   
Ingredients: 
Parangi pattai (Smilax china)                                      - 175 grams (5 Palam) 
 
Ammukkara ver (Withania somnifera)                          
Sangam kuppi ver (Azima tetracantha)                      
Siru pirappan kizhangu (Calamus rotang)                   
Kondrai pattai (Cassia fistula)                                       -35grams (1 Palam)    
Saaranai  ver (Trianthema decandra)                              
Kodiveli ver (Plumbago zeylanica)                              
 
Adhimadhuram (Glycyrrhiza  glabra)                         
Koththa malli (Coriandrum sativum)                                  
Omam (Trachyspermum  ammi)                                           
Adhividaiyam (Aconitum heterophyllum)                         
Vaal milagu (Piper cubeba)                                               
Vendhayam (Trigonella  foenum-graecum)                    
Sitraraththai (Alpinia  officinarum)                                
Akkara kaaram (Anacyclus pyrethrum)                      
Thippili (Piper longum)                                                             15.3grams (3 Kazhanju) 
Saadhikkai (Myristica fragrans)                                  
Saadhipathiri (Myristica fragrans)                             
Kiraambu (Syzygium aromaticum)                           
Karuncheeragam (Nigella sativa)                               
Seeragam(Cuminum cyminum)                
Chukku (Zingiber officinalae)                                             
Milagu (Piper nigrum)                                                           
 Paal  ( Milk)                                         -  5.3 lit (4 Padi)      
Sarkarai  (Sugar)                                     - An half the amount of chooranam.                             
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EXTERNAL MEDICINE: SANGAMVER THYLAM 
Ingredients: 
Sangam kuppi ver (Azima tetracantha)                    - 875 grams (1/4 Thulaam) 
Milagu (Piper nigrum)                                                     
Karuncheeragam (Nigella sativa)                                
Maasikkai (Quercus  infectoria)                               -   35 grams  (1 Palam) 
Ealam ( Elettaria cardamonum)                                    
Neer ( Water)                                                             -   21.5 lit ( 1 Dhuni) 
Nallennai (Gingelly oil)                                             -   1.34 lit (2 Padi) 
Paal ( Milk)                                                                -  As per requirement 
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PROPERTIES OF TRIAL DRUGS 
 
INTERNAL MEDICINE: PARANGIPATTAI CHOORANAM 
 
1. PARANGIPATTAI 
  Botanical name             - Smilax china 
  English name             -  China root 
  Family                    -  Liliaceae    
 
Organoleptic characters 
  Taste                                    -  Inippu 
  Potency                                -  Thatppam 
  Division                               - Inippu 
 
General properties 
                  ¾¡¸õ ÀÄÅ¡¾ó ¾¡Ð¿ð¼õ ÒñÀ¢ª¨Å 
                  §Á¸ ¸¢Ãó¾¢ Å£úãÄó-§¾¸Ó¼ý 
                  Ìð¨¼ À¸ó¾§Áü ¦¸¡ûÅÁÉõ §À¡õÀÈí¸¢ô 
                  Àð¨¼Â¢¨É ÔîºÃ¢òÐô À¡÷. 
                                       - §¾¨ÃÂ÷ Ì½Å¡¸¼õ 
Actions 
 Alterative 
 Anti-syphilitic 
 Aphrodisiac 
 Depurative 
Chemical constituents 
 Sarsaponin 
 Parallin 
 Stigmasterol 
 Daucosterol 
 Isoeryl-S-methyl-cysteamine sulphoxide 
 
2. AMMUKKARA VER 
Botanical name                     - Withania somnifera 
English name                       -  Winter cherry 
Family                                 -  Solanaceae 
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Organoleptic Characters 
Taste                                     -  Kaippu 
Potency                                 -  Veppam 
Division                                -  Kaarppu 
 
General properties 
           ¦¸¡ïºó ÐÅ÷ôÀ¡í ¦¸¡ÊÂ¸Âõ Ý¨ÄÂÃ¢ 
           Á¢ïÍ¸Ãô À¡ýÀ¡ñÎ ¦ÅôÀ¾ôÒ-Å¢ïº¢ 
           Ó¸Í×Ú §¾¡¼Óõ§À¡ §Á¡¸õ «É Öñ¼¡õ 
           «ÍÅ¸ó ¾¢ì¦¸ýÈÈ¢. 
                        - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Actions 
 Diuretic 
 Tonic 
 Febrifuge 
 Alterative 
 Aphrodisiac 
 
Chemical constituents 
 Somniferine 
 Withanine 
 Perinponyine 
 Tropine 
 Anahygrine 
 
3.SANGAMKUPPI VER 
Botanical name               - Azima tetracantha 
English name                  - Misteletoeberry thorn 
Family                            -  Salvadoraceae 
 
Organoleptic charecters 
Taste                               - Kaippu 
Potency                          - Veppam 
Division                          - Kaarppu 
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General properties 
          Å£ì¸õ ¸ÃôÀ¡ý Å¢¾¡¸õ ¸¢Ãó¾¢ÌýÁõ 
          °ì¸Á¢Ì Ý¨ÄÅ¡ö §Å¡ÎÀ¢ò¾ò-¾¡ìÌÅ¢¼õ 
          Å£Ú§Á¡ ¸ñÐÄíÌõ Å£ÍÀº¢ Ãò¾Óñ¼¡õ 
          ÜÚºí¸õ §ÅÃ¢¨Ä ¸ðÌ. 
                  - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Actions 
 Diuretic 
 Anti-periodic 
 Tonic 
 Expectorant 
 Stimulant 
 
Chemical constituents 
 Azimine 
 Maltol 
 Benzyl chloride 
 Furancarboxaldehyde 
 
4. SIRUPPIRAPAN KIZHANGU 
Botanical name           - Calamus rotang 
English name               - Cane 
Family                          - Arecaceae 
 
Organoleptic characters 
Taste                        -  Kaarppu 
Potency                     - Veppam 
Division                      - Kaarppu 
 
General properties 
              ¾ó¾§Ã¡ ¸ò¨¾ò ¾½¢Â¡¾ Å¡¾ò¨¾ 
              ¯óÐÝ ¨Äô À¢Êô¨À §Â¡ðÎí¸¡ñ-ÅóÐ 
              ¸ÃôÒó ¾¢ÈôÒ¦ÁÉì ¸¡ðÎ¿¨¸ Á¡§¾ 
              À¢ÃôÀí ¸¢Æí¸¾¨Éô §ÀÏ. 
                   - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
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Chemical constituents 
 Saponins 
 Alkaloids 
 Flavanoids 
Actions 
 Expectorant 
 Anti-vatha 
 
5. KONDRAI PATTAI 
Botanical name                 - Cassia fistula 
English name                    - Pudding pipe tree 
Family                               - Fabaceae 
 
Organoleptic characters 
Taste                                   - Thuvarppu 
Potency                               - Veppam 
Division                              -  Kaarppu 
 
General properties 
  Ìð¼õ ¸¢ÕÁ¢ ¦¸¡ÎïÝ¨Ä Å¡¾¨ÁÂõ 
                  Ðð¼ ÁÄÁÕº¢ àô§À¡õ-¾ðÊ 
                  ÍÃì¸¢ýÈ §À¾¢ Ôñ¼¡õ Ðöì¸ò ÐÅ÷ìÌõ 
                  ºÃì¦¸¡ý¨Èì ¸¡Ã½í§¸ º¡üÚ. 
                                -  «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Fistulic acid 
 Rhein 
 Tryphtophan 
 Aspartic acid 
 Glutamic acid 
 Leucine 
 Glucose 
 Argenine 
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Actions 
 Laxative 
 Vermifuge 
 Febrifuge 
 
6. SAARANAI VER 
Botanical name            - Trianthema decandra 
English name               - Horsepurslane 
Family                          - Aizoaceae 
 
Organoleptic characters 
Taste                              - Kaippu 
Potency                          - Veppam 
Division                         - Kaarppu 
 
General properties 
º£¾ï ºÄ§¾¡¼ó §¾Áø¾ ØõÒÌýÁõ 
Å¡¾ï º¢Úº¢Ãí Åý§Á¸õ - µ¾Ã¢Â 
¸¡ºÓ¾ø §¿¡¦ÂøÄ¡í ¸¡ýº¡ È¨¼ì¸¢Æí¸¡ø 
¿¡ºÓÚ ¦Áý§È ¿Å¢ø. 
- «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Tanins 
 Flavanoides 
 Ethyl acetate 
 Glucose 
Actions 
 Expectorant 
 Diuretic 
 Laxative 
7. KODIVELI VER 
Botanical name               - Plumbago indica 
English name                  - Ceylon lead -wort 
Family                             - Plumbaginaceae 
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Organoleptic characters 
Taste                 - Kaarppu 
Potency                   - Veppam 
Division                     - Kaarppu 
 
General properties 
              ¸ðÊÅ¢Ã½í¸¢Ãó¾¢ ¸¡ø¸û «¨ÃÂ¡ôÒ 
              ¸ðÊîÝ ¨ÄÅ£ì¸í ¸¡úãÄõ-ÓðÊÃò¾ì 
              ¸ðÎ¿£ §ÃüÈí ¸Éò¾ ¦ÀÕÅÂ¢Úõ 
              «ðÎí ¦¸¡Ê§ÅÄ¢ Â¡õ. 
       - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Plumbagic acid 
 Methylester 
 Lupeol 
 Uridine 
 
Actions 
 Anti-periodic  
 Diaphoretic 
 Tonic 
 Stomachic 
 
8. ATHIMATHURAM  
BOTANICAL NAME            -  Glycyrrhiza glabra 
ENGLISH NAME                  -  Liquorice root 
FAMILY                                -  Fabaceae 
 
Organoleptic characters 
Taste                                        - Inippu 
Potency                                    -  Seetham 
Division                                   - Inippu 
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General properties 
                               ¸ò¾¢Ã¢ ÓôÀ¢½¢Â¡ø ÅÕÒñ ¾¡¸ 
                ¸ñ§½¡ö ¯ý Á¡¾õÅ¢ì¸ø ÅÄ¢¦ÅñÌð¼õ 
                À¢ò¾õ¦ÁÖõ ÒÕì¸¢ ¸¢Ã¢îºÃõ ¬Å÷ò¾ 
                À¢ò¾Á¾ ã÷î¨º Å¢¼ À¡¸õ 
- §¾¨ÃÂ÷ Ì½Å¡¸¼õ 
Actions 
 Emolient 
 Demulcent 
 Mild expectorant 
 Tonic 
 
Chemical constituents: 
 Glycyrrihizin 
 Liquiritigenin 
 Liquiritin 
 Iso liquiritigenin 
 Formonetin 
 Licuraside 
 
9. KOTHAMALLI 
Botanical name                        - Coriandrum sativum 
English name                           - Coriander seeds 
Family                                      - Umbelliferae 
 
Organoleptic characters 
Taste                                          - Kaarppu 
Potency                                     - Seethaveppam 
Division                                    -  Kaarppu 
 
General properties 
               ¦¸¡òÐÁøÄ¢ ¦ÅôÀõ Ìª¢÷¸¡öîºøÀ¢ò¾Áó¾ï 
               º÷ò¾¢Å¢ì¸ø ¾¡¸¦Á¡Î ¾¡¦Á¡Î ¾¡Ð¿ð¼õ-Íò¾§ÂØõ 
               Å¡¾ Å¢¸¡÷Á¼÷ Åý¸÷ò¾ À¢Å¢Ã½õ 
               â¾Äò¾¢ø Ä¡¾¸üÚõ §À¡Üú 
- «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
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Chemical constituents 
 Gnaphaloside 
 Quercetin 
 Rutin 
 Luteolin 
 Coriandrones 
Actions 
 Stomachic 
 Stimulant 
 Diuretic 
 Carminative 
 
10.OMAM 
Botanical name                      - Trachyspermum ammi 
English name                         -  
Family                                   - Apiaceae 
 
Organoleptic characters 
Taste                                      - Kaarppu 
Potency                                 -  Veppam 
Division                                -  Kaarppu 
 
General properties 
              º£¾ÍÃí ¸¡ºï ¦ºÃ¢Â¡Áó ¾õ¦À¡ÕÁø 
              §À¾¢Â¢¨Ãî ºø¸ÎôÒ §ÀÃ¡Áõ-µ¾¢ÕÁø 
              Àø¦Ä¡ÎÀø ãÄõ À¸Á¢¨Å§¿¡ ¦Âý¦ºÔ§Á¡ 
              ¦º¡ø¦Ä¡Î§À¡õ µÁ¦ÁÉî ¦º¡ø 
- «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Essential oil 
 Thymol 
 Caravacrol 
 Camphene 
 Pinene 
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Actions 
 Stomachic 
 Anti-spasmodic 
 Antiseptic 
 Tonic 
 Stimulant 
 
11. ADHIVIDAYAM 
Botanical name                     -  Aconittum heterophyllum 
English name                        -  Indian atis root 
Family                                   - Ranunculaceae 
 
Organoleptic characters 
Taste                                        - Kaippu 
Potency                                    - Veppam 
Division                                   -  Kaarppu 
 
General properties 
         «¾¢Å¢ ¼Âõº÷ì¸ Ã¡üÒ¾§¿¡ö ¦ÅôÒ 
         ¦¸¡¾¢ÁÕ× §À¾¢¦Â¡Î §¸¡¨Æ-±¾¢÷Å¡ó¾¢ 
         ±ýÚ¨ÃìÌõ §¿¡öìÜð¼õ øÄ¡ ¾¸üÈ¢ 
         Ìý¨È ¿¢¸÷Ó¨ÄÂ¡ö ÜÚ. 
                       - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Atisine 
 Hetisine 
 Heterophylline 
 Atisenol 
Actions 
 Stomachic 
 Astringent 
 Febrifuge 
 Tonic 
 Anti periodic 
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12. VAAL MILAGU 
Botanical name              - Piper cubeba 
English name                 - Tailed  pepper 
Family                            - Piperaceae 
 
Organoleptic characters 
Taste                                 - Kaarppu 
Potency                            - Veppam 
Division                           - Kaarppu 
 
General properties 
Å¡¾À¢ò¾ ³Âõ ÅÂ¢üÚ ÅÄ¢¾¡¸ï 
º£¾õ ÀÄ§¿¡ö º£¨¾Ôí¸¡ñ-§À¡¾ 
«¾¢¾£ ÀÉÁ¡õ «½í¸Ã§º ¿¡Ùó 
Ð¾¢Å¡ø Á¢ª¸Õó¾î ¦º¡ø. 
                            - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
 
Chemical constituents 
 Sesqirterpenehydrocarbons 
 Piperenol 
 Zeylenol 
 Cyclohexane 
 
Actions 
 Stimulant 
 Diuretic 
 Expectorant 
 Carminative 
13.VENTHAYAM 
Botanical name                      -  Trigonella foenum 
English name                         - Fenugreek 
Family                                    - Fabaceae  
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Organoleptic characters 
Potency                - Thatppam 
Division               -  Kaarppu 
 
General properties 
             À¢ò¾×¾¢Ãõ§À¡Ìõ §ÀÃ¡ì¸½í¸Ùõ§À¡õ 
             «ò¾¢ÍÃó ¾¡¸õ «¸Öí¸¡ñ-¾òÐÁ¾¢ 
             §Å¸ ÕÁ¦Ä¡Î Å£Ú ¸Âõ ¾½¢Ôõ 
             §À¡¸ÓÚõ ¦Åó¾Âò¨¾ô §À¡üÚ. 
                          - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Diosgenin 
 Tigogenin 
 Neotigogenin 
 Vitexin 
 Luteolin 
Actions 
 Refrigerant 
 Laxative 
 Tonic 
 Diuretic 
 Emollient 
 
14. SITRARTHAI 
Botanical name           - Alpinia officinarum 
English name          - Galangal the lesser 
Family                        - Zingiberaceae 
 
Organoleptic characters 
Taste                             -  Kaarppu 
Potency                         - Veppam 
Division                        -  Kaarppu 
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General properties 
                 Å¡¾À¢ò ¾í¸ÃôÀ¡ý Å¡¾ï º¢§Ã¡§Ã¡¸ï 
                 §º÷ó¾¸À Óò§¾¡¼ï º£¾¦Á¡Î-§¿÷ó¾ÍÃõ 
                 ÁüÈÃò¨¾ì ¸¡ðÊ ÅÕÁ¢ÕÁÖó¾£Õõ 
                 º¢üÈÃò¨¾ ÅýÁÕó¾¡ø §¾÷ 
                                - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Essential oil 
 Limonene 
 Cineol 
 Linalool 
 Cedrol 
 Eugenol 
Actions 
 Expectorant 
 Febrifuge 
 Stomachic 
 
15. AKKARAKARAM  
Botanical name           -  Anacyclus pyrethrum 
English name            -  Pellitory of spain 
Family                        -  Asteraceae 
 
Organoleptic characters 
Taste                  -  Kaarppu 
Potency            -  Veppam 
Division            -  Kaarppu 
 
General properties 
                 «ì¸Ã ¸¡Ãõ «¾ý§À÷ ¯¨Ãò¾ì¸¡ø 
                 ¯ì¸¢Ã¸¡ø «ò§¾¡¼õ µÎí¸¡ñ-Óì¸¢ÂÁ¡ö 
                 ¦¸¡ñ¼¡ø ºÄõ °Úõ ¦¸¡õÀ¨É§Â ¾¡¸ÍÃõ 
                 ¸ñ¼¡ø ÀÂó§¾¡Îí ¸¡ñ 
                    - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
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Chemical constituents 
 Volatile oil 
 Anacyclin 
 Pellitorine 
 Pyrethrin 
Actions 
 Stimulant 
 Sialogogue  
 
16.THIPPLI 
Botanical name      - Piper longum 
English name           - Long pepper 
Family                      -  Piperaceae 
 
Organoleptic characters 
Taste                    -  Inippu 
Potency                 - Thatppam 
Division                - Inippu 
 
General properties 
                 ¸ðÊ ¦Â¾¢÷¿¢ýÚ ¸Î§¿¡¦Âø Ä¡õÀ½¢Ôõ 
                 ¾¢ðÊ Å¢¨ÉÂ¸Öõ §¾¸¦Áò¾-ÒðÊÂ¡õ 
                 Á¡ÁÛìÌ Á¡Á¦ÉÉ ÁüÈÅ÷ìÌ ÁüÈÅÉ¡í 
                 ¸¡Á¦ÁÛó ¾¢ôÀ¢Ä¢ìÌõ ¨¸. 
- §¾¨ÃÂ÷ Ì½Å¡¸¼õ 
 
Chemical constituents 
 Caryophyllene 
 Piperine 
 Sesamine 
 Pipernonaline 
 Piplasterol 
Actions 
 Stimulant 
 Carminative 
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17. SAADHIKKAI 
Botanical name                         - Myristica fragrans 
English name                            -  Nut meg 
Family                                      -  Myristicaceae 
 
Organoleptic characters 
Taste                               -  Thuvarppu 
Potency                            - Veppam   
Division                                -  Kaarppu 
 
General properties   
               ¾¡Ð ¿ð¼õ §À¾¢ ºÕÅ¡º¢ Âïº¢Ã §¿¡ö 
               µÐÍÅ¡ ºí¸¡ºõ ¯ð¸¢Ã½¢- §Å§¾¡ 
               ÊÄì¸¡ö ÅÕõÀ¢½¢§À¡õ ²üÈÁÂø À¢ò¾í 
               ÌÄì¸¡ö ÂÕóÐÅ÷ìÌì ÜÚ 
                       - §¾¨ÃÂ÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Dimeric phenylpropanoids 
 Myricetin 
 Essential oil 
 Fixed oil  
Actions 
 Stimulant 
 Aromatic 
 Tonic 
 Aphrodisiac 
18. SAATHIPATHIRI 
Botanical name        - Myristica fragrans 
English name          - Arillus of  the  nut 
Family                  - Myristicaceae 
 
Organoleptic characters 
Taste                                 - Kaarppu,Thuvarppu 
Potency                             - Veppam  
Division                             - Kaarppu 
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General properties 
                º¡¾¢¾Õõ Àò¾¢Ã¢ìÌò ¾¡Àî ÍÃó¾½¢Ôõ 
                µÐ¸¢ýÈ À¢ò¾õ ¯ÂÕí¸¡ñ -¾¡ÐÅ¢÷ò¾¢ 
                Ôñ¼¡í ¸¢Ã¸½¢§Â¡ §¼¡¾ì ¸Æ¢îºÄÚõ 
                Àñ¼¡í Ì¨È§Â À¸÷. 
                           - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Eugenol 
 Sabinene 
 Myristicin 
 Elemicine 
Actions 
 Carminative 
 Aphrodisiac 
 Stimulant 
 Hypnotic 
19. KIRRAMBU 
Botanical name                 - Syzygium aromaticum 
English name                   -  Cloves 
Family                              - Myrtaceae 
 
Organoleptic characters 
Taste                                   - Kaarppu  
Potency                              - Veppam 
Division                             - Kaarppu 
 
General properties 
                À¢ò¾ ÁÂì¸õ §À¾¢§Â¡Î Å¡ó¾¢Ôõ §À¡õ 
                Íò¾Å¢Ãò ¾ì¸ÎôÒó §¾¡ýÚ§Á¡-¦Áò¾ 
                ÄÅí¸í ¦¸¡ñ¼ÅÕì §¸ü Í¸Á¡Ìõ 
                ÁÄÁí§¸ ¸ðÎ ¦ÁÉ Å¡úòÐ 
                                   - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
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Chemical constituents 
 Caryophyllene oxide 
 Eugenol acetate 
 Methyl palmitate 
 Eugenine 
 Acetophenone 
 Proppyl benzoate 
Actions 
 Anti-spasmodic 
 Carminative 
 Stomachic 
 
20. KARUNCHEERAGAM 
Botanical name                   -  Nigella sativa 
English name                      -  Black cumin 
Family                                 -  Ranunculaeae 
 
Organoleptic characters 
Taste                                      - Kaippu 
Potency                                 -  Veppam 
Division                                -  Kaarppu 
 
General properties  
              ¸Õïº£Ã Ã¸ò¾¡ý ¸ÃôÀ¦É¡Î ÒñÏõ 
              ÅÕïº¢Ã¡öô À£¿ºÓ Á¡üÚõ-«Õó¾¢É¡ø 
              ¸¡öîºø ¾¨ÄÅÄ¢Ôí ¸ñÅÄ¢Ôõ §À¡ÓÄ¸¢ø 
              Å¡öîº ÁÕó¦¾É§Å ¨Å 
                                                         - §¾¨ÃÂ÷ Ì½Å¡¸¼õ 
 
Chemical constituents 
 Nigellinine 
 N-oxide 
 Nigellicine 
 N-oxide 
 Fatty acids 
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Actions     
 Diuretic 
 Stomachic 
 Emollient 
 Anthelmintic 
 Parasiticide 
 
21. SEERAGAM 
Botanical name          - Cuminum cyminum 
English name              - Cumin seeds 
Family                       - Apiaceae 
 
Organoleptic characters 
Taste                       - Kaarppu,Inippu 
Potency                      - Thatpam 
Division                  - Inippu 
 
General properties 
             À¢ò¾¦ÁÛ Áó¾Ã¢¨Âô À¢ýÉô ÀÎò¾¢ÂÅý 
             ºòÐÕ¨Å ÔóÐÈóÐ º¡¾¢òÐ-Áò¾¦ÉÛõ 
             Ã¡º¨ÉÔ Á£¦ÅýÚ ¿ñÀ¨Éô ÀÄÀÎò¾¢ 
             §À¡ºÉÌ §¼¡Ã¢¦ºÔõ §À¡÷ 
                           - §¾¨ÃÂ÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Cuminin 
 Terpinene 
 3, 5-Dihydroxy flavone 
 Luteoline 
 Apigenin 
Actions 
 Anti-spasmodic 
 Astringent 
 Anthelmintic 
 Carminative 
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22. CHUKKU 
Botanical name         -  Zingiber officinale 
English name              - Dried ginger 
Family                     -  Zingiberaceae 
  
Organoleptic characters 
Taste                -  Kaarppu 
Potency               - Veppam 
Division                  - Kaarppu 
 
General properties 
 
                Ý¨ÄÁó¾õ ¦¿ï¦ºÃ¢ôÒ §¾¡¼§Áô ÀõÁÆ¨Ä 
        ãÄõ ¨ÃôÀ¢ÕÁø ãìÌ¿£÷-Å¡Ä ¸À 
        §¾¡¼Á¾¢ º¡Ãó ¦¾¡¼÷Å¡¾ ÌýÁ¿£÷ò 
        §¾¡¼õ¬ Áõ§À¡ìÌï ÍìÌ. 
                     - §¾¨ÃÂ÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Gingerols 
 Dihydrogingerol 
 Gingerdione 
 Hexaahydrocurcumin 
Actions 
 Anti-emetic 
 Anti-spasmodic 
 Anti-inflammatory 
  Antiperiodic 
 Carminative 
 Antiperiodic 
 
23. MILAGU 
Botanical name         -  Piper nigrum 
English name            - Black pepper 
Family                       - Piperaceae 
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Organoleptic characters 
Taste                    -  Kaippu,Kaarppu 
Potency                 - Veppam  
Division                - Kaarppu 
 
General properties 
              º£¾ÍÃõ À¡ñÎ º¢§ÄòÁí ¸¢Ã¡½¢ÌýÁõ 
              Å¡¾õ «Õº¢À¢ò¾õ Á¡ãÄõ-µÐºýÉ¢ 
               
              ¿¡ºí ¸È¢Á¢ª¸¢É¡ø 
                     - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Chavicine 
 Piperidine 
 Isochavinic acid 
 Methyl caffeic acid 
Actions 
 Acrid 
 Carminative 
 Antiperiodic 
 Resolvent 
 Stimulant 
 Antidote 
 
24.SUGAR 
Botanical Name          -  Saccharum officinarum. Linn 
English Name          -  Sugar cane 
Family                       -  Poaceae 
 
Organoleptic character 
Taste                    -  Sweet 
Potency                 -  Coolent  
Division                   -  Sweet 
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General properties:  
º£É¢î º÷ì¸¨ÃìÌò ¾£Ã¡¾ ÅýÍÃÓí 
ÜÉ¢ìÌõ Å¡¾ò¾¢ý ÜðÎÈ×õ -²É¢ÕìÌõ 
Å¡ó¾¢ ¦Â¡Î¸¢ÕÁ¢ Á¡È¡¾ Å¢ì¸Ö§Á 
§À¡ó¾¢¨º¨Â Å¢ðÎô ÒÃñÎ. 
- «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
 
Actions: 
 Antiseptic 
 Demulcent 
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EXTERNAL MEDICINE:  SANGAM VER THYLAM 
 
1. SANGAMKUPPI VER 
Botanical name                - Azima tetracantha 
English name                   -  Salvadoraceae     
Family                              - Misletoberry thorn 
 
Organoleptic characters  
Taste                   -  Kaippu 
Potency                      - Veppam 
Division                    - Kaarppu 
 
General properties  
              Å£ì¸õ ¸ÃôÀ¡ý Å¢¾¡¸õ ¸¢Ãó¾¢ÌýÁõ 
              °ì¸Á¢Ì Ý¨ÄÅ¡ö §Å¡ÎÀ¢ò¾ò-¾¡ìÌÅ¢¼õ 
              Å£Ú§Á¡ ¸ñÐÄíÌõ Å£ÍÀº¢ Ãò¾Óñ¼¡õ 
              ÜÚºí¸õ §ÅÃ¢¨Ä ¸ðÌ.  
                        - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Azimine 
 Azcarpine 
 Carpine 
 High cone of N-methyl glucosinolate 
 Neoascorbigen 
 High concentration of N-methoxy -3-indolylmethyl-
glucosinolate 
Actions 
 Diuretic 
 Antiperiodic 
 Tonic 
 Expectorant 
 Stimulant 
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2. MILAGU 
Botanical name        - Piper nigrum 
English name             - Black pepper 
Family                       - Piperaceae 
 
Organoleptic characters 
Taste                       -  Kaippu,Kaarppu 
Potency                     - Veppam  
Division                      - Kaarppu 
 
General properties 
                º£¾ÍÃõ À¡ñÎ º¢§ÄòÁí ¸¢Ã¡½¢ÌýÁõ 
                Å¡¾õ «Õº¢À¢ò¾õ Á¡ãÄõ-µÐºýÉ¢ 
                 
                ¿¡ºí ¸È¢Á¢ª¸¢É¡ø 
                              - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Chavicine 
 Piperidine 
 Isochavinic acid 
 Methyl caffeic acid 
Actions 
 Acrid 
 Carminative 
 Antiperiodic 
 Resolvent 
 Stimulant 
                                                                 
3. KARUNCHEERAGAM 
Botanical name              - Nigella sativa 
English name                 - Black cumin 
Family                            - Ranunculaeae 
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Organoleptic characters 
Taste                               - Kaippu 
Potency                           -  Veppam 
Division                          - Kaarppu 
 
General properties  
              ¸Õïº£Ã Ã¸ò¾¡ý ¸ÃôÀ¦É¡Î ÒñÏõ 
              ÅÕïº¢Ã¡öô À£¿ºÓ Á¡üÚõ-«Õó¾¢É¡ø 
              ¸¡öîºø ¾¨ÄÅÄ¢Ôí ¸ñÅÄ¢Ôõ §À¡ÓÄ¸¢ø 
              Å¡öîº ÁÕó¦¾É§Å ¨Å 
                           - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
 Chemical constituents 
 Nigellinine 
 N-oxide 
 Nigellicine 
 N-oxide 
 Fatty acids 
Actions 
 Diuretic 
 Stomachic 
 Emollient 
 Anthelmintic 
 Parasiticide 
 
4. MAASIKKAI 
Botanical name              - Quercus infectoria 
English name                 -  Oak galls 
Family                            -  Fagaceae 
 
Organoleptic characters 
Taste                              - Thuvarppu 
Potency                          -  Thatppam 
Division                          - Kaarppu 
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General properties 
            «ì¸Ãí¸û §À¡ì¸¢Å¢Îõ Á¡È¡¾ ¦ÅôÀ¸üÚõ 
            ¦ÁöìÌÚ¾¢ Á¡º¢ì¸¡ö ¦Áý§ÁÖõ-¾ì¸¦¾¡Õ 
            À¡Ä÷¸½ §¿¡ö§À¡ìÌõ Àý§Á¸ Óó¦¾¡¨ÄìÌõ 
            §ÅÄ¨ÉÂ ¸ñ½¡ö Å¢ªõÒ 
                          - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Tanic acid 
 -Sitosterol 
 Amentoflavone 
 Hexamethyl ether 
 Methyl olenate 
Actions 
 Astringent 
 Styptic 
 Tonic 
 
5. EALAM 
Botanical name         - Electtaria cardamomum 
English name             -  Lesser cardamom     
Family                         -  Zingiberaceae 
 
Organoleptic characters 
Taste                         - Kaarppu 
Potency                   - Veppam 
Division                    -  Karppu 
 
General properties  
              ¦¾¡ñ¨¼ Å¡ö¸×û ¾¡ÖÌ ¾í¸ª¢ø 
              §¾¡ýÚõ §¿¡Â¾¢ º¡ÃõÀý §Á¸ò¾¡ø 
              ¯ñ¨¼ §À¡ø±Øí ¸ðÊ ¸¢Ã¢îºÃõ 
               
              Àñ¨¼ ¦Åì¨¸ Å¢¾¡¸§¿¡ö ¸¡ºÓõ 
              À¡Øï §º¡Áô À¢½¢Å¢óÐ ¿ð¼Óõ 
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              «ñ¨¼ Â£¨ªÅý À¢ò¾õ ¨Åì¦¸øÄ¡õ 
              ¬Ä Á¡í¸Áú ²Ä ÁÕó¾§¾ 
 
Chemical constituents 
 Alpha-terpinyl acetate 
 Limonene 
 Terpinolene 
 Linalyl acetate 
 myrcene 
Actions 
 Stimulant 
 Carminative 
 Stomachic 
 
6. NALLENNAI (GINGELLY OIL) 
ELLU 
Botanical name           - Sesamum indicum 
English name              - Sesame  
Family                        - Pedaliaceae      
 
Organoleptic characters 
Taste                          - Inippu 
Potency                      - Veppam 
Division                     - Inippu 
 
General properties 
                    ±ûÙÁÕó ¨¾ì¦¸ÎìÌõ ±ÈÉÄ¡ó ¾¢ñ¨Á¾Õõ 
           ¯ûª¢¨Ä¨Âî §º÷ìÌõ ¯¾¢Ãò¨¾ò-¾ûÙÁ¢Õ 
           ¸ñÏì ¦¸¡ª¢¦¸¡ÎìÌí ¸¡ºÓñ¼¡õ À¢ò¾ÓÁ¡õ 
           ÀñÏì ¸¢¼÷ÒÃ¢Ôõ À¡÷ 
                          - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents 
 Sesamolin 
 Seasangolin 
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 Seasamolinal 
 Seasomol 
 r-tocopherol 
Actions 
 Diuretic 
 Laxitive 
 Lactogogue 
 Tonic 
 
S MILK) 
 
GENERAL PROPERTIES: 
À¡Ä÷¸¢ÆÅ÷ ÀÆïÍÃ§¾¡÷ Òñ½¡ª¢  
Ý¨ÄÂ÷ §Á¸ò§¾¡÷ Ð÷ÀÄò§¾¡÷ ²ÖÁ¢Å÷ 
±øÄ¡÷ìÌ Á¡Ìõ ¨ªò¾Å÷ìÌìï º¡¾¸Á¡ö 
¿øÄ¡ö ÀÍÅ¢ýÀ¡ø ¿¡ðÎ.  
 
 It is a good nutritive supplement for new born, young adults and older adults. It 
cures vatha diseases, veneral diseases, and also useful in the treatment of emaciated 
individuals. 
 
Other aspects about milk 
 Milk is a translucent white liquid produced by the mammals, a pH ranging from 6.4 
ion for young 
peptides, Vitamins, phospholipids and fatty acids. 
 
Nuttrients in milk 
                             Biotin 
                             Pantothenic acid 
                             Iodine 
                             Selenium 
                             Thaiamine 
                             Vitamin D 
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MATERIALS AND METHODS 
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS NGIPATTAI  
  (EXTERNAL) IN 
THE TREATMENT OF  (PSORIASIS) 
 
STUDY DESIGN:  
 STUDY TYPE               :  An open clinical trail 
 STUDY PLACE            :   Ayothidoss Pandithar Hospital,  
           National Institute of Siddha, 
           Tambaram   Sanatorium, Chennai - 47. 
 STUDY PERIOD          :  12 Months 
              SAMPLE SIZE             :  40 patients  (20 Patients in OPD and 20 Patients in IP) 
 
STANDARD OPERATING PROCEDURE: 
SOURCE OF RAW DRUGS: 
 
  The required raw drugs for the trial medicines were purchased from a well reputed 
raw drug shop and the raw drugs were authenticated. After that the raw drugs were purified 
as per siddha  literatures authority by Medicinal Botany , and then the trial drugs were 
prepared in the Gunapadam laboratory of National Institute of Siddha by following 
Standard operating Procedures. 
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Preparation of trial drugs:   Internal medicine    -Parangipattai chooranam   
 Ingredients: 
Parangi pattai (Smilax china)                                      - 175 grams (5 Palam) 
Ammukkara ver (Withania somnifera)                          
Sangam kuppi ver (Azima tetracantha)                      
Siru pirappan kizhangu (Calamus rotang)                   
Kondrai pattai (Cassia fistula)                                       -35grams (1 Palam)    
Saaranai  ver (Trianthema decandra)                              
Kodiveli ver (Plumbago zeylanica)                              
Adhimadhuram (Glycyrrhiza  glabra)                         
Koththa malli (Coriandrum sativum)                                  
Omam (Trachyspermum  ammi)                                           
Adhividaiyam (Aconitum heterophyllum)                         
Vaal milagu (Piper cubeba)                                               
Vendhayam (Trigonella  foenum-graecum)                    
Sitraraththai (Alpinia  officinarum)                                
Akkara kaaram (Anacyclus pyrethrum)                      
Thippili (Piper longum)                                                             15.3grams (3 Kazhanju) 
Saadhikkai (Myristica fragrans)                                  
Saadhipathiri (Myristica fragrans)                             
Kiraambu (Syzygium aromaticum)                           
Karuncheeragam (Nigella sativa)                               
Seeragam(Cuminum cyminum)                
Chukku (Zingiber officinalae)                                             
Milagu (Piper nigrum)                                                           
 Paal  ( Milk)                                                                           -  5.3 lit (4 Padi)      
Sarkarai  (Sugar)                                                      - An half the amount of chooranam.                      
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METHOD OF PURIFICATION OF RAW DRUGS: 
Parangipattai (Smilax china)                             
 Clean it with white cloth then peel of the outer layer of Parangi pattai root 
bark.(Ref:sigicha rathina theebam:28)     
Chitiramoolam ver (Plumbago zeylanica) 
   Remove the inner nerve of the root and powder the outer part of root. Take a pot 
with milk and its mouth is covered with white cloth then the powder over it and closed it 
with another vessel.Gently heat it for 3 hours then dry and grind (Ref:sigicha rathina 
theepam :29) 
Amukkara ver  (Withania somnifera) 
Take a pot with milk and its mouth is covered with white cloth then the powder over 
it and closed it with another vessel.Gently heat it for 3 hours then dry and grind (Ref:sigicha 
rathina theepam :29) 
Sangam kuppi ver (Azima tetracantha)  
Take a pot with milk and its mouth is covered with white cloth then the powder over 
it and closed it with another vessel.Gently heat it for 3 hours then dry and grind (Ref:sigicha 
rathina theepam :29) 
Saaranai  ver (Trianthema decandra)        
       Take a pot with milk and its mouth is covered with white cloth then the powder over it 
and closed it with another vessel.Gently heat it for 3 hours then dry and grind (Ref:sigicha 
rathina theepam :29) 
Siru pirappan kizhangu (Calamus rotang) 
Clean it with white cloth then peel of the outer layer .(Ref:sigicha rathina 
theebam:28)     
Kondrai pattai (Cassia fistula)       
Clean it with white cloth then peel of the outer layer .(Ref:sigicha rathina 
theebam:28)   
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Saadhipathiri (Myristica fragrans) 
 Remove the dust particle and dried. . (Ref:sigicha rathina theepam :29) 
Kiraambu (Syzygium aromaticum)   
 Remove the dust particle and dried   . (Ref:sigicha rathina theepam :29) 
Adhimadhuram (Glycyrrhiza  glabra)               
  Clean with water ,peel of the outer layer. (Ref:sigicha rathina theepam :30) 
Millagu (Piper nigrum) 
 Soak in the buttermilk for three hours then dried and powdered (Ref: Sigicha Rathina 
Theepam :28) 
Vaal milagu (Piper cubeba)       
 Soak in the buttermilk for three hours then dried and powdered (Ref: Sigicha Rathina 
Theepam :28)                         
Karuncheeragam (Nigella sativa)   
 Dried for six hours and powdered. ( ref: sarakku sudhi sei muraigal :6)  
Seeragam( Cuminum cyminum)                          
 Dried for six hours and powdered. ( ref: sarakku sudhi sei muraigal :6)  
Thippili (Piper longum)  
 Soak in the lemon juice then dried and powdered (Ref: Sigicha Rathina Theepam :29)  
Koththa malli (Coriandrum sativum)                                                 
 Soak in the lemon juice then dried and powdered (Ref: Sigicha Rathina Theepam :29)  
Chukku (Zingiber officinalae)      
 Soak in the diluted sodium carbonate water then dried and powdered (ref: sarakku 
sudhi sei muraigal :6 
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Omam (Trachyspermum  ammi)   
 Soak in the diluted sodium carbonate water then dried and powdered (ref: sarakku 
sudhi sei muraigal :6 
Vendhayam (Trigonella  foenum-graecum)    
 Soak in the vinegar then dried and powdered (Ref: Sigicha Rathina Theepam :29) 
Akkara kaaram (Anacyclus pyrethrum)     
 Remove the dust particle and dried   . (Ref:sigicha rathina theepam :29) 
Sitraraththai (Alpinia  officinarum)       
 Remove the dust particle and dried   . (Ref:sigicha rathina theepam :29) 
Adhividaiyam (Aconitum heterophyllum)                        
 Remove the dust particle and dried   . (Ref:sigicha rathina theepam :29) 
 
METHOD OF PREPERATION: 
 
The above mentioned first seven ingredients are dried, and make it into the fine 
powder. Take required quantity of milk in pot, the top of the pot covered with cloth. The 
fine powdered placed over the cloth and it closed by another pot. Allowed to boil the milk. 
Then the fine powder mixed with the remaining part of powdered ingredients. Finally add 
sugar which is half the amount of powder. Then the medicine stored in an air tight 
container.  
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EXTERNAL MEDICINE: SANGAMVER THYLAM 
Ingredients: 
Sangam kuppi ver (Azima tetracantha)                    - 875 grams (1/4 Thulaam) 
Milagu (Piper nigrum)                                                     
Karuncheeragam (Nigella sativa)                                
Maasikkai (Quercus  infectoria)                               -   35 grams  (1 Palam) 
Ealam ( Elettaria cardamonum)                                    
Neer ( Water)                                                             -   21.5 lit ( 1 Dhuni) 
Nallennai (Gingelly oil)                                             -   1.34 lit (2 Padi) 
Paal ( Milk)                                                                -  As per requirement 
 
METHOD OF PREPARATION:  
 First prepare decoction of Sangam ver. Grind other drugs with the use of milk and 
make it into karkam. Then the karkam mixed with Sangamver decoction and added oil. 
Then boiled till it attained the suitable consistency and filter it. 
 
DRUG STORAGE:  
The trial drug Parangipattai chooranam is stored in clean and dry container. 
Sangamver Thylam is stored in clean and dry narrow mouthed bottles. 
 
DISPENSING: 
The Chooranam is given in packets and oil is given in bottle 
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INGREDIENTS OF THE INTERNAL MEDICINE: 
 
PARANGIPATTAI CHOORANAM 
 
1. PARRANGI PATTAI                                                      2.AMUKKARA VER 
      
 
 
 
 
 
 
 
 
 
 
3. SIRUPIRAPAN KIZHANGU                                            4.SANGAMVER 
                                        
 
 
 
 
 
 
 
 
 
 
 
 
5.KONDRAIPATTAI                                                                6. SAARANAI VER 
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7.KODIVELI VER                                                            8. ATHIMATHURAM 
 
 
 
 
 
 
 
 
 
 
 
] 
 
9. KOTHAMALLI                                                                               10.OMAM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11.ATHIVIDAYAM                                                                      12. VAAL  MILAGU 
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13. VENTHAYAM                                                                14.SIRRARATHAI 
 
 
 
 
 
 
 
 
 
 
 
 
 
15. AKKARAGARAM                                                                    16. THIPPLI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 17. SAATHIKKAI                                                              18.SAATHIPATHIRI 
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          19. KIRAMBU                                                                   20.SEERAGAM 
                                            
 
 
 
 
 
 
 
 
 
 
 
21. KARUNCHEERAGAM                                                    22. SUKKU 
 
 
 
 
 
 
 
 
 
 
 
 
 
23. MILAGU                                                                       24. SARKKARAI 
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INGREDIENTS OF EXTERNAL MEDICINE  
 
SANGAM VER THYLAM 
 
 
1.SANGAM VER                                                            2. MILAGU 
                                          
 
 
 
 
 
 
 
 
 
 
 
 
3. KARUNCHEERAGAM                                                    4. ELAM 
 
 
 
                                                                                              
 
 
 
 
 
 
 
                                                                  
6. NALLENNAI  
5. MAASIKKAI 
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7. MILK 
 
 
 
 
 
 
 
INTERNAL MEDICINE - PARANGIPATTAI CHOORANAM 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SANGAMVER THYLAM -EXTERNAL MEDICINE 
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 SUBJECT SELECTION: 
Patients reporting with symptoms of inclusion criteria were subjected to screening 
test and documentation. 
INCLUSION CRITERIA 
 Age : 16-60 years 
 Sex : Both male and female 
 Patients having the following signs and symptoms 
1. Erythema 
2. Thickness 
3. Scaling  
4. with or without itching 
5. Auspitz sign + 
6. Candle crease sign + 
 Willing to participate in trial and signing consent by fulfilling the condition of 
proforma. 
 Willing to give specimen of blood for the investigation to start and end of the 
treatment and willing to take photograph before and after treatment. 
EXCLUSION CRITERIA 
 Insulin Dependent Diabetes Mellitus 
 Pregnancy and lactation 
 Psoriasis with evidence of any other skin disease  
 Psoriatic arthropathy 
 Cardiac diseases 
  
 Evidences of secondary infection in the lesions. 
 Any other chronic illness 
 
WITHDRAWAL CRITERIA 
 Intolerance to the drug and development of any serious adverse effect during 
drug trial. 
 Poor patient compliance & defaulters 
 Patient unwilling to continue the course of clinical Study. 
 Occurrence of any other systemic illness 
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TESTS AND ASSESMENTS: 
            1. Clinical assessment  
2. Siddha system assessment 
3. Routine investigations 
1. CLINICAL ASSESMENT: 
 Erythema 
 Thickness 
 Macules 
 Papules 
 Plaques 
 Itching 
 Coin shaped lesion 
 Scaling 
 Candle grease sign  
 Auspitz sign 
  
2. INVESTIGATIONS BASED ON SIDDHA SYSTEM: 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
8. Moothiram  
I) Neerkkuri      
                      II) Neikkuri    
3. INVESTIGATION 
BLOOD 
 Hb  
 Total WBC Count 
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 DC 
 Polymorphs 
 Lymphocytes  
 Eosinophils 
 Monocytes  
 Basophils  
 
 Total RBC count  
 ESR  (½  /1 Hr ) 
 Blood sugar (F &PP) 
 Serum cholesterol 
URINE 
 Albumin 
 Sugar(F & PP)                          
 Deposits 
RENAL FUNCTION TESTS 
             Blood Urea 
             Serum Creatinine 
             Uric acid 
LIVER FUNCTION TESTS 
              Serum total bilirubin 
              Direct bilirubin 
              Indirect bilirubin 
              Serum Alkaline phosphatises 
             SGOT & SGPT 
 
DATA COLLECTION: 
Required information was collected from each patient by using the following forms: 
FORMS:  
 FORM I            Screening and selection Proforma 
 FORM II           Clinical assessment Proforma 
 FORM III          Laboratory investigation Proforma 
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 FORM IV         Drug compliance form 
 FORM V          Patient information sheet 
 FORM VI         Consent form 
 FORM VII       Withdrawal form / Pharmacovigilance 
 FORM VIII      Dietary Advice form 
 FORM IX        Adverse reaction form 
STUDY ENROLLMENT: 
 Patients reporting at the OPD with clinical feature of erythematous patches, scaling, 
itching were chosen for enrolment based on the inclusion and exclusion criteria. 
 The enrolled patients were informed about the study, trial drug, possible outcomes 
and the objectives of the study in the language and terms understandable to them and 
getting consent in the Informed Consent form (Form VI). 
 Complete clinical history, complaints and duration, examination findings-- all were 
recorded in the prescribed Proformas. 
 Screening Form- I was filled up, Form II and Form III for recorded the patients, 
history, clinical examination of symptoms and signs and laboratory investigations 
respectively. If there is any abnormal laboratory reports obtained then excluded from 
this study. Patients were advised to take the trial drug and appropriate dietary advice 
(Form VIII)   was given according to the patients, perfect understanding. 
 
CONDUCT OF THE STUDY: 
On The First Day of the treatment Purgation was given with Meganatha kuligai -2 
tablets with hot water in the early morning for balancing the vital humours. Then the trial 
Parangipattai chooranam Sangamver Thylam
given for 48 days.  
 
Among the 40 patients were treated with trial medicines only. If there is a need of 
IPD to the patients were admitted in ward for the clinical assessment.  
 
  OPD patients are requested to visit the hospital once in 7 days. In each and every 
visit clinical assessment and prognosis was recorded. In IPD patients the clinical assessment 
and prognosis was recorded daily. This was monitored by the Faculty and HOD of the 
Department of Sirappu Maruthuvam.  
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Laboratory investigations were done before and after the treatment. For IPD patients, 
who were not in a position to stay in the hospital for a long time, they were advised to attend 
the OPD for further follow-up. At the end of the trial, the patients were advised to visit the 
OPD for further 6 months for follow-up for any recurrence. Defaulters were not be allowed 
to continue and withdrawn from the study with fresh 
 DATA ANALYSIS: 
After enrolling the patients in the study, a separate file for each patient was 
maintained and all forms kept in the file. Study No. 
of the file for easy identification. Whenever the patients visit OPD during the study period, 
necessary entries were made at the assessment forms. The screening forms were filled 
separately. Forms would be further scrutinized by Senior Research Officer (Statistics) for 
logical errors and incompleteness of data to avoid any bias. No modification in the results is 
permitted for unbiased reports. 
ADVERSE/SERIOUS EFFECTS MANAGEMENT 
In this study, no adverse events were observed during the course of treatment. 
OUTCOME 
Good outcome  Clearence of lesions and 75% reduction in the PASI Score in before and 
after treatment. 
Moderate outcome  Clearence of lesions and 50% reduction in the PASI Score in before 
and after treatment. 
Mild outcome  Slight clearance of lesions and 25% reduction in the PASI Score in before 
and after the treatment. 
Nil outcome  No clearance of lesions or No reduction of PASI Score. 
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Psoriasis Area and Severity Index (PASI) 
 
A Psoriasis Area and Severity Index (PASI) is a quantitative rating scale for 
measuring the severity of psoriatic lesions based on area coverage and plaque 
appearance 
 
Erythema/ Thickness/Scaling-Rating score   Area Scoring 
0 - None        0-Nil   
1- Slight        1-1%-9% 
2- Moderate        2- 10%-29% 
3-Severe        3-30%-49% 
4-Very severe        4-50%-69% 
         5-70%-89% 
         6-90%-100% 
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 Add together each of Erythema/ Thickness/Scaling scores for each of the body       
regions to give 4 separate sub totals A1, A2, A3 and A4 
 Multiply each subtotal by amount of body surface area represented by that region i.e. 
A1 x 0.1 for head, A2 x 0.2 for upper limbs, A3 x 0.3 for trunk, A4 x 0.4 for lower 
limbs to give a value B1, B2, B3 and B4 for each body region respectively. 
           A1 x 0.1=B1;   A2 x 0.2=B2; A3 x0.3=B3; A4 x 0.4=B4 
                                                    PASI Calculation 
Patient name   
Date   
Plaque 
Characteristic 
Rating Score 
Body region and weighting factor 
Head Upper Limbs Trunk Lower Limbs 
Erythema  0 = None         
Thickness 
1 = Slight 
        
2 = Moderate 
Scaling 
3 = Severe 
        
4 = Very Severe 
      Totals A1= A2= A3= A4= 
Weighting Factor A1x0.1=B1 A2x0.2=B2 A3x0.3=B3 A4x0.4=B4 
Surface area totals B1= B2= B3= B4= 
  
Degree of involvement 
as % for each body 
region  
affected (score each  
region between 0 and 
6) 
0 = None 
    
1 = 1-9% 
2 = 10-29% 
3 = 30-49% 
4 = 50-69% 
5 = 70-89% 
6 = 90-100% 
Surface area totals x % involvement 
totalsSum Scores above = 
B1xscore=C1 B2xscore=C2 B3xscore=C3 B4xscore=C4 
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 For each body region multiply subtotal B1, B2, B3 and B4 by the score(0-6) of the % 
of body region involved to give 4 sub totals C1, C2, C3 and C4 
  
 
Results:   
 Good        -  Clearance of lesions and Reduction of PASI Score from 3, 4 to 1, 0 
 Moderate  - Partial clearance of lesions and Reduction of PASI Score from 3, 4 to 2. 
 Mild        -  Slight clearance of lesions and Reduction of PASI Score from 4 to 3 
 Nil           -  NO Clearance of lesions or No reduction PASI Score   
 
Secondary Outcome: 
 Occurrence of types of lesions related to Aetiological factors. 
 
ETHICAL ISSUES: 
 The trial drug was mentioned in the List of books mentioned in the Drugs and 
Cosmetics Act 1940. Hence no preclinical and toxicity studies would be carried out. 
 The patient would be informed about the treatment and other procedures in his 
vernacular language. After getting the consent only (language understandable to the 
patient) they were enrolled in the study.  
 To prevent any infection, while collecting blood sample from the patient, only 
were used.              
 The data collected from the patient would be kept confidential.  
 Treatment would be provided free of cost.  
 In any adverse reaction observed during the trial the patients would be given 
alternative treatment at National Institute of Siddha for further management case 
being inducted. 
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BIO-CHEMICAL AND ELEMENTAL ANALYSIS 
                                                  Qualitative Analysis  
SL.N
O 
EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample 
 Lighter Brown in 
Colour 
 
2. Solubility:   
a. A little of the sample is 
shaken well with distilled 
water. 
b. A little of the sample is 
Shaken well with con. Hcl 
 Con. H2SO4. 
 
Completely soluble 
 
 
 
Completely soluble 
 
 
 
 
 
Absence of Silicate 
3. Action of Heat: 
A small amount of the sample is 
taken in a dry test tube and 
heated gently at first and then 
Strong. 
 
White fumes  evolved 
Brown fumes not 
evolved 
 
Presence of 
Carbonate.                 
Absence of Nitrate. 
4. Flame  Test: 
A small amount of the sample is 
made into a paste with con. Hcl 
in a watch glass and introduced 
into non-luminous part of the 
Bunsen flame. 
 
White flame  is 
appeared 
 
 
Absence of Copper. 
5 Ash Test: 
A filter paper is soaked into a 
mixture of sample and cobalt 
nitrate solution and introduced 
into the Bunsen flame and 
ignited. 
 
No Yellow colour 
flame. 
 
Absence of Sodium. 
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Preparation of the Extract 
 5gm of Parangopattai chooranam was weighed accurately and placed in a 250 ml 
clean beaker. Then 50 ml distilled water was added and dissolved well. Then it is boiled well 
for about 10 minutes. It was cooled and filtered in a 100 ml volumetric flask and then it was 
made up to 100 ml with distilled water. This fluid was taken for analysis. 
 
SL. 
NO. 
EXPERIMENT OBSERVATION INFERENCE 
TEST FOR ACID RADICALS 
1. Test For Sulphate: 
a. 2 ml of the above prepared 
extract is taken in a test tube to this 
added 2ml of 4% ammonium 
oxalate solution. 
b. 2ml of the above prepared 
extract is added with 2 ml of dil-
Hcl is added until the effervescence 
ceases off. Then 2ml of Barium 
chloride solution is added. 
Cloudy appearance 
present 
 
 
 
A white precipitate 
insoluble in con. Hcl 
is obtained 
Presence of      
Sulphate 
 
 
 
Sulphate is 
Confirmed. 
2. Test For Chloride: 
2 ml of the above prepared 
Extract is added with dil. HNO3 till 
the effervescence ceases. Then 2 
ml of silver nitrate solution is 
added. 
 
Cloudy appearance 
present (Mild trace 
element) 
 
Presence of 
Chloride 
3. Test For Phosphate: 
2 ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2 ml of con. HNO3 
 Cloudy yellow 
appearance Present 
Presence of 
Phosphate 
4. Test For Carbonate: 
2m1 of the extract is treated with 
2m1 magnesium sulphate solution 
 cloudy appearance 
Presence of 
Carbonate 
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Test For Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated H2SO4   and viewed 
the test tube vertically down. 
 
Brown gas is not 
evolved 
 
 
Absence of Nitrate 
 
 
 
6. Test For Sulphide: 
1 gm of the substance is 
treated with 2m1 of con. Hcl. 
 
No Rotten egg 
Smelling gas evolved 
 
Absence of 
Sulphide. 
7. 
 
 
 
 
Test for fluoride & oxalate 
 2 m1 of The Extract Is Added 
With 2m1of Acetic Acid and 2 m1 
calcium Chloride solution and 
heated. 
 
 
No Cloudy 
appearance. 
 
 
 
Absence of  
Fluoride & Oxalate 
8.  
 
 
 
Test for Nitrite: 
3drops of extract is placed on a 
filter paper,on that 2 drops of acetic 
Acid and 2 drops of benzidine 
solution is placed. 
 
 
No characteristic 
Changes. 
 
 
 
Absence of nitrite. 
9. 
 
 
 
 
 
Test For Borate: 
2 pinches of the substance is made 
into paste by using sulphuric acid 
and alcohol (95%) and introduced 
into the blue flame. 
 
 
Bluish green colour 
flame not appeared  
 
 
Absence of borate. 
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II. TEST FOR BASIC RADICALS 
1 Test For Lead: 
2 m1of the extract is added with 
2m1of potassium iodide solution. 
 
 No Yellow 
precipitate 
is obtained 
 
Absence of Lead. 
2. Test for Copper: 
a. One pinch of substance is 
made into paste with con. Hcl 
in a watch glass and  introduced 
into the non-luminous part of the 
flame. 
b. 2 ml of extract is added with 
excess of ammonia solution. 
 
No Blue colour flame  
precipitate 
 
 
 
No Blue colour 
precipitate  
 
Absence of 
Copper. 
 
 
 
Absence of 
Copper. 
3. Test For Aluminium:         
Take the 2m1of the extract sodium 
hydroxide is added in drops to 
excess. 
 
No characteristic 
changes 
 
 
Absence of 
Aluminium. 
 
4. Test  For  Iron: (Ferrous) 
To the 2 ml of extract 2m1                
ammonium thiocyanate solution       
and 2m1of con.HNO3 is added. 
 
Blood red colour 
Appeared 
 
 
 
Presence of Iron 
 
5. Test For Zinc: 
To 2m1 of the extract sodium 
hydroxide solution is added in 
drops to excess. 
 
White precipitate is 
not 
Formed 
 
Absence of Zinc. 
 
6. Test For Calcium: 
2m1 of the extract is added with 
2m1 of 4% ammonium oxalate 
Solution. 
 
Cloudy appearance 
and white precipitate   
is obtained 
 
   Presence of     
Calcium. 
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7. Test For Magnesium: 
 To 2ml of extract sodium                 
hydroxide solution is added in 
drops to excess. 
 
 White precipitate is 
not 
obtained. 
 
Absence of     
Magnesium. 
8. Test For Ammonium: 
To 2ml of extract few ml of 
Nessler's reagent and excess of 
sodium hydroxide solution are 
added. 
 
 
No brown colour 
appeared. 
 
 
 
  Absence of 
  Ammonium. 
9. Test For Potassium: 
A pinch of substance is treated 
with 2ml of sodium nitrite solution 
and then treated with 2m1 of cobalt 
nitrate in 30% glacial acetic acid. 
 
Yellowish 
precipitate is 
obtained 
 
  Presence of 
   Potassium. 
10. Test For Sodium:                        
2 pinches of the substance is 
made into paste by using HCL 
and introduced into the blue flame 
of Bunsen burner. 
 
 
 No Yellow colour  
Flame appeared. 
 
 
 Absence of 
Sodium. 
 
11. Test For Mercury: 
 2m1 of the extract is treated with 
2ml of sodium hydroxide solution. 
 
 Yellow precipitate      
is not obtained 
 
Absence of 
Mercury. 
12. Test For Arsenic:                     
  2m1 of the extract is treated with 
2m1 of sodium hydroxide solution. 
 
No brownish red 
Precipitate is 
obtained 
 
 
Absence of 
Arsenic. 
   
    III. MISCELLANEOUS 
1. Test for Starch: 
2ml of extract is treated with weak 
iodine solution. 
 
 
 Blue colour 
developed 
 
Presence of Strarch 
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2. Test For Reducing Sugar: 
5. ml of Benedict's qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for   2 minutes. The 
colour changes are noted. 
 
 
Brick red colour 
developed 
 
 
Presence of 
Reducing sugar. 
3. Test For The Alkaloids: 
a. 2m1 of the extract is treated 
with 2ml of potassium Iodide 
solution.                        
                            
b. 2m1 of extract is treated with  
2ml of picric acid. 
 
c. 2m1 of the extract is treated with 
2ml of phosphotungstic acid. 
  
Red colour 
developed 
 
 
 
Trace Yellow 
colour developed 
 
White precipitate 
developed 
 
Presence of 
Alkaloid. 
 
 
Trace of  
Alkaloid present. 
 
Presence of 
Alkaloid. 
4. Test for Tannic Acid:   
   2ml of extract is treated with  
2ml of ferric chloride solution. 
 
Black precipitate is 
obtained 
 
Presence of Tannic 
acid. 
5. Test for Unsaturated Compound: 
   To the 2ml of extract 2ml of 
Potassium Permanganate solution is 
added. 
 
Potassium 
Permanganate is  
not decolourised 
 
Absence of 
Unsaturated 
Compound 
6. Test For Amino Acid: 
2 drops of the extract is placed on a 
filter paper and dried well and 2 ml 
of biuret reagent is added 
 
No Violet colour 
developed 
 
Absence of Amino 
acids. 
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7. Test For type of Compound: 
  2ml of the extract is treated with 2 
ml of ferric chloride solution. 
  
No Green colour 
developed 
 
 
 
 
No Red colour 
developed 
 
 
 
 
No Violet colour 
developed 
 
 
 
No blue colour 
 Developed 
 
Absence of oxy 
quinole 
epinephrine 
and pyro catechol. 
 
Anti pyrine, 
Aliphatic          
amino acids and 
Meconic acid are 
absent. 
 
Apomorphine, 
Salicylate and 
Resorcinol are 
absent. 
 
Morphine, Phenol 
cresol and hydro 
quinone are absent 
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PRELIMINARY PHYTOCHEMICAL SCREENING   
PARANGIPATTAI CHOORANAM 
 
The preliminary phytochemical screening test was carried out for each extracts of 
Parangipattai Chooranam as per the standard procedure. 
 
1. Detection of alkaloids:  
Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
  
Formation of a yellow colored precipitate indicates the presence of alkaloids.  
 Fil
Iodide). Formation of brown/reddish precipitate indicates the presence of alkaloids.  
 
Potassium Bismuth Iodide). Formation of red precipitate indicates the presence of alkaloids. 
  
Presence of alkaloids confirmed by the formation of yellow colored precipitate.  
2. Detection of carbohydrates: 
 Extracts were dissolved individually in 5 ml distilled water and filtered. The filtrates were 
used to test for the presence of carbohydrates. 
 :  
 To 2 ml of plant sample extract, two drops of alcoholic solution of - naphthol are added. 
The mixture is shaken well and few drops of concentrated sulphuric acid is added slowly 
along the sides of test tube. A violet ring indicates the presence of carbohydrates.   
  
Filtrates were treated with Benedict
indicates the presence of reducing sugars. 
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3. Detection of glycosides:  
Extracts were hydrolyzed with dil. HCl, and then subjected to test for glycosides.  
 Extracts were treated with Ferric Chloride solution and 
immersed in boiling water for about 5 minutes. The mixture was cooled and extracted with 
equal volumes of benzene. The benzene layer was separated and treated with ammonia 
solution. Formation of rose-pink color in the ammonical layer indicates the presence of 
anthranol glycosides.  
b) Cardiac glycoside (Keller-Killiani test):  Extract was shaken with distilled water (5 
mL). To this, glacial acetic acid (2 mL) containing a few drops of ferric chloride was added, 
followed byH2SO4 (1 mL) along the side of the test tube. The formation of brown ring at the 
interface gives positive indication for cardiac glycoside and a violet ring may appear below 
the brown ring 
4. Detection of saponins 
 a) Froth Test: Extracts were diluted with distilled water to 20ml and this was shaken in a 
graduated cylinder for 15 minutes. Formation of 1 cm layer of foam indicates the presence of 
saponins.  
b) Foam Test: 0.5 gm of extract was shaken with 2 ml of water. If foam produced persists 
for ten minutes it indicates the presence of saponins.  
5. Detection of phytosterols  
 Extracts were treated with chloroform and filtered. The filtrates were 
treated with few drops of Conc. Sulphuric acid, shaken and allowed to stand. Appearance of 
golden yellow color indicates the presence of triterpenes. 
6. Detection of phenols Ferric Chloride Test:  
Extracts were treated with 3-4 drops of ferric chloride solution. Formation of bluish black 
color indicates the presence of phenols.  
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7. Detection of tannins Gelatin Test:  
The extract is dissolved in 5 ml of distilled water and 2 ml of 1% solution of Gelatin 
containing 10% NaCl is added to it. White precipitate indicates the presence of phenolic 
compounds.  
8. Detection of Flavonoids  
a) Alkaline Reagent Test: Extracts were treated with few drops of sodium hydroxide 
solution. Formation of intense yellow color, which becomes colorless on addition of dilute 
acid, indicates the presence of flavonoids. 
 b) Lead acetate Test: Extracts were treated with few drops of lead acetate solution. 
Formation of yellow color precipitate indicates the presence of flavonoids.  
9. Detection of proteins and aminoacids 
 a) Xanthoproteic Test: The extracts were treated with few drops of conc. Nitric acid. 
Formation of yellow color indicates the presence of proteins. 
b) Ninhydrin Test: To the extract, 0.25% w/v ninhydrin reagent was added and boiled for 
few minutes. Formation of blue color indicates the presence of amino acid. 
 10. Detection of diterpenes Copper Acetate Test: 
 Extracts were dissolved in water and treated with 3-4 drops of copper acetate solution. 
Formation of emerald green color indicates the presence of diterpenes   
11. Gum and Mucilage:  
To 1ml of extract add 2.5ml of absolute alcohol and stirring constantly. Then the precipitate 
was dried in air and examine for its swelling properties. Swelling was observed that will 
indicate presence of gum and mucilage. 
12. Test for Fixed oils and Fats  
a. Spot test  : A small quantity of extract is pressed between two filter papers. Oil stain on 
the paper indicates the presence of fixed oils.  
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 13. Test for Quinones 
Extract was treated with sodium hydroxide blue or red precipitate indicates the presence of 
Quinones. 
The Preliminary phytochemical studies of aqueous extract of Parangipattai Chooranam 
were done using standard procedures. The results were presented in tables. The present study 
reveals that the bioactive compounds were present in all the extracts of Parangipattai 
Chooranam. 
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PHYSIOCHEMICAL ANALYSIS OF PARANGIPATTAI CHOORANAM 
1. Loss On Drying: 
An accurately weighed 2g of Parangipattai Chooranam formulation was taken in 
a tarred glass bottle. The crude drug was heated at 1050C for 6 hours in an oven till a 
constant weight. Percentage moisture content of the sample was calculated with reference 
to the shade dried material. 
2. Determination of total ash: 
Weighed accurately 2g of Parangipattai Chooranam formulation was added in 
crucible at a temperature 6000C in a muffle furnace till carbon free ash was obtained. It 
was calculated with reference to the air dried drug.  
3. Determination of acid insoluble ash: 
Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric acid and 
filtered using an ash less filter paper. Insoluble matter retained on filter paper was washed 
with hot water and filter paper was burnt to a constant weight in a muffler furnace. The 
percentage of acid insoluble as was calculated with reference to the air dried drug. 
4. Determination of water soluble ash: 
Total ash 1g was boiled for 5min with 25ml water and insoluble matter collected 
on an ash less filter paper was washed with hot water and ignited for 15 min at a 
temperature not exceeding 4500C in a muffle furnace. The amount of soluble ash is 
determined by drying the filtrate.  
5. Determination of water soluble Extractive: 
5gm of air dried drug, coarsely powered Parangipattai Chooranam was 
macerated with 100ml of distilled water in a closed flask for twenty-four hours shaking 
frequently. Solution was filtered and 25 ml of filtrated was evaporated in a tarred flat 
bottom shallow dish, further dried at 1000 C and weighted. The percentage of water 
soluble extractive was calculated with reference to the air dried drugs.   
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6. Determination of alcohol soluble extractive: 
2.5gm. of air dried drugs, coarsely powdered Parangipattai Chooranam was 
macerated with 50 ml. alcohol in closed flask for 24 hrs. With frequent shaking it was 
filtered rapidly taking precaution against loss of alcohol. 10ml of filtrate was then 
evaporated in a tarred flat bottom shallow dish, dried at 1000C and weighted. The 
percentage of alcohol soluble extractive was calculated with reference to air dried drug. 
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Flowchart of the Patients completed the Study 
 
 
 
 
   
                                           
 
                                                                 
 
                                              
    
              
                        
 
 
 
 
 
Screened  100 
Excluded from the Study (57) 
Included to the Study (43) 
Withdrawer from the Study (03) 
Completed the Study (40) 
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1. SEX DISTRIBUTION 
 
 
 
 
 
 
 
 
 
 
Observation 
Among the 40 patients were selected for this study, 67.5% were males and      
32.5%  were females. 
 
 
 
 
 
 
 
SI.NO SEX NO OF CASES PERCENTAGE 
1 MALE 27 67.5% 
2 FEMALE 13 32.5% 
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2. AGE DISTRIBUTION 
 
SI.NO AGE NO OF CASES PERCENTAGE 
1      20 -30        11    27.50% 
2      31 -40        10    25% 
3      41-50        13    32.50% 
4      51-60         6    15% 
 
 
 
 
Observation: 
 The patients were selected were selected from all age groups as given above   
and the Maximum numbers of patients were in the age between 41 to 50. 
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3. FAMILY HISTORY 
 
S.NO Criteria No of cases Percentage 
1 Family history(+ve)      1 2.5% 
2 Family history (-ve) 39 97.5% 
 
 
 
Observation: 
 97.5% of the patients showed negative family history. 
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4. DIETARY HABITS 
 
S.NO      Dietary habits   No of cases Percentage 
    1         Vegetarian          1    97.5% 
    2      Non Vegetarian           39    2 .5% 
 
 
 
Observation: 
97.5% of the cases were non-vegetarians. 
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5. THINAI REFERENCE 
 
.NO     THINAI NO OF CASES PERCENTAGE 
1 Kurinji (Hill Area) 0 0% 
2 Mullai (Forest Area) 0 0% 
3 Marutham 
(Fertile land) 
15 37.5% 
4 Neithal 
(Coastal Area) 
25 62.5% 
5 Paalai (Desert land) 0 0% 
 
 
 
Observation: 
 62.5% of the patientswere from Neithal (Coastal Area) and then remaining 37.5% 
from Marutham(Fertile land). 
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6. KAALAM DISTRIBUTION (According to Age): 
 
In siddha literature human life has been divided into three periods as follows  
  1. Vatham 
2. Pitham 
3.Kabam 
 
The duration of each period is said to be 33 years 
 
SI.No Kaalam No of cases Percentage 
1 Vaathakaalam 
 (1-33 Years) 
         12     30% 
2 Pithakaalam 
(34 -66 years) 
        28      70% 
3 Kabakaalam 
(67 -100 years) 
         0         0% 
 
 
 
Observation:  
70% of the patients were Vathakaalam and the remaining 30% patients reported in 
Pithakaalam 
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7. YAAKAIILAKKANAM (Physical constitutions) 
 
SI.No Yaakkaiillakkanam No of cases Percentage 
1 Vaathaudal          0        0% 
2 Pithaudal          0        0% 
3 Kabaudal          0        0% 
4 Thonthaudal          40       100% 
 
 
Observation: 
 
  All the patients (100%) had Thonthaudal 
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8. GUNAM (Quality and characters)    
 
SI.No Gunam No of cases Percentage 
1 SathuvaGunam 0 0% 
2 RajoGunam 25 62.5% 
3 ThamoGunam 15 37.5% 
 
 
 
 
Observation: 
62.5%   patients had RajoGunam and 37.5% had  Thamogunam. 
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9. DURATION OF THE ILLNESS 
 
SI.No Duration of the illness No of cases Percentage 
  1         1 - 3 years         13        32.5% 
  2         4 -  6 years         15        37.5% 
  3         7- 9 years         1        2.5% 
  4         10  12 years         5        12.5% 
  5 > 10 years         6        15% 
 
 
 
 
Observation: 
                  37.5% of the patients were suffering with the illness for 4 to 6 years. 
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10. HISTORY OF REMISSION AND RELAPSES 
 
SI.No Remissions  and          
Relapses 
No of cases Percentage 
   1     Present        30   75% 
   2     Absent        10    25% 
 
 
 
 
Observation: 
  75% of the patients had the  history of Remission and Relapse. 
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11. CLINICAL FEATURES 
 
SI.No Clinical Features No of cases Percentage 
     1 Scaling 40 100% 
     2 Itching 31 77.5% 
     3  Fissure 10 25% 
     4 Oozing 6 15% 
     5 Auspitz sign 40 100% 
     6 Lichenification 3 7.5% 
     7  phenomenon 5 12.5% 
     8 Nail Changes 7 17.5% 
     9 Candle grease sign 40 100% 
    10 Palm and sole lesions 2 5% 
    11 Joint involvement 0 0% 
 
 
: 
Observation: 
In this study 100% of the patients had Scaling, Auspitz sign, and Candle grease sign. 
77.5% had Itching, 25% had Fissure, 15% had Oozing, 17.5% had Nail changes, 12.5% had  
 phenomenon 
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12. DISTRIBUTION OF MUKKUTRAM 
The derangement of Vatham, Pitham inKaalanjagapadai are as follows 
 
Vatham 
SI.No Classification of  Vaatham No of cases    Percentage 
   1 Praanan            0           0% 
   2 Abaanan            0           0% 
   3 Udhanan            0           0% 
   4 Samaanan           40          100% 
   5 Viyaanan           40          100% 
   6 Naagan            0           0% 
   7 Koorman            0           0% 
   8 Kirukaran            0           0% 
   9 Devathathan            5           12.5% 
  10 Dananjeyan            0           0% 
  
Observation: 
Samaanan and Viyanan were affected in all the 100% of the patients. Devathathan were 
affected in 12.5% of the patients. 
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PITHAM 
SI.No Classification of Pitham No of cases Percentage 
1 Analakam         0       0% 
2 Ranjakam         2         5% 
3 Saathakam         40       100% 
4 Prasakam         40       100% 
5 Aalosakam          0          0% 
 
Observation: 
Saathakam and Prasakam were affected in all the cases. Ranjakam was affected in 5% of 
the patients. 
 
13. UDAL KATTUKKAL 
 
SI.No Udalkattukal No of cases Percentage 
     1 Saaram         40        100% 
     2 Senneer         40        100% 
     3 Oon         3        7.5% 
     4 Kozhuppu         0        0% 
     6 Enbu         0        0% 
     7 Moolai         0        0% 
     8 Sukkilam/Suronitham         0        0% 
 
Observation: 
Among 40 patients, Saaram, Senneer were affected in all the cases. 
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14. NEERKKURI REFERENCE 
 
SI.No Neerkuri No of cases Percentage 
1 Pale yellow       15    37.5% 
2 Yellow       11     27.5% 
3 Dark yellow        3     7.5% 
4 Straw        1     2.5% 
5 Colourless        10     25% 
 
Observations: 
 In this study 37.5% of the patients had Neerkuri with Pale yellow, 27.5% with yellow, 
25% with colourless, 7.5% with dark yellow and 2.5% with straw colour. 
 
 
15. NEIKKURI REFERENCES 
 
SI.No NEIKKURI No of cases Percentage 
    1 Aravananeendal (Vaatham) 3 7.5% 
    2 Azhipolparaviyathu (Pitham) 1 2.5% 
    3 Muthothuninrathu (Kabam) 23 57.5% 
    4 Others 13 32.5% 
 
Observation: 
In this case 7.5% of the patients had Neikuri with Vatham (Araavananeendathu), 2.5% 
with Pitham (Azhipolparaviyathu), 57.5% with kabam (Muthothuninrathu) and 32.5% with 
other pattern. 
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16. ENVAGAI THERVUGAL 
 
 
 
Observation: 
              In Envagaithervugal, Niram was affected in all the 40 cases. Sparisam was affected in 
62.5% of patients.Thenaadinadai seen in KaalanjagapadaipatientsVaathapitham 75 %, 
Pithavatham 15%, kabavatham 2.5%,  Kabapitham 7.5%. 
 
 
 
 
 
 
 
 
 
SI.No EnvagaiThervugal No of cases  Percentage 
1 Naadi   
 a)Vaathapitham         30      75% 
b)Pithavatham         6      15% 
c)Kabavatham         1      2.5% 
d)Kabapitham         3      7.5% 
2 Sparisam         25      62.5% 
3 Naa         0      0% 
4 Niram         40     100% 
5 Mozhi         0      0% 
6 Vizhi         0      0% 
7 Malam         0      0% 
8 Moothiram         0      0% 
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17. Phytochemical analysis of the Paranagiattai chooranam 
 
S.no Phytochemicals Test Name H2O Extract 
1. Alkaloids  
 -ve 
 -ve 
 -ve 
 -ve 
2. Carbohydrates 
 +ve 
 +ve 
3. Glycoside  
 +ve 
Keller Killiani -ve 
4. Saponin    
Froth Test +ve 
Foam Test -ve 
5. Phytosterol  -ve 
6. Phenols Ferric Chloride Test -ve 
7. Tannins Gelatin Test -ve 
8. Flavonoids  
Alkaline Reagent Test +ve 
Lead acetate Test +ve 
9. Proteins and amino acids Xanthoproteic Test +ve 
10. Diterpenes Copper Acetate Test +ve 
11. Gum & Mucilage Extract + Alcohol -ve 
12. Fat & Fixed Oil Spot Test -ve 
13. Quinones NAOH + Extract +ve 
 
+ve/-ve present or absent if component tested 
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18. Physiochemical properties  of the  Parangipattai chooranam 
 
S.no Parameters Percentage 
   
1 Loss on drying 2.83% 
   
2 Total ash value 3.14% 
   
3 Acid insoluble ash Less than 1% 
   
4 Water soluble ash 1.12% 
   
5 Water soluble extraction 47.75% 
   
6 Alcohol soluble extraction 12.74% 
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19. RESULTS 
 
OPD / IPD CASES CLINICAL IMPROVEMENT 
 
 
SI.No 
 
OP / IP NO 
       
          NAME 
 
 
AGE 
/SEX 
       PASI SCORE  
  RESULTS  BT  AT   PASI 
   1 IP 9905 E.Arokkiyasamy 36/M 61.6 12.4 PASI 75   GOOD 
   2 IP0067-18 R.Kumari 39/F  40 3 PASI 75   GOOD 
   3 IP0244-18 S.Shanthi 52/F 50.1 0.9 PASI 75   GOOD 
   4 IP028-18 K.Banumathy 42/F 53.4 10.8 PASI 75   GOOD 
   5 IP0286-18 A.Reginamary 46/F 54 7.1 PASI 75   GOOD 
   6 IP01314-18 K.Maragatham 23/F 60 34.2 PASI 50 MODERATE 
   7 IP0344-18 E.Sivaprakasam 56/F 26.1 4 PASI 75   GOOD 
   8 IP0398-18 U.Sivarajan 26/M 52.2 11.4 PASI 75   GOOD 
   9 IP 0412-18 N.Magendran 40/M 42 6.6 PASI 75   GOOD 
  10 IP0440-18 K.Philips 58/M 40 9 PASI 75   GOOD 
  11 IP0445-18 R.Suganya 27/F 50.4 15.5 PASI 75   GOOD 
  12 I 69878 P.Neela 49/F 60 14.4 PASI 75   GOOD 
  13 I 77988 M.Kannan 38/M 60 33 PASI 50 MODERATE 
  14 J 34545 R.Rajkumar 29/M 46.4 12.3 PASI 75   GOOD 
  15 J 48749 M.Syedvasim 23/M 46 27.4 PASI 25    MILD 
  16 J 13057 M.Ravi 42/M 51.6 19.2 PASI 50 MODERATE 
  17 I 87056 R.N.Muthukrishnan 41/M 61.2 19.2 PASI 75    GOOD 
  18 J 62036 A.Suhasini 23/F 44.6 17.1 PASI 50 MODERATE 
  19 I 97780 P.Banumathy 41/M 65.7 43.2 PASI 25    MILD 
  20 J 81528 I.Farookbasha 35/M 50.1 21.5 PASI 50 MODERATE 
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SI.NO 
    
 
  OP / IP 
NO 
         
            
              NAME 
 
 
AGE/SEX 
 
       PASI SCORE 
 
 
 RESULTS 
 
 BT 
 
AT 
 
   PASI 
  21 J 87800 C.Gurumoorthy 28/M 57.5 7.6 PASI 75   GOOD 
  22 J 67522 M.M.Jainudheen 29/M 43.2 3.8 PASI 75   GOOD 
  23 I 31536 V.Deivanayagi 42/F 44.4 8.8 PASI 75   GOOD 
  24 J 91152 M.Beerjamel 45/M 69.6 64.3 PASI 25   MILD 
  25 J 81580 E.Ramesh 28/M 46.8 18 PASI 50 MODERATE 
  26 G 00139 M.Sampath 47/M 40.4 16.5 PASI 50 MODERATE 
  27 J 54269 S.Rigana 26/F 61.2 12.4 PASI 75    GOOD 
  28 J 77788 M.Ramachandran 43/M 61.2 15.2 PASI 75    GOOD 
  29 J 86400 M.Gopi 37/M 56.1 18.6 PASI 50 MODERATE 
  30 K 02675 K.Narasimman 50/M 50.4 29.4 PASI 25     MILD 
  31 K 04682 A.Raguman 28/M 66 60 PASI 25     MILD 
  32 J 65921 S.Prakasam 46/M 61.2 12.4 PASI 75    GOOD 
  33 I 53668 Chinu raj 51/M 55.2 23.3 PASI 50 MODERATE 
  34 J 12488 D.Senthil raj 41/M 57.6 23.3 PASI 50 MODERATE 
  35 J 30741 G.Muthukumar 36/M 70.8 42 PASI 25     MILD 
  36 H 25851 G.Balamurugan 37/M 61.2 28 PASI 50 MODERATE 
  37 K 06255 N.Hari 31/M 67.2 14.6 PASI 75     GOOD 
  38 J 95136 K.Murugesan 52/M 35.7 14.4 PASI 50 MODERATE 
  39 K 10016 C.Vijayalakshmi 27/F 43.4 16.6 PASI 50 MODERATE 
  40 K 19342 J.Sridevi 34/M 61.2 11.8 PASI 75     GOOD 
 
 
NOTE : 
 
BT : Before treatment; AT : After treatment 
 
PASI SCORE 
 
PASI 25 = 25% (Mild) reduction in the PASI Score in before and after treatment. 
 
PASI 50 = 50% (Moderate) reduction inthe PASI Score in before and after treatment. 
 
PASI 75 = 75% (Good) reduction in the PASI Score in before and after treatment. 
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20. PROGNOSIS: 
 
 
Sl.No.          RESULTS NO OF CASES  PERCENTAGE 
1 GOOD             21          52.5% 
2 MODERATE             13          32.5% 
3 MILD              6          15% 
 
 
 
Observation: 
             The trial drug Paranagipattai chooranam (Internal) and Sangamver thylam (External) 
were given to 40 patients for 48 days. Good improvement was observed in 21 Patients 
(52.5%), Moderate improvement in 13 (32.5%), and Mild improvement in 6 (15%) cases. 
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IP 0244-18 S.SHANTHI 52 / F PASI BEFORE TREATMENT 50.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PASI AFTER TREATMENT 0.9 
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J 13057 M.RAVI 42/M PASI BEFORE TREATMENT 51.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PASI AFTER TREATMENT 19.2 
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IP 0067 -18 R.KUMARI 39/ F BEFORE TREATMENT PASI 40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AFTER TREATMENT PASI 3 
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STATISTICAL ANALYSIS 
 
 
Summary Statistics of PASI Score Before and After treatment 
 
   Variable 
  
  Mean Std.dev 
   
Before treatment    53.14 10.05 
   
After treatment    19.08 14.05 
   
 
Statistical Significance of treatment on PASI Score. 
 
Variable  Obs Mean ± Std.dev t Value   p Value  
         
Before treatment         40 53.14 ± 10.05      
    
18.51 
  
p< 0.0001 
 
After treatment         40 19.08 ± 14.05    
         
 
All collected were entered into MS Excel software using different columns as 
variables and rows as patients .SPSS software was used to perform stastical analysis. 
Basic descriptive stastics include frequency distributions and cross -tabulatons were 
performed. The quality variables were expressed as Mean ± Standard deviation and 
qualitative data as percentage. A Probability value of <0.05 was considered to indicate 
as Stastical significance. Paired t test was performed for determining the significance 
between before and after treatment. The mean ± standard deviation of PASI Score at 
before and after treatment were 53.14±10.05 and 19.08±14.05 significance of the p 
value is 0.0001. 
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BEFORE AND AFTER TREATMENT 
 
SI. 
NO 
 
 
 
 
IP/OP 
NO  
 
 
NAME 
 
 
AGE/ 
SEX 
 
Hb (gms/dl) 
 
Total RBC  
COUNT 
(mill/cu.mm) 
 
ESR (mm/hr) 
TotalWBC 
(cells/cu.mm) 
BT AT BT AT BT AT BT AT 
1 IP 9905 E.Arokkiyasamy 36/M 15.7 16 4.6  5 34/70 16/42 8,600 7,100 
2 IP 0067-18 R.Kumari 39/F 12.5 12 4.5 4.8 11/20 9/20 6,100 7,600 
3 IP 0244-18 S.Shanthi 52/F 12.4 11.9 4.5 4.3 12/24 12/22 6,400 7,200 
4 IP 0284-18 K.Banumathy 42/F 11.7 12 4.0 5 32/66 31/64 9,200 9,220 
5 IP 0286-18 A.Reginamary 46/F 14.4 14.5 4.9 4.9 16/32 16/32 7,200 8,400 
6 IP 01314-18 K.Maragatham 23/F 12.1 12.5 4.3 5.5 13/34 13/34 8,300 8,000 
7 IP 0344-18 E.Sivaprakasam 56/M 15.2 15.2 4.7 4.8 20/40 20/40 12,800 10,900 
8 IP 0398-18 U.Sivarajan 26/M 15.6 14.6 5.4 5.0 2/6 2/4 7,800 6,100 
9 IP 0440-18 K.Philips 58/M 14.6 14.6 4.4 5 6/14 5/13 9,200 9,000 
10 1P 0412-18 Magendran 40/M 12.7 12 3.7 4 4/10 6/8 5,600 6,000 
11 IP 0445-18 R.Suganya 27/F 12.5 11.5 4.3 4.1 14/30 14/30 6,500 7,100 
12 I 69878 P.Neela 49/F 13.5 13 4.5 4 6/12 6/13 8,100 8,100 
13 I 77988 M.Kannan 38/M 16.5 16 5.5 4.5 6/12 6/10 10,200 11,500 
14 J 34545 R.Rajkumar 29/M 14.1 14.1 4.8 4.9 4/8 4/9 6,500 6,500 
15 J 48749 M.Syedvasim 23/M 14.0 15.0 5.2 5.4 4/18 4/18 5,400 5,900 
16 J 13057 M.Ravi 42/M 15.7 14.7 5.7 5.2 4/8 4/6 4000 6,400 
17 I 87056 R.N.Muthukrishnan 41/M 15.0 14.2 4.2 3.9 14/18 16/34 6,900 5,000 
18 J 62036 A.Suhasiny 23/F 11.8 11 4.3 4.4 30/60 20/42 5,800 5,600 
19 I 97780 P.Banumathy 41/F 13.8 13 4.7 4.5 6/12 4/10 10,100 9,000 
20 J 81528 I.Farookbasha 35/M 16.6 16 5.5 5.4 6/14 5/11 9,900 9,000 
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S.NO 
 
 
 
 
 
IP/OP 
NO 
 
 
 
          
          NAME 
 
 
 
 
AGE/ 
SEX 
 
 
 
     Hb 
 (gms/dl) 
 
 
Total RBC 
COUNT 
(milli/cu.m
m) 
 
 
 
ESR (mm/hr) 
 
 
Total WBC 
(cells/cu.mm) 
 
BT AT BT AT BT AT BT AT 
21 J 87800 C.Gurumoorthy 28/M 13.0 13.6 3.8 4 10/24 9/21 5,800 6,800 
22 J 67522 M.M. Jainudeen 29/M 15.9 15.1 5.3 4.9 2/6 2/6 7,800 6,000 
23 I 31536 V.Deivanayagi 42/F 11.6 11 3.8 4.4 12/26 10/24 6,800 7,000 
24 J 91152 M.Beerjamel 45/M 14.9 14 5.2 5 2/4 2/4 7,800 8,200 
25 J 81580 E.Ramesh 28/M 15 14 5.3 5.1 4/8 4/8 7,700 7,800 
26 G 00139 M.Sampath 47/M 14.6 14.5 5.0 4.9 4/16 4/16 8,800 6,400 
27 J 54269 S.Rigana 26/F 11.5 11 4.8 5 5/16 4/8 7,200 8,000 
28 J 77788 M.Ramachandran 43/M 14.1 14.2 4.9 4.8 6/12 6/12 8,500 6,900 
29 J 86400 N.Gopi 37/M 15 14 4.8 4.9 2/10 3/7 8,000 7,900 
30 K 02675 K.Narasimman 50/M 12.5 11.6 3.9 3.8 10/20 10/18 5,100 6,600 
31 K 04682 A.Raguman 28/M 15.4 14.4 5.4 5 6/12 4/8 7,000 9,000 
32 J 65921 S.Prakasam 46/M 14.4 14.7 5.3 5.1 2/8 2/8 8,800 8,000 
33 I 53668 S.Chinu raj 51/M 14 13 4.4 4.1 4/10 4/8 8,800 9,000 
34 J 12488 D.Senthil raj 41/M 14.5 12.5 5.1 4.4 10/20 10/18 7,200 9,200 
35 J 30741 G.Muthukumar 36/M 14.4 14.2 4.6 4.4 4/10 4/8 5,500 5,000 
36 G 25851 G.Balamurugan 37/M 16 15 5.2 5.4 10/22 9/20 7,200 7,500 
37 K 06255 N.Hari 31/M 14.4 14.0 4.8 5 4/10 4/9 12,600 12,000 
38 J 95136 K.Murugesan 52/M 14.8 14.5 4.6 5.2 7/10 4/8 8,100 8,600 
39 K 10016 C.Vijayalakshmi 27/F 11.2 11.1 4.3 4 22/44 22/43 7,900 7,100 
40 K 19342 J.Sridevi 34/F 11 11.5 4.2 4.8 4/10 4/8 10,900 10,000 
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SI. 
NO 
 
 
 
 
IP/OP 
NO  
 
 
NAME 
 
 
AGE/ 
SEX 
 
SGOT 
(IU/L)   
 
     SGPT 
    (IU/L) 
   Alkaline 
phosphatase 
BT AT BT AT BT AT 
1 IP 9905 E.Arokkiyasamy 36/M 19 14 15 13 64 63 
2 IP0067-18 R.Kumari 39/F 17 16 12 11 70 112 
3 IP0244-18 S.Shanthi 52/F 17 18 13 12 114 100 
4 IP0284-18  K.Banumathy 42/F 12 18 11 8 84 111 
5 IP0286-18 A.Reginamary 46/F 13 13 21 19 96 103 
6 IP01314.18 K.Maragatham 23/F 21 20 30 28 69 77 
7 IP 0344-18 E.Sivaprakasam 56/M 19 18 18 10 97 86 
8 IP 0398-18 U.Sivarajan 26/M 19 17 15 17 78 102 
9 IP0440-18 K.Philips 58/M 22 20 14 17 80 86 
10 1P0412-18 Magendran 40/M 36 29 19 23 51 77 
11 IP0445-18 R.Suganya 27/F 24 15.8 15 15.7 112 114 
12 I 69878 P.Neela 49/F 19 18 10 13 53 60 
13 I 77988 M.Kannan 38/M 0.4 0.4 29 27 93 111 
14 J 34545 R.Rajkumar 29/M 20 22 26 23 70 77 
15 J 48749 M.Syedvasim 23/M 19 20 28 42 115 113 
16 J 13057 M.Ravi 42/M 20 25 17 25 80 73 
17 I 87056 R.N.Muthukrishnan 41/M 20 14 28 13 71 64 
18 J 62036 A.Suhasiny 23/F 17 17 14 15 70 77 
19 I 97780 P.Banumathy 41/F 15 15 17 14 66 67 
20 J 81528 I.Farookbasha 35/M 14 20 20 19 60 77 
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SI.NO 
 
 
 
IP /OP 
NO 
 
NAME 
 
AGE/ 
SEX 
 
     SGOT 
     (IU/L) 
 
SGPT 
(IU/L) 
 
Alkaline 
phosphatase 
      
  BT 
    
AT 
   
BT 
   
AT 
  
BT 
 
AT 
21 J 87800 C.Gurumoorthy 28/M 20 19 16 17 107 109 
22 J 67522 M.M. Jainudeen 29/M 23 19 20 17 84 72 
23 I 31536 V.Deivanayagi 42/F 20 18 20 26 72 77 
24 J 91152 M.Beerjamel 45/M 24 26 43 35 47 45 
25 J 81580 E.Ramesh 28/M 30 24 44 29 100 94 
26 G 00139 M.Sampath 47/M 14 14 15 13 81 59 
27 J 54269 S.Rigana 26/F 10 12 17 20 59 88 
28 J 77788 M.Ramachandran 43/M 17 16 9 16 94 74 
29 J 86400 N.Gopi 37/M 30 35 38 35 87 112 
30 K 02675 K.Narasimman 50/M 38 24 27 29 63 75 
31 K 04682 A.Raguman 28/M 20 33 31 35 91 112 
32 J 65921 S.Prakasam 46/M 16 22 29 33 66 72 
33 I 53668 S.Chinu raj 51/M 19 14 22 18 88 76 
34 J 12488 D.Senthil raj 41/M 20 14 27 15 63 75 
35 J 30741 G.Muthukumar 36/M 15 23 18 33  65 77 
36 G 25851 G.Balamurugan 37/M 16 17 18 22 70 77 
37 K 06255 N.Hari 31/M 20 23 18 17 84 112 
38 J 95136 K.Murugesan 52/M 13 17 17 16 87 117 
39 K 10016 C.Vijayalakshmi 27/F 13 14 6 11 74 83 
40 K 19342 J.Sridevi 34/F 18 28 23 25 72 97 
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SI. 
NO 
 
 
 
IP/OP 
NO  
 
NAME 
 
AGE/ 
SEX 
 
TOTAL 
BILIRUBIN 
 
    
DIRECT 
BILIRUBN 
 
    
INDIRECT 
   
BILIRUBIN 
BT AT BT AT BT AT 
1 IP 9905 E.Arokkiyasamy 36/M 0.7 0.5 0.4 0.3 0.3 0.3 
2 IP 0067-18 R.Kumari 39/F 0.6 0.4 0.3 0.2 0.2 0.1 
3 IP 0244-18 S.Shanthi 52/F 0.4 0.7 0.2 0.2 0.2 0.5 
4 IP 0284-18 K.Banumathy 42/F 0.3 0.4 0.1 0.2 0.2 0.2 
5 IP 0286-18 A.Reginamary 46/F 0.4 0.5 0.1 0.2 0.3 0.3 
6 IP 01314-18 K.Maragatham 23/F 0.8 1.2 0.3 0.2 0.4 0.3 
7 IP 0344-18 E.Sivaprakasam 56/M 0.7 1.1 0.3 0.3 0.5 0.6 
8 IP 0398-18 U.Sivarajan 26/M 0.6 0.4 0.5 1.1 0.9 0.7 
9 IP 0440-18 K.Philips 58/M 0.4 0.5 0.4 0.6 0.3 0.6 
10 1P0412-18 Magendran 40/M 1.5 1.2 0.6 1.1 0.9 0.7 
11 IP 0445-18 R.Suganya 27/F 0.6 0.5 0.3 0.2 0.3 0.3 
12 I 69878 P.Neela 49/F 0.3 0.9 0.3 0.4 0.1 0.3 
13 I 77988 M.Kannan 38/M 0.8 0.7 0.4 0.2 0.4 0.4 
14 J 34545 R.Rajkumar 29/M 1.0 1.2 0.4 0.5 0.6 0.7 
15 J 48749 M.Syedvasim 23/M 1.0 1.3 0.4 0.5 0.6 0.8 
16 J 13057 M.Ravi 42/M 0.5 0.6 0.2 0.1 0.3 0.3 
17 I 87056 R.N.Muthukrishnan 41/M 1.3 1.6 0.4 0.5 0.9 0.1 
18 J 62036 A.Suhasiny 23/F 0.3 0.7 0.1 0.1 0.2 0.3 
19 I 97780 P.Banumathy 41/F 0.8 0.7 15 15 0.5 0.5 
20 J 81528 I.Farookbasha 35/M 0.9 0.6 0.3 0.3 0.6 0.1 
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SI.NO 
 
 
 
IP/OP 
NO 
 
NAME 
 
AGE/ 
SEX 
 
TOTAL 
BILIRUBIN 
 
DIRECT 
BILIRUBIN 
 
INDIRECT 
BILIRUBIN 
 
BT 
 
AT 
 
BT 
 
AT 
 
BT 
 
AT 
21 J 87800 C.Gurumoorthy 28/M 1.8 1.8 0.7 0.6 1.2 0.5 
22 J 67522 M.M. Jainudeen 29/M 0.8 1.2 0.3 0.4 0.5 0.4 
23 I 31536 V.Deivanayagi 42/F 0.7 1.2 0.3 1.2 0.5 0.7 
24 J 91152 M.Beerjamel 45/M 1.0 1.2 0.4 0.7 0.6 0.5 
25 J 81580 E.Ramesh 28/M 0.7 0.9 0.3 0.3 0.4 0.7 
26 G 00139 M.Sampath 47/M 1.2 1.1 1.2 1.1 0.8 0.7 
27 J 54269 S.Rigana 26/F 0.3 1.2 0.1 1.1 0.2 0.7 
28 J 77788 M.Ramachandran 43/M 0.6 0.7 0.2 0.3 0.4 0.7 
29 J 86400 N.Gopi 37/M 0.5 1.1 0.2 1.2 0.3 0.4 
30 K 02675 K.Narasimman 50/M 0.8 1.4 0.3 0.5 0.5 0.9 
31 K 04682 A.Raguman 28/M 1.1 1.2 0.4 0.7 0.8 0.7 
32 J 65921 S.Prakasam 46/M 0.8 1.2 0.3 0.3 0.5 0.4 
33 I 53668 S.Chinu raj 51/M 1.0 0.9 0.3 1.1 0.7 0.8 
34 J 12488 D.Senthil raj 41/M 0.9 0.9 0.3 0.7 0.6 0.7 
35 J 30741 G.Muthukumar 36/M 1.0 1.1 1.1 1.2 0.7 0.7 
36 G 25851 G.Balamurugan 37/M 0.8 0.3 0.6 0.3 0.6 0.4 
37 K 06255 N.Hari 31/M 0.6 1.1 0.3 1.1 0.4 0.6 
38 J 95136 K.Murugesan 52/M 0.2 0.5 0.2 0.5 0.3 1.2 
39 K 10016 C.Vijayalakshmi 27/F 0.4 0.6 0.2 0.3 0.2 0.7 
40 K 19342 J.Sridevi 34/F 0.3 0.7 0.2 0.1 0.5 0.7 
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SI. 
NO 
 
 
 
IP/OP 
NO 
 
NAME 
 
AGE/ 
SEX 
 
FASTING 
(mg/dl) 
 
POST 
PRANDIAL 
(mg/dl) 
 
UREA 
(mg/dl) 
 
CREATININE 
(mg/dl) 
BT AT BT AT BT AT BT AT 
1 IP 9905 E.Arokkiyasamy 36/M 94 97 110 112 11 12 1.2 1.1 
2 IP 0067-18 R.Kumari 39/F 95 91 102 104 24 20 1.1 1.0 
3 IP 0244-18 S.Shanthi 52/F 104 103 130 131 17 16 0.8 0.9 
4 IP 0284-18 K.Banumathy 42/F 87 107 97 120 12 11 0.7 0.6 
5 IP 0286-18 A.Reginamary 46/F 100 120 100 118 10 13 0.7 0.8 
6 IP 01314-18 K.Maragatham 23/F 87 90 92 101 13 14 0.8 0.9 
7 IP 0344-18 E.Sivaprakasam 56/M 104 114 128 129 11 15 0.9 1.1 
8 IP 0398-18 U.Sivarajan 26/M 98 99 110 117 14 15 0.6 0.5 
9 IP 0440-18 K.Philips 58/M 81 89 112 120 14 19 1.0 1.1 
10 1P0412-18 Magendran 40/M 86 88 121 129 13 14 0.7 0.6 
11 IP 0445-18 R.Suganya 27/F 83 100 90 108 13 17 0.7 0.8 
12 I 69878 P.Neela 49/F 94 117 99 119 41 40 1.1 1.0 
13 I 77988 M.Kannan 38/M 85 100 98 115 12 16 1.0 0.6 
14 J 34545 R.Rajkumar 29/M 80 93 74 124 14 16 1.0 1.2 
15 J 48749 M.Syedvasim 23/M 99 104 89 129 13 14 1.4 1.1 
16 J 13057 M.Ravi 42/M 85 114 98 108 22 16 1.4 1.3 
17 I 87056 R.N.Muthukrishnan 41/M 89 105 88 106 24 22 1.0 0.6 
18 J 62036 A.Suhasiny 23/F 93 99 87 115 18 26 0.9 1.2 
19 I 97780 P.Banumathy 41/F 94 142 93 160 21 19 0.7 0.8 
20 J 81528 I.Farookbasha 35/M 89 135 90 139 20 17 0.9 0.8 
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SI. 
NO 
 
 
IP/OP 
NO 
 
NAME 
 
AGE/ 
SEX 
 
FASTING 
(mg/dl) 
 
POST 
PRANDIAL
(mg/dl) 
 
UREA 
(mg/dl) 
 
 
CREATININE 
(mg/dl) 
 
BT 
 
AT 
 
BT 
 
AT 
 
BT 
 
AT 
 
BT 
 
AT 
21 J 87800 C.Gurumoorthy 28/M 102 130 110 135 14 20 1.0 1.0 
22 J 67522 M.M. Jainudeen 29/M 84 106 95 106 16 17 1.0 1.0 
23 I 31536 V.Deivanayagi 42/F 77 94 88 120 26 40 1.1 0.8 
24 J 91152 M.Beerjamel 45/M 91 100 96 117 11 13 0.9 0.9 
25 J 81580 E.Ramesh 28/M 99 106 98 120 16 20 1.2 1.2 
26 G 00139 M.Sampath 47/M 77 121 98 129 24 23 1.2 1.1 
27 J 54269 S.Rigana 26/F 82 132 99 134 21 23 0.7 0.9 
28 J 77788 M.Ramachandran 43/M 98 105 97 135 23 19 0.9 0.7 
29 J 86400 N.Gopi 37/M 95 111 98 123 11 20 0.9 0.7 
30 K 02675 K.Narasimman 50/M 103 133 112 139 18 23 0.8 1.2 
31 K 04682 A.Raguman 28/M 91 112 98 120 13 20 1.0 1.1 
32 J 65921 S.Prakasam 46/M 85 129 98 112 14 17 1.0 0.9 
33 I 53668 S.Chinu raj 51/M 110 130 98 120 13 32 0.9 1.1 
34 J 12488 D.Senthil raj 41/M 115 130 110 135 13 14 0.9 0.7 
35 J 30741 G.Muthukumar 36/M 89 127 98 132 28 33 1.1 1.2 
36 G 25851 G.Balamurugan 37/M 100 135 98 138 10 17 1.0 1.2 
37 K 06255 N.Hari 31/M 107 129 89 130 15 18 1.0 0.8 
38 J 95136 K.Murugesan 52/M 94 138 93 135 20 17 1.1 1.2 
39 K 10016 C.Vijayalakshmi 27/F 98 135 89 134 20 28 0.9 0.9 
40 K 19342 J.Sridevi 34/F 82 123 90 130 17 22 0.9 1.1 
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SI. 
NO 
 
 
 
IP/OP 
NO  
 
NAME 
 
AGE/ 
SEX 
 
URINE 
SUGAR 
(F) 
 
URINE 
SUGAR 
  (PP) 
  
ALBUMIN 
 
DEPOSITS 
Epithelial 
    cells 
Pus  
cells  
BT AT BT AT BT AT BT AT BT AT 
1 IP 9905 E.Arokkiyasamy 36/M NIL NIL NIL NIL NIL NIL 2-4 2-3 2-4 1-2 
2 IP 0067-18 R.Kumari 39/F NIL NIL NIL NIL NIL NIL 2-3 1-2 1-2 0 
3 IP 0244-18 S.Shanthi 52/F NIL NIL NIL NIL NIL NIL 3-5 2-3 1-3 1-2 
4 IP 0284-18 K.Banumathy 42/F NIL NIL NIL NIL NIL NIL 3-5 1-2 1-2 1-2 
5 IP 0286-18 A.Reginamary 46/F NIL NIL NIL NIL NIL NIL 2-3 1-2 1-2 0 
6 IP 01314-18 K.Banumathy 23/F NIL NIL NIL NIL NIL NIL 3-4 2-3 1-2 1-2 
7 IP 0344-18 E.Sivaprakasam 56/M NIL NIL NIL NIL NIL NIL 2-3 1-2 1-2 0 
8 IP 0398-18 U.Sivarajan 26/M NIL NIL NIL NIL NIL NIL 2-4 2-3 1-2 1-3 
9 IP 0440-18 K.Philips 58/M NIL NIL NIL NIL NIL NIL 2-4 2-4 2-3 1-3 
10 IP0412-18 Magendran 40/M NIL NIL NIL NIL NIL NIL 2-3 1-2 2-3 1-3 
11 IP 0445-18 R.Suganya 27/F NIL NIL NIL NIL NIL NIL 2-3 2-3 1-2 0 
12 I 69878 P.Neela 49/F NIL NIL NIL NIL NIL NIL 3-6 2-4 1-2 2-4 
13 I 77988 M.Kannan 38/M NIL NIL NIL NIL NIL NIL 2-3 3-4 1-2 2-3 
14 J 34545 R.Rajkumar 29/M NIL NIL NIL NIL NIL NIL 2-4 2-3 1-2 1-2 
15 J 48749 M.Syedvasim 23/M NIL NIL NIL NIL NIL NIL 2-3 1-2 2-4 1-2 
16 J 13057 M.Ravi 42/M NIL NIL NIL NIL NIL NIL 2-4 1-3 1-2 1-2 
17 I 87056 R.N.Muthukrishnan 41/M NIL NIL NIL NIL NIL NIL 2-3 2-3 1-2 1-3 
18 J 62036 A.Suhasiny 23/F NIL NIL NIL NIL NIL NIL 2-4 2-3 2-3 1-2 
19 I 97780 P.Banumathy 41/F NIL NIL NIL NIL NIL NIL 2-5 1-2 1-2 1-2 
20 J 81528 I.Farookbasha 35/M NIL NIL NIL NIL NIL NIL 2-3 1-3 1-2 1-2 
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SI. 
NO 
 
 
IP/OP 
NO 
 
 
NAME 
 
AGE/ 
SEX 
 
URINE 
SUGAR(F) 
 
 
URINE 
SUGAR 
(PP) 
 
 
ALBUMIN 
 
DEPOSITS 
Epithelial 
cells 
Pus cells 
BT AT BT AT BT AT BT AT 
21 J 87800 C.Gurumoorthy 28/M NIL NIL NIL NIL NIL NIL 1-2 1-3 1-2 1-2 
22 J 67522 M.M. Jainudeen 29/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-3 1-2 
23 I 31536 V.Deivanayagi 42/F NIL NIL NIL NIL NIL NIL 1-3 1-4 1-3 1-2 
24 J 91152 M.Beerjamel 45/M NIL NIL NIL NIL NIL NIL 1-4 1-3 1-4 1-2 
25 J 81580 E.Ramesh 28/M NIL NIL NIL NIL NIL NIL 1-3 1-4 1-3 1-2 
26 G 00139 M.Sampath 47/M NIL NIL NIL NIL NIL NIL 1-3 1-4 1-3 1-2 
27 J 54269 S.Rigana 26/F NIL NIL NIL NIL NIL NIL 1-4 1-3 1-2 1-2 
28 J 77788 M.Ramachandran 43/M NIL NIL NIL NIL NIL NIL 1-3 1-4 1-2 0 
29 J 86400 N.Gopi 37/M NIL NIL NIL NIL NIL NIL 1-3 1-3 1-3 1-2 
30 K 02675 K.Narasimman 50/M NIL NIL NIL NIL NIL NIL 1-3 1-3 1-4 1-2 
31 K 04682 A.Raguman 28/M NIL NIL NIL NIL NIL NIL 1-4 1-5 1-2 1-2 
32 J 65921 S.Prakasam 46/M NIL NIL NIL NIL NIL NIL 1-4 1-2 1-2 1-2 
33 I 53668 S.Chinu raj 51/M NIL NIL NIL NIL NIL NIL 1-4 1-2 1-2 0 
34 J 12488 D.Senthil raj 41/M NIL NIL NIL NIL NIL NIL 1-4 1-2 1-4 1-3 
35 J 30741 G.Muthukumar 36/M NIL NIL NIL NIL NIL NIL 1-5 1-4 1-2 1-2 
36 G 25851 G.Balamurugan 37/M NIL NIL NIL NIL NIL NIL 1-3 1-3 1-3 1-3 
37 K 06255 N.Hari 31/M NIL NIL NIL NIL NIL NIL 1-4 1-3 1-4 1-3 
38 J 95136 K.Murugesan 52/M NIL NIL NIL NIL NIL NIL 1-4 1-2 1-3 1-2 
39 K 10016 C.Vijayalakshmi 27/F NIL NIL NIL NIL NIL NIL 1-4 1-3 1-4 1-2 
40 K 19342 J.Sridevi 34/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-3 1-2 
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DISCUSSION 
The purpose of this trial is to evaluate the efficacy of the Siddha herbal formulation 
Parangipattai  Chooranam  Sangamver  Thylam  
treatment of Kaalanjakapadai (Psoriasis). 
 
Kaalanjakapadai (Psoriasis) is one of the commonest Skin disorder seen in day to day 
dermatological practice. It is chronic, inflammatory and proliferative skin disease with scaling 
and itching. Even though, Kaalanjagapadai is non-contagious disease, the affected patients 
with self  consciousness, frustruation and excommunication from the family/society shame, 
often leading to severe mental depression. Remissions and relapse of this disease is quite 
common and there is no specific treatment available in other systems of medicine. However 
encouraging results are obtained in our Siddha system. With this background the disease 
Kaalanjaga padai was chosen for the dissertation work. 
 
Based on various criteria, the data were collected and tabulated. The criteria were age 
distribution, sex predominance, family history, dietary habits and incidence of the disease with 
reference to thinai, seasonal variation, clinical manifestations and assessment of the 
improvement in the prognosis of the disease with the trial drug. 
 
The trial drug was prepared in Gunapadam lab of National Institute of Siddha after the 
authentication of the raw drugs by Assistant professor of medicinal botany NIS Chennai. 
 
The Biochemical, study of the trial drug was done and the results were documented. The 
Bio-chemical analysis of Parangipattai Chooranam had shown the presence of Sulphate, 
Chloride, Carbonate, Iron, Calcium, Potassium, Phosphate, Reducing Sugar, Starch and 
Alkaloids, Preliminary phytochemical screening test was carried out for each extracts of 
Parangipattai chooranam in standard procedure had reveals the presence of Carbohydrates, 
Glycoside, Saponin, Flavonoids, Protein and Amino acids, Diterpenes, and Quinones and 
Physiochemical analysis results had shown, Loss on drying is 2.83%, Total ash value is 3.14%, 
Acid insoluble ash is less than 1%, Water soluble ash is 1.12%. Water soluble extraction is 
47.75%, Alcohol soluble extraction is 12.74%. 
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The Clinical study was conducted with well-defined protocol and a proper Proforma 
after the approval of Institutional Ethical Committee. For this dissertation study, 40 patients 
were selected, 29 patients were treated in the Outpatient department of Sirappu Maruthuvam 
and 11 patients were admitted in the IP department of Sirappu Maruthuvam, in Ayothidoss 
Pandithar Hospital - National Institute of Siddha, Tambaram Sanatorium, Chennai  600 047. 
 
In Siddha System, the first day of treatment is necessary to balancing the vitiated 
kutram. Hence a Meganatha kuligai 2 tablet with Hot water was given for Viresanam 
(Purgation) in the early morning to normalize the vitiated vaatha kutram. During the treatment, 
the patients were advised to follow pathiyam (Dietary regimen). 
 
Internal Drug: Parangipattai chooranam- 2 gm b.d with warm water . 
 
External Drug: Sangamver thylam- q.s for external application. 
 
40 patients of both genders were recruited for this study. Among the 40 cases, 27(67.5%) were 
males and 13(32.5%) were females. Generally Kaalanjaga padai occurs with almost equal 
frequency in males and females. In this study, more number of Male cases was reported. 
 
In this trial 40 cases were selected. Among 40 patients 13 (32.5%) patients between 41 
and 50 years, 11 (27.5%) patients between 20 and 30 years, 10 (25%) patients between 31 and 
40 years, 6 (15%) patients between 51 and 60 years. In this present study, considerable 
numbers of patients were reported (13 patients) between the age of 41-50 among study sample. 
 
Among 40 cases recruited to this study, 1 (2.5%) patient had family history of psoriasis. 
Recent studies regarding psoriasis also emphasize on this concept that psoriasis has a genetic 
predisposition. 
 
In this study only 1(2.5%) patients was vegetarian, and remaining 39(97.5%) patients 
were non vegetarian 
In this present study, considerable numbers of patients were reported from neithal
(62.5%), and marutham (37.5%). 
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Highest number of patients 23(57.5%) were admitted during Pinpani Kaalam (Maasi -
Panguni) and 14 patients (35%) were admitted during Munpani kaalam (Maagazhi-Thai), 
remaining 3 patients were affected in Kaar kaalam (Aavani purattasi). 
 
Most of the patients 15 (37.5%) were affected in duration of 4 -6 years, 13(32.5%) were 
affected by the illness from 1 -3 years, 6 (15%) were affected from above 10 years. 5(12.5%) 
were affected from 10 -12 years, 1(2.5%) were affected from 7 -9 years. 
 
Out of 40 patients (100%) patients had clinical features of Scaling, Auspitz sign positive, 
Candle grease sign positive, 31(77.5%) patient had Itching, 10 (25%) had fissure, 7(17.5%) had 
Nail changes, 6(15%) had Oozing, 5(12.5%) had Koebner s phenomenon, 3(7.5%) had 
Lichenification, 2 ( 5%) had palm and sole lesions. 
 
Among 40 cases, all cases had itching and scaling which were markedly reduced after the 
treatment. 
 
The outcome of this study was clinically observed by PASI Score, which showed 
encouraging results of good improvement in 21 patients (52.5%), moderate improvement in 13 
patients (32.5%), and mild improvement in 6 (15%) of total 40 cases. 
 
In this study, no adverse events were observed during the course of the treatment. At 
the time of discharge, all the patients were advised to attend Out-Patient Department of 
Sirappu Maruthuvam of NIS for 6 months further follow-up treatment. 
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SUMMARY 
 
The disease Kaalanjaga padai was taken for the clinical study with Parangipattai
Chooranam as internal medicine and Sangamver Thylam as external application. For the
clinical study, 40 cases were selected based on the approved protocol. 
 
The trial was approved by the Institutional Ethical Committee (IEC) (Date of IEC
Approval & its Number:NIS/IEC/2016/11/16/14.10.2016). The trial was registered in
Clinical Trial Registry of India (CTRI REF/2018/02/017568) Hence the study is safely 
executed on patients and there was no adverse drug reactions noted during the study 
period. 
 
The detailed study on Kaalanjaga padai with reference to its aetiology,          
pathogenesis, investigations, clinical features, diagnosis and treatment with trial drugs was 
done. 
 
The outcome results of my study was clinically observed by PASI SCORE that is 
52.5% of cases had shown good improvement, 32.5% of cases had shown moderate 
improvement and remaining 15% of cases had shown mild improvement. 
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CONCLUSION 
 
This clinical study validated the Siddha herbal formulation of the trial drug 
psoriatic population. It was found to be
good resulting on Kaalanjaga padi patients in reducing clinical signs and symptoms like 
itching, scaling and erythema. The literature evidence for this drug is Agasthiyar
paripooranam -400 which is well-known Shasthric preparation 
 
In this study, no adverse reactions were reported. Hence, it is concluded that the trial 
drugs are clinically safe. 
 
The cost of the trial medicines is low. These drugs are easily available and the 
dosage is also convenient. 
 
The quantitative outcome of PASI score shows there is extremely significant 
reduction between at the commencement and end of the treatment i.e from 53.14±10.05 and 
19.08±14.05 The qualitative outcome shows there is 52.5% of cases shown good 
improvement, 32.5% of cases shown moderate improvement and 15% shown mild 
improvement. The clinical trial conducted in selected patients was very much satisfactory 
and the results were encouraging. 
 
Parangipattai
chooranam (External) are well responded in the
treatment of Kaalanjaga padai. 
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(external medicine) in the treatment of Kaalanjaga padai (Psoriasis)
Secondary IDs if Any Secondary ID Identifier
NIL NIL
Details of Principal
Investigator or overall
Trial Coordinator
(multi-center study)
Details of Principal Investigator
Name Ms Lalitha Sivasankaran
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600 047. 
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS 
 (EXTERNAL) IN THE TREATMENT OF   
 (PSORIASIS) 
Principal Investigator: Dr. S. LALITHA                                                              
 
FORM I - SCREENING & SELECTION PROFORMA 
 
1. SERIAL NO:      2. OP /IP NO:                              
3. NAME:            4. AGE/GENDER:    
5. OCCUPATION:           6. INCOME:  
 
INCLUSION CRITERIA 
 Erythema         YES\ NO 
 Thickness                YES\ NO  
 Scaling         YES\ NO 
 Itching :with or without itching      YES\ NO 
 Auspitz sign +        YES\ NO 
 Candle crease sign +       YES\ NO 
 Age : 20-60 years        YES\ NO 
 Sex : Both male and female      YES\ NO 
 Willing to attend OPD or admission in IPD for the trial   YES\ NO 
 Willing to give specimen of blood for the investigation   YES\ NO 
 Willingness for consent       YES\ NO 
 Willing to take photograph before and after treatment.            YES\ NO 
 
EXCLUSION CRITERIA 
 Diabetes Mellitus        YES\ NO 
 Pregnancy and lactation       YES\ NO 
 Psoriasis with evidence of any other skin disease  YES\ NO 
 Psoriatic arthropathy       YES\ NO 
 Cardiac disease        YES\ NO 
         YES\ NO 
 Evidences of secondary infection in the lesions    YES\ NO 
 Any other chronic illness                                YES\ NO 
 
ADMITTED TO TRAIL 
YES  NO  
If Yes, 
OPD 
 IPD  
  Serial NO:  
Date:        
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                           Signature of the HOD   
DEPARTMENT OF SIRAPPU MARUTHUVAM 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600 047. 
 
 
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS 
 (EXTERNAL) IN THE TREATMENT OF   
 (PSORIASIS) 
Principal Investigator: Dr.S.LALITHA.                                                              
 
FORM II-A  HISTORY TAKING PROFORMA 
 
STUDY  NO:   OP / IP NO: 
NAME: AGE / GENDER: 
ADDRESS: CONTACT NO : 
 RELIGION :  H / C / M / O. 
OCCUPATION: INCOME: 
MARITAL STATUS :       1. Married 2. Unmarried 
DATE OF INTIAL ASSESSMENT:  
COMPLAINTS & DURATION:   
 
 
 
                                             
PERSONAL HISTORY: 
PERSONAL HABITS YES NO 
IF YES 
SPECIFY 
DURATION 
AMOUNT/Qty 
Smoking     
Tobacco Chewing     
Alcohol     
Narcotic  Drug Addiction     
  
HISTORY OF PREVIOUS ILLNESS AND TREATMENT TAKEN: 
 
 
FAMILY HISTORY:  
Whether this problem runs in family? 1. Yes            2. No    
If yes, mention the relationship of affected 
person(s) 
1._________________ 
 
2._________________ 
 
 
 
 
1. Vegetarian    2. Non-vegetarian 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
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DIETARY STYLE: 
 
FORM II B 
GENERAL EXAMINATION: 
1. Body weight [Kg]    :                      
2. Height [cms]                       :                        
3. Body Temperature [F]       :   
4. Blood Pressure (mm/Hg)  :      
5. Pulse Rate /min.        : 
6. Heart Rate / min.         : 
7. Respiratory Rate /min.  :   
                                                                                  Yes            No   
8. Pallor   :   
9. Jaundice   :   
10. Clubbing   : 
11. Cyanosis   : 
12. Pedal Oedema   : 
13. Lymphadenopathy            :                                        
14. Jugular venous pulsation   :   
SYSTEMIC EXAMINATION 
  Cardiovascular system  :  
  Respiratory system   :  
  Gastro-intestinal system  :  
  Central Nervous system  :  
  Urogenital system   :  
  Endocrine system             :  
 
SIDDHA SYSTEM OF EXAMINATION 
1. THEGI (BODY CONSTITUTION): 
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji (Hilly terrain) 
2. Mullai (Forest range) 
3. Marutham (Plains) 
4. Neithal (Coastal belt) 
5. Paalai (Aridregion) 
3. KAALAM: 
1. Kaar kaalam    (Aavani-Purattasi) 
2. Koothir kaalam     (Ippasi-Kaarthigai) 
3. Munpani kaalam     (Maargazhi-Thai) 
4. Pinpani kaalam       (Maasi-Panguni) 
5. Ilavenil kaalam        (Chithirai-Vaigasi) 
6. Muthuvenil kaalam (Aani-Aadi) 
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4. GUNAM: 
1. Sathuvam  
2. Rasatham 
3. Thamasam 
 
5. PORIPULANGAL (SENSORY ORGANS):          
                  
  
 
 
 
 
 
 
 
6.KANMENDRIYAM (MOTOR ORGANS) : 
        
 
 
 
 
 
 
 
7.KOSANGAL (SHEATH):                
 
 
 
 
 
 
  
   
 
8. SEVEN UDAL THAATHUKKAL (SEVEN SOMATIC COMPONENTS) 
 
Before treatment After treatment 
Saaram Normal  /Affected Normal  /Affected 
Senneer  Normal  /Affected Normal  /Affected 
Oon Normal  /Affected Normal  /Affected 
Kozhuppu Normal  /Affected Normal  /Affected 
Enbu Normal  /Affected Normal  /Affected 
Moolai Normal  /Affected Normal  /Affected 
Sukkilam / Suronitham Normal  /Affected Normal  /Affected 
 
 Before treatment After treatment 
Mei (Skin) Normal  / Affected Normal  / Affected 
Vai (Tongue) Normal  / Affected Normal  / Affected 
Kann (Eye) Normal  / Affected Normal  / Affected 
Mooku (Nose) Normal  / Affected Normal  / Affected 
Sevi (Ear) Normal  / Affected Normal  / Affected 
 Before treatment After treatment 
Kai(Upper limb)  Normal  /Affected Normal  /Affected 
Kaal (Lower limb) Normal  /Affected Normal  /Affected 
Vai (Oral cavity) Normal  /Affected Normal  /Affected 
Eruvai (Anal region) Normal  /Affected Normal  /Affected 
Karuvai (Uro-
Genital region) 
Normal  /Affected Normal  /Affected 
Before treatment After treatment 
Annamaya kosam Normal  /Affected Normal  /Affected 
Pranamaya kosam  Normal  /Affected Normal  /Affected 
Manomaya kosam  Normal  /Affected Normal  /Affected 
Vignanamaya kosam  Normal  /Affected Normal  /Affected 
Ananthamaya kosam Normal  /Affected Normal  /Affected 
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9. UYIR THAATHUKKAL: [THREE HUMORS] (VALI/ AZHAL/ IYYAM) 
 
A) VALI 
 
 1th day 8
th 
day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 49
th day
Praanan        
Abaanan        
Samaanan        
Udhaanan        
Viyaanan        
Naagan        
Koorman         
Kirukaran        
Devathathan        
Dhananjeyan        
 
 
B) AZHAL 
 
 1th day 8th day 15th day 22
nd 
day 
29th 
day 36
thday 43
rd 
day 
49th 
day 
Analakam         
Ranjakam          
Saathakam          
Prasakam          
Aalosakam         
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C) IYYAM 
 
 1
th 
day 
8th 
day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 49
th day 
Avalambagam        
Kilethagam        
Pothagam        
Tharpagam        
Santhigam        
 
 
10. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 
I. NAADI: [PULSE PERCEPTION] 
 
NAADI 1
th  
day 8
th day 15
th 
day 
22ndd
ay 29
thday 36
th  
day 43
rdday 49th day 
        
 
II. SPARISAM: [PALPATION] 
 
Day SPARISAM 
1th  day  
8th day  
15th  day  
22nd  day  
29th  day  
36th  day  
43rd day  
49th day  
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III. NAA: [TONGUE] 
 
NAA 1thday 8thday 15
th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 49
th day 
        
 
 
 
IV. NIRAM: [COMPLEXION]   
    1. Vadham         
     2. Pitham 
      3. Kabam  
 
V. MOZHI: [VOICE] 
      1. High Pitched 
      2. Low Pitched 
      3. Medium Pitched 
 
VI.VIZHI: [EYES] 
VIZHI 1th  day 8th day 15thday 22ndday 29thday 36th  day 43rdday 49thday 
        
 
VII. MALAM: [BOWEL HABITS / STOOLS] 
 Before treatment After treatment 
Niram   
Irugal   
Ilagal   
Others   
 
VIII. MOOTHIRAM [URINE EXAMINATION]  
NEERKKURI: 
Neerkkuri Before treatment After treatment 
Niram   
Manam   
Edai   
Nurai   
Enjal   
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NEIKKURI:  
 
Neikkuri Before treatment After treatment
 Aravana needathu/ 
Snake like pattern 
  
Azhipol paraviyathu 
Annular/Ringedpattern 
  
Muththothu ninrathu  
Pearlbeadepattern 
  
Other patterns   
 
 
12. CLINICAL EXAMINATION:        
           
   CLINICAL EXAMINATION OF SKIN 
 
1.Site 
2.Shape      :        Coin shape                Irregular                  Dispersed  
3. Erythema:     Present     Absent 
4. Macule              :   
5. Papule               : 
6. Pustule              :  
7. Itching:     No            Mild                  Moderate                 Severe 
8. Scaling:     Mild                    Moderate                 Severe 
9.Fissures           Present                      Absent 
10.Oozing:          No          Mild                  Moderate                
Severe          
11.Lichenification:   Present                      Absent 
12. Auspitz sign      :  Present               Absent 
13.  Present               Absent 
14. Candle grease sign: Present               Absent 
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EXAMINATION OF NAILS: 
1.  Pitting:     Present    Absent 
2   Thickening:    Present                  Absent 
3.  Collection of Hyperkeratotic debris: Present                Absent 
4.  Separation of distal portion of nail: Present                Absent 
 
  EXAMINATION OF JOINTS: 
                      YES                            
NO 
                          Joint Involvement    
           
    
 
 
PSORIASIS AREA AND SEVERITY INDEX (PASI) 
       A Psoriasis Area and Severity Index (PASI) is a quantitative rating 
scale for measuring the severity of psoriatic lesions based on area 
coverage and plaque appearance 
 
Erythema / Thickness / Scaling-Rating score     Area Scoring 
0 - None      0-Nil   
1- Slight      1-1-9% 
2- Moderate      2- 10%-29% 
3-Severe      3-30%-49% 
4-Very severe      4-50%-69% 
        5-70%-89% 
        6-90%-100% 
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                                        PASI CALCULATION 
Plaque Characteristic Rating Score 
Body region and weighting factor
Head 
Upper 
Limbs 
Trunk 
Lower 
Limbs 
Erythema  0 = None         
Thickness 
1 = Slight 
        
2 = Moderate 
Scaling 
3 = Severe 
        
4 = Very Severe 
      Totals     
Weighting Factor 
    x 
0.1 
   x 0.2   x 0.3    x 0.4 
Surface area totals     
  
Degree of involvement as  
% for each body region  
affected (score each  
region between 0 and 6) 
0 = None 
    
1 = 1-9% 
2 = 10-29% 
3 = 30-49% 
4 = 50-69% 
5 = 70-89% 
6 = 90-100% 
Surface area totals x % involvement totals 
Sum Scores above = 
    
 Add together each of Erythema/Thickness/Scaling scores for each of the body regions 
to give 4 separate sub totals A1, A2, A3 and A4 
 Multiply each subtotal by amount of body surface area represented by that region i.e. 
A1 x 0.1 for head, A2 x 0.2 for upper limbs, A3 x 0.3 for trunk, A4 x 0.4 for lower 
limbs to give a value B1, B2, B3 and B4 for each body region respectively. A1 x 
0.1=B1;   A2 x 0.2=B2; A3 x0.3=B3; A4 x 0.4=B4 
 For each body region multiply subtotal B1, B2, B3 and B4 by the score(0-6) of the % 
of body region involved to give 4 sub totals C1, C2, C3 and C4 
  
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                           Signature of the HOD 
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DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS 
 (EXTERNAL) IN THE TREATMENT OF   
 (PSORIASIS) 
Principal Investigator: Dr.S.LALITHA 
 1. SERIAL NO:       
2. OP /IP NO:                              
3. NAME:             
4. AGE/GENDER: 
                                         FORM-III - LABORATORY INVESTIGATIONS 
 
BLOOD INVESTIGATIONS NORMAL VALUES 
BEFORE TMT 
( DATE) 
AFTER TMT 
(DATE) 
Hb (gm/dl) M:12-15 W:11.5-12   
T.WBC (cells/cu.mm) 4000-11000   
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-40   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
 
T.RBC (million cells / cu.mm) 
 
M:4.0-5.5 
W:3.5-4.5 
 
 
 
 
ESR (mm/hour) ½ hr. M:6-12 
W:7-18 
  
  1 hr.    
Blood glucose 
(mg/dl) 
Fasting 70-110   
PP 80-140   
Random 80-120   
RFT (mg/dl) 
Blood urea 16-50   
Serum Creatinine 0.6-1.2   
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LFT (mg/dl) 
Total bilirubin 0.2-1.2   
Direct bilirubin 0.1-1.2   
Indirect bilirubin 0.2-0.7   
SGOT 0-40   
SGPT 0-35   
Alkaline 
phosphatise 80-290   
 
 
 
 
 
 
 
 
 
 
 
 
 
Date:          
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URINE INVESTIGATION BEFORE TMT( DATE) AFTER TMT ( DATE)
Albumin   
Fasting sugar   
PP sugar   
Deposits   
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DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
 AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS 
 (EXTERNAL) IN THE TREATMENT OF   
 (PSORIASIS) 
Name of Principal Investigator: Dr.S.LALITHA        
FORM IV- DRUG COMPLIANCE FORM 
SERIAL NO: 
NAME:  
DRUG NAME:  
 
On 1st     day-Date:  Drugs issued: (Gms) Drugs returned:    (Gms) 
On 8th   day-Date:   Drugs issued: (Gms) Drugs returned:    (Gms) 
On 15th day-Date:              Drugs issued: (Gms) Drugs returned:    (Gms) 
On 22th day-Date:           Drugs issued: (Gms) Drugs returned:    (Gms) 
On 29th day-Date:             Drugs issued: (Gms) Drugs returned:    (Gms) 
On 36th day-Date:              Drugs issued: (Gms) Drugs returned:    (Gms) 
On 42th day-Date:              Drugs issued: (Gms) Drugs returned:    (Gms) 
On 48th day-Date:              Drugs issued: (Gms) Drugs returned:    (Gms) 
 
   Day    Date          Morning   Evening   Day    Date    Morning   Evening 
Day 1    Day25    
Day2    Day26    
Day3    Day27    
Day4    Day28    
Day5    Day29    
Day6    Day30    
Day7    Day31    
Day8    Day32    
Day9    Day33    
Day10    Day34    
Day11    Day35    
Day12    Day36    
Day13    Day37    
Day14    Day38    
Day15    Day39    
Day16    Day40    
Day17    Day41    
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Date:          
Station: 
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Day18    Day42    
Day19    Day43    
Day20    Day44    
Day21    Day45    
Day22    Day46    
Day23    Day47    
Day24    Day48    
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DEPARTMENT OF SIRAPPU MARUTHUVAM 
. AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS 
C   (EXTERNAL) IN THE 
TREATMENT OF    (PSORIASIS) 
          FORM-V  INFORMATION SHEET 
Name of Principal Investigator  :  Dr.S.LALITHA 
Name of the institute                   : National Institute of Siddha, 
                                                      Tambaram Sanatorium, 
                                                       Chennai-47. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL: 
I, Dr.S.Lalitha Studying as M.D(Siddha) at National Institute of  Siddha, Tambaram 
Sanatorium is doing a trial on the study Kaalanjagapadai (Psoriasis). Psoriasis is a most 
common persistent skin disease, occurring throughout the world. In this regard, I am in a 
need to ask you few questions. I will maintain confidentiality of your comments and data 
obtained. There will be no risk of disclosing your identity and no physical, psychological or 
professional risk is involved by taking part in this study. Taking part in this study is 
voluntary. No compensation will be paid to you for taking part in this study. 
           You can choose not to take part. You can choose not to answer a specific question. 
There is no specific benefit for you if you take part in the study. However, taking part in the 
study may be of benefit to the community, as it may help us to understand the problem of 
defaulters and potential solutions. 
             If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal medicine 
parangipattai chooranam  (Internal medicine-2gm, Twice a Day with Palm Hot water for 48
days) and Sangam Ver Thylam (External medicine), if you wish to stay in the In Patient ward  
Treatment will be provided to you assuring that you will not be definitely hurt in any course 
of treatment. 
  The information I am collecting in this study will remain between you and the 
principal investigator (myself).  
            If you wish to find out more about this study before taking part, you can ask me all 
the questions you want or contact Dr.S.Lalitha, PG Scholar cum principal investigator of this 
study, attached to National Institute of Siddha, Chennai-47. You can also contact the 
Member-secretary of Ethics committee, National Institute Siddha,Chennai 600047, Tel no : 
91-44-22380789, for rights and participation in the study.  
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FORM-V  
hY1fh,`xd øyb( ya*÷ ya*4hW `]3h~,`0xd C]c+ 
øq% _K-P÷ _$F+ f3h+y[) xb\+øz[Y~ _K-P÷ f~.b _K-PhY~# 
`]~h]~,N. b~XxW4 h/dX~L+ _K.P[ t*[~$hW bh[( `V[+ò 
Mb#x_ t]*2f~^Y) z`^)  æ Ü®ò f~ò\\~b 
 
a~F[W.b~# z`^)             æ ybf~^ f~.b _K.P[ a~F[W+ô 
                             b+`]+ fW0yd]~^+ô zf#xWó ìéò 
 
    ybf~^ f~.b _K.P[ a~F[W.b~( `0d y_$`V,N `^~#F [K+ a#  
hY1fh,`xd o#E+ ybx\, `b~4T+ ya^~( _K.P[ t]*2f~^~( 
rR`0R%yY#ò  
 
    f~.b _K.P[.b~( hY1fh,`xd o#E+ ya^WP ybx\, `b~4T+ lK 
ya^T+ò "-b ya^~( yb\~( f~[,N a~X b~0RhxY n$`R.b~ ub~( zfb~( y`( 
qb~] zf*L+ f~\ f_^+ u]~,NdyW u(\P u]~,`~#X~y^ hc,`R+ò "P 
_$X[)hG4T, `][ DV^ ya* u(\ò "-b t]*2f~ f+_-b_h f~\ yh%[~hxY 
yh0hI+ô ybx\ `]~yfb~4hI+ô ybx[^W t*[h `]~yfbxW4T+ b3hxY 
q0`R.bI+ q%yY#ò 
 
    "-b t]*2f~4T b3h% [~K,`.b~# y`]~( q0`R+ `0f.b~( q%_K-bh 
`]3h~,`0xd C]c+  îh~ uYI uE`W.b~(z[-a})  î y[xY øhx\ _x\÷ 
qcI4T, `~# ìè a0hG4T q0zh%Y y[/R+ò z[Y~ _K-bh f3h+y[) 
xb\+ ìè a0hG4T yaL%Y "d3hY~( z[Y~y^ bd[ y[/R+òz[Y~ 
ya^Y)h% é a0hG4T lKMxX _K.P[_xW4T []y[/R+ò  
    "P f+`-b_W b3hYP uxW.P [~[]3hG+ ]hf~^_h x[4h,`R+ oW 
qFb~uY~4h~yX#ò "b~( `^c,`V Mb\~^ o-b qb[~ zbxhL+ [Z3h,`d 
_0dPò"-b t]*2f~^~# y`P qdJ4T y[F `b~,N n$`R+ `0f.b~( ybf~^ 
f~.b _K.P[_xW^~( b4h _$F f~h~2xf uY~4h,`R+ò "-b t]*2f~^~( b3hxY 
q0`R.b~^ `~XT q3hG4T [~K,`_~(x\z^W~( o,y`P y[/R_WJ+ [~\h~ 
zh%Y MH q]~x_ q%YP 
 
    "-b t]*2f~ f+`-b_h _$X [~`]3hG4T+ ya^~# b#x_ `$X~L+ 
Mb#x_ 
t]*2f~^Y]W Ü®ò f~ò\\~b `0d y_$ `V,`Y) f~X,N _K.P[ `~]~I uQhI+ò 
xh,y`f~ o/æçèìïéîçèçë 
y_J+ "-b t]*2f~4T ×ÛÝ f#F z`X,`0R%YPò   
 
  "-b _K-P hYfh,`xd ya*4hh f~.b _K.P[.b~( DX,`0R%YPò  
n$hWy[ q`y^h.b~( q%Y "P y`#X _K-P "P[x] ya^Y~hY~d+ o-b[~b  
`4h [~xYIhxYL+ n$`R.b[~(x\ò y_J+ qcI MxX^~( h.b]~ô `h(ô h],`#  
`/d3h%ô q,Nô NY~,N Mb\~^x[hxY b[~).P `.b~^+ h4T_F 
uX~IF.b,`Rh~XP      
 168 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600 047. 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS 
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Name of Principal Investigator: Dr.S.Lalitha      
 
FORM-VI  CONSENT FORM 
 
I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions I have asked have been answered 
to my satisfaction.  
            I consent voluntarily to participate as a participant in this study and understand 
that I have the   right to withdraw from the study at any time without in any way it 
affecting my further medical care . 
 
"I have received a copy of the information sheet/consent form". 
 
Date:  
Signature of the participant 
In case of illiterate participant 
 
        I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm 
individual has given consent freely  
 
 
Date: 
 
 
 
Signature of a witness  
(Selected by the participant bearing no connection with the survey team)   
       
          
            
 
 
 
    Left thumb Impression of the Participant 
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 DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS 
 (EXTERNAL) IN THE TREATMENT OF   
 (PSORIASIS) 
. 
Name of Principal Investigator: Dr.S.LALITHA      
 
FORM VII - WITHDRAWAL FORM 
 
1. SERIAL NO OF THE CASE:    
2. OP / IP NO:     
3. NAME:      
4. AGE:         
5. GENDER:                          
6. DATE OF TRIAL COMMENCEMENT:  
7. DATE OF WITHDRAWAL FROM TRIAL:  
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes/ No 
Irregular treatment:                           Yes/ No 
Shift of locality:                                     Yes/No 
Increase in severity of symptoms:     Yes/No 
Development of severe adverse drug reactions:   Yes/No 
Development of adverse event:                                              Yes/No 
(If YES, give the details of adverse reaction in Form VII -B  Adverse      
Reaction Form / Pharmaco Vigilance Form) 
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Name of Principal Investigator: Dr.S.LALITHA      
 
FORM VII - A  ADVERSE REACTION FORM / PHARMACO VIGILANCE FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                             AGE:                     GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF THE ADVERSE REACTION OCCUR: 
DESCRIPTION OF ADVERSE REACTION: 
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AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS  
(INTE  (EXTERNAL) IN THE TREATMENT OF   
 (PSORIASIS) 
 
Name of Principal Investigator:Dr.S.LALITHA   
 
FORM VIII  DIETARY ADVICE FORM 
 
 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
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